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Staphylococcus aureus (SA) is a worldwide distributed, opportunistic pathogen 
colonizing 25-30% of the human population mostly without signs of infections. 
However, if infections (e.g. wound-, organ infections, sepsis) occurs, those are often 
associated with a significant morbidity and mortality. SA possesses a broad range of 
pathogenicity-, virulence- and resistance factors, whose presence is partially 
associated with specific phylogenetic developmental lines. Thus, the evaluation of 
transmission of infections is essentially based on phylogenetic analytics. This requires 
the development of reproducible, highly discriminatory typing methods for distinction 
of different SA strains. Thus, reproducible, polymerase chain reaction and sequencing 
based methods such as spa (SA protein A)-typing, multilocus sequencing typing 
(MLST) up to whole genome sequencing were developed. In contrast to spa-typing 
which is based on the sequencing of the single gene spa, MLST is based on the 
sequencing of seven housekeeping genes defining different sequence types (STs) 
which can be clustered to clonal complexes (CC). STs and CCs are today the grid for 
the international SA nomenclature in epidemiologic studies. DNA microarrays (MA) 
represents a special technique in which ST and CC are deduced from characteristic 
hybridization patterns of numerous genloci which are compared to a database of a 
large strain collection. In addition to the phylogenetic analysis the DNA MA hold a large 
number of locis for adhesion, virulence, toxin and resistance genes and thus provide a 
large amount of data. Comparison of multiple isolates investigated by DMA MA thus, 
requires supplementary bioinformatic methods for interpretation and presentation. 
Overall, there are plenty of moleculargenetic based studies of infection epidemiology 
of SA. But, most of them referred to countries with a high level of microbiological 
diagnostic. For Africa there is only very limited epidemiological data on SA (inclusive 
methicillin-resistant SA [MRSA]) especially of non-nosocomial (this means not 
acquired in hospital) SA (e.g. community-associated (CA) methicillin-resistant or 
methicillin-susceptible SA [MRSA, MSSA]). In order to fill this knowledge gap, four 
studies were performed as basis for this doctoral thesis investigating a) different 
bioinformatic tools for analysis of the molecular epidemiology of SA, b) the 




institutions and c) the applicability of mass spectrometry for analysis of SA 
epidemiology. 
For characterization of the bioinformatic tools the subtyping potential of spa-typing 
versus DNA MA analysis were compared in a study with 46 nasal CA-MSSA and 46  
CA-MRSA of infections, collected in the federal state of Saarland. Further, the results 
were evaluated by three bioinformatic methods (splits graph, hierarchical 
agglomerative clustering [HAC] and principal component analysis [PCA]). Finally, in 
order to test the applicability of the DNA MA analytics in the African cohort, a relatively 
small cohort of isolates of 52 Nigerian MSSA was analyzed by DNA MA and splits 
graph method. 
In a big, multicentric, African-German, cross-sectional geographic comparative 
analysis, 1200 CA-SA isolates of healthy volunteers and patients of Sub-Saharan 
Africa and Germany were subsequently analyzed by DNA MA. In addition, association 
and comparative analyses of STs, CCs and gene composition of these isolates with 
respect to geographic (Germany or Africa) or clinical/nasal origin (nasal/asymptomatic 
or clinical/invasive) were performed. Finally, the potential applicability of identification 
of CCs or spa–types of CA-SA of CC5, CC8, CC15, CC30, CC45, CC121 and 
spa-types t002, t003, t504 based on their MALDI-TOF mass spectrometric profile, were 
also analyzed. 
Expected results on the epidemiology of CA-MRSA/MSSA were firstly gained by the 
DNA MA study of the federal state of Saarland, showing a higher subtyping potential 
of the DNA MA compared to spa-typing. Evaluation of the DNA MA data by the three 
previously mentioned bioinformatic methods yielded a diverse assignment of CC5 
isolates to 3 to 7 clusters with exception of 12 CC5 isolates that always clustered in 
two identical clusters. It does not make these methods a failure but the use of different 
mathematical algorithms analyzing hybridization pattern differences or similarities may 
lead to minor differences. Further, MSSA displayed a high degree of diversity in 
comparison to the CA-MRSA group, which was dominated by the CC5 Rhine-Hesse 
epidemic strain (89%).  
The further analysis of African MSSA of the study with Nigerian MSSA identified a 
heterogeneous and divergent nature of the examined Nigerian MSSA and confirmed 
that the DNA MA is a suitable genotyping method of African SA. The results of the 
multicentric consortium study showed a total of 40 different CCs and STs, including 5 




predominant in Sub-Saharan Africa (Gabon, Mozambique, Tanzania) (CC80, CC88, 
CC121, CC152) or Germany (CC22, CC30, CC45, CC398). The rate of MRSA carriers 
in the African (3%) and German populations (1%) were very low, probably because the 
investigation was limited to CA-SA. Analysis of gene profiles identified a high 
prevalence of the Panton-Valentine leukocidin encoding genes lukF/S-PV in African 
isolates. Generally, continent-specific differences for the CCs and the CA-SA gene 
profiles could be identified. Furthermore, it became apparent that in addition to the 
good first-line characterization by DNA MA, standardized, complex analytical methods 
for association and epidemiological analyses are required. 
The last investigation purpose, the evaluation of comparative mass spectra analysis 
showed that only SA of CC121 were correctly identified based on their mass 
spectrometric profile on the CC level, while no clear discrimination was achieved for 
other CCs or spa-types. 
Taken together, this work identified country specific differences in the distribution of 
CCs, and specific genes of the examined regions, especially concerning only clinical 
isolates. The work provide first clues to the genetic based reasons which may explain 
the purported difference in clinical presentation and course of diseases caused by SA.  
Additionally, it was shown that DNA MA in contrast to mass spectrometry is a suitable 
tool for SA characterization e.g. in outbreak situations. However, it should be noted 
that as specific requirement of a challenging DNA MA based phylogenetic analyses, 
application of complex bioinformatic analysis methods are required for interpretation of 
multiple isolates, and that the characteristics and algorithms of the chosen 
bioinformatic method may result in slight differences in the data interpretation. 
 Zusammenfassung 
Staphylococcus aureus (SA) ist ein weltweit verbreitetes, opportunistisches Pathogen, 
dass 25-30% der Bevölkerung häufig symptomfrei kolonisiert. Treten jedoch invasive 
Infektionen auf (z.B. Wund-, Organinfektion, Sepsis), so sind diese mit erheblicher 
Morbidität und Mortalität assoziiert. SA besitzt ein breites Spektrum an Pathogenitäts-, 
Virulenz- und Resistenzfaktoren, deren Vorhandensein teilweise mit besonderen 
phylogenetischen Entwicklungslinien assoziiert ist. So basiert die Bewertung von 
Infektionsübertragung und Ausbruchsgeschehen vielfach auch auf phylogenetischer 




die unterschiedlichen SA-Stämme auch ausreichend trennscharf charakterisieren 
können. Daher wurden reproduzierbare, einheitlich auswertbare 
Polymerasekettenreaktionen und Sequenzierungsmethoden wie spa (SA Protein A)-
Typisierung, Multilokussequenztypisierung (MLST), bis hin zur 
Gesamtgenomsequenzierung entwickelt. Im Gegensatz zur spa-Typisierung, 
basierend auf der Sequenzierung des einzelnen Gens spa, basiert die MLST auf der 
Sequenzierung von insgesamt sieben Haushaltsgenen, die verschiedene 
Sequenztypen (ST) definieren, welche zu klonalen Komplexen (CC) gruppiert werden. 
STs und CCs bilden heutzutage das Gerüst der internationalen SA Nomenklatur in 
epidemiologischen Studien. Eine besondere Technik stellen DNA Microarrays (MA) 
dar, mit deren Hilfe ST und CC aus charakteristischen Hybridisierungsmustern 
zahlreicher Genloci durch Vergleich mit einer Datenbank einer großen 
Stammsammlung abgeleitet werden. Neben dieser phylogenetischen Zuordnung 
besitzt der DNA MA zahlreiche Loci für Adhäsions-, Virulenz- und Toxingene und liefert 
daher eine große Masse an Daten. Der Vergleich zahlreicher, mittels DNA MA 
untersuchter, Isolate erfordert daher zur Interpretation und Präsentation ergänzende 
bioinformatische Methoden. 
Insgesamt gibt es für SA eine umfangreiche Studienlage zur molekulargenetisch 
typisierten Infektionsepidemiologie; überwiegend bezieht diese sich jedoch auf Länder 
mit einem hohen Standard mikrobieller Diagnostik. Für Afrika gibt es nur wenige 
molekular-epidemiologische Daten von SA (inklusive Methicillin-resistenter SA 
[MRSA]), insbesondere von nicht nosokomialen (d.h., nicht im Krankenhaus 
erworbenen) SA (wie z.B. ambulant erworbener (CA) Methicillin-resistenter oder -
empfindlicher SA [MRSA, MSSA]). Um diese Wissenslücke zu füllen, wurden als 
Grundlage dieser Promotionsarbeit vier Studien durchgeführt zur Untersuchung a)  
verschiedener bioinformatischer Werkzeuge zur Analyse der molekularen 
Epidemiologie von SA, b) der Epidemiologie von afrikanischen und deutschen CA-
MSSA/MRSA, die nicht in Gesundheitsinstitutionen erworben wurden, und c) der 
Anwendbarkeit der Massenspektrometrie zur Analyse der Epidemiologie von SA.  
Zur Charakterisierung der bioinformatischen Werkzeuge wurde das 
Subtypisierungspotential der spa-Typisierung und der DNA MA Analyse in einer Studie 
mit 46 nasalen CA-MSSA und 46 von Infektionen stammenden CA-MRSA des 
Bundeslandes Saarland verglichen. Zudem wurden die Ergebnisse mit drei 




[HAC] und Hauptkomponentenanalyse [PCA]) zur DNA Analyse evaluiert. Um die 
Anwendbarkeit der DNA MA Analytik auch in afrikanischen Kohorten zu überprüfen, 
wurde eine relativ kleine Isolatkohorte von 52 nigerianischen MSSA Isolaten mittels 
DNA MA und splits graph Analyse untersucht. In einer großen, multizentrischen, 
afrikanisch-deutschen, geographisch vergleichenden Querschnittsuntersuchung 
wurden 1200 CA-SA Isolate, gesunder Freiwilliger und von Patienten aus Sub-Sahara 
Afrika und Deutschland, mittels DNA MA analysiert. Zudem wurden Assoziations- und 
vergleichende Analysen der CC, ST und der Genausstattung der Isolate, hinsichtlich 
ihrer geographischen Herkunft (Deutschland oder Afrika) bzw. ihres 
klinischen/kommensalen Ursprung, durchgeführt. Schließlich wurde die mögliche 
Anwendbarkeit der Identifikation von CCs oder spa–Typen von CA-SA des CC5, CC8, 
CC15, CC30, CC45, CC121 und der spa- Typen t002, t003, t504 basierend auf MALDI-
TOF Massenspektrometrieprofilen analysiert. 
Die mit diesen Untersuchungen angestrebten Ergebnisse, zur Epidemiologie von CA-
MSSA/MRSA, wurden zunächst mit der DNA MA Studie des Bundeslandes Saarland 
gewonnen, welche ein höheres Subtypisierungspotential für den DNA MA im Vergleich 
zur spa–Typisierung zeigte. Die Auswertung der DNA MA Daten mittels der zuvor 
genannten drei bioinformatischen Methoden zeigte eine unterschiedliche Zuordnung 
von CC5 Isolaten zu 3 bis 7 Isolatgruppen mit Ausnahme von zwölf CC5 Isolaten. 
Diese zwölf CC5 Isolate wurden immer zwei identischen Isolatgruppen zugeordnet. 
Dies heißt nicht, dass die Methoden fehlerhaft sind, sondern dass die Anwendung 
unterschiedlicher mathematischen Algorithmen, die entweder die Unterschiede oder 
die Ähnlichkeiten der Hybridisierungsmuster untersuchen, zu geringfügigen 
Unterschieden führen. Zudem zeigten die MSSA eine hohe Diversität im Vergleich zur 
CA-MRSA Gruppe, die vom CC5 Rhine-Hesse epidemischen Stamm dominiert wurde 
(89%).  
Die weitere Analyse afrikanischer Stämme aus der Studie mit  nigerianischen MSSA 
zeigte eine heterogene und divergente Natur der untersuchten nigerianischen MSSA 
und bestätigte, dass der DNA MA eine geeignete Methode zur Genotypisierung 
afrikanischer SA ist. Die Ergebnisse der multizentrischen deutsch-afrikanischen 
Konsortialstudie wies innerhalb der Isolatgruppe insgesamt 40 verschiedene CCs und 
STs nach, einschließlich 5 neuer STs. Die Mehrheit, 15 von 22 (68%) der CCs, die 
auch am häufigsten identifiziert wurden, waren entweder in Sub-Sahara Afrika (Gabon, 




CC30, CC45, CC398) vorherrschend. Die Rate an MRSA Trägern in der afrikanischen 
(3%) und deutschen Bevölkerung (1%) war sehr gering, vermutlich durch die auf CA-
SA beschränkte Untersuchung. Die Analyse der Genprofile zeigte eine hohe Prävalenz 
der Panton-Valentin Leukozidin kodierenden Gene lukF/S-PV in afrikanischen 
Isolaten. Allgemein konnten kontinentspezifische Unterschiede für die CC und CA-SA 
Genprofile identifiziert werden. Zudem wurde ersichtlich, dass ergänzend zur guten 
Erstcharakterisierung durch den DNA MA, standardisierte, komplexe analytische 
Methoden für Assoziationsanalysen und epidemiologische Untersuchungen 
erforderlich sind. 
Das letzte Untersuchungsziel, die Bewertung vergleichender 
Massenspektrometrieanalysen zeigte, dass - basierend auf ihrem Spektrometrieprofil 
- nur SA des CC121 korrekt identifiziert werden konnten, während keine korrekte 
Identifikation anderer CC oder spa-Typen möglich war. 
Zusammenfassend identifizierte diese Arbeit länderspezifische Unterschiede in der 
Verteilung klonaler Komplexe und spezifischer Gene in den untersuchten Regionen, 
insbesondere bei alleiniger Betrachtung klinischer Isolate. Sie gibt wertvolle Hinweise 
auf die genetisch basierten Gründe, welche die angeblichen Unterschiede in der 
klinischen Präsentation und dem Verlauf von durch SA verursachten Infektionen in sich 
entwickelnden und industriellen Ländern erklären könnten. Zudem wurde gezeigt, dass 
der DNA MA im Gegensatz zur Massenspektrometrie eine geeignete Methode zur SA 
Charakterisierung z.B. in Ausbruchssituationen ist. Es darf jedoch nicht unerwähnt 
bleiben, dass als besondere Anforderung an eine anspruchsvolle, DNA MA-basierte 
phylogenetische Analytik mehrerer Isolate die Anwendung komplexer 
bioinformatischer Analysemethoden zur Interpretation erforderlich ist, und dass die 
Charakteristiken und Algorithmen der gewählten bioinformatischen Methode zu 





 Staphylococcus aureus 
Staphylococcus aureus (SA) is a globally distributed major human pathogen and 
human commensal. Thus, it is a global serious public health threat and the causative 
agent of an economic burden for health care systems (Köck et al., 2010). SA is the 
most important member of the staphylococcal family and responsible for a wide 
spectrum of infections ranging from harmless skin infections such as folliculitis up to 
life-threatening infections such as pneumonia, endokarditis and bacteremia (Gordon & 
Lowy, 2008). Staphylococci are gram- and catalase positive, facultative anaerobic, 
immobile and non-spore-forming bacteria with a diameter of 0.5 to 1.5 µm. Since 2010, 
staphylococci constitute their own family, the Staphylococcaceae, and are no longer 
part of the Micrococacceae (Lemon et al., 2010). The genus Staphylococcus 
comprises at least 46 species, which can be divided into coagulase positive and 
negative staphylococci, 16 species of them can be found in humans. The name 
Staphylococcus was introduced by Ogston 1882 to describe micrococci responsible 
for inflammation and suppuration. The name derives from the Greek “staphyle” which 
translates as “bunch of grapes” and “kokkos”, meaning “grain” or “berry” (Ogston, 
1882). The name describes its typical morphology, indicating that the round single 
bacteria cells build grape like clusters because of their manner of cell division in 
multiple levels. Two years later Rosenbach (1884) introduced the scientific name 
Staphylococcus aureus (SA), adding the Latin “aureus” for “golden”. The name 
describes the golden colony color caused by the carotenoid staphyloxantin of this 
staphylococcus species (Rosenbach, 1884). 
SA colonizes the skin, groin, axilla, vagina, throat and mostly the vestibules of the nose 
as an opportunistic pathogen. Up to 50% (Kirkliauskienė et al., 2010) of the human 
population are colonized transiently and 10 to 20% persistently (van Belkum et al., 
2009, Wertheim et al., 2004). Colonization occurs without symptoms, but is associated 
with an increased infection risk for nasal carriers (Kluytmans et al., 1997, Lowy, 1998). 
On the other hand, non-carriers in comparison to carriers have a fourfold higher 
mortality rate in cases of exogenous bacteremia (Wertheim et al., 2004). Invasion into 




foreign material such as catheters or a compromised immune system. The bacterium 
is able to spread from its port of entry into adjacent tissues or the blood system. 
The reason for the success and the high pathogenicity of SA as a human commensal 
and opportunistic pathogen are three characteristics: i) resistance genes, ii) virulence 
genes and iii) successful transmission. The first big challenge is its resistance to 
several antibiotic classes and the prevalence of multiresistant staphylococci, especially 
of methicillin-resistant SA (MRSA). The second challenge is its wide array of virulence 
determinants as part of the pathogenesis of various diseases (Archer, 1998, Feng et 
al., 2008, Gill et al., 2005, Takeuchi et al., 2005). Third, they are able to spread 
successful in different environments: i) hospitals, health-care institutions and in the 
community as well as in ii) human and animals. 
2.1.1 Resistance of SA 
Betalactams has since the introduction of penicillin been the antibiotic class of choice 
for the treatment of SA infections. However, development of resistance has from the 
very beginning been a serious issue. Thus, only very shortly after penicillin was 
introduced in 1940 the first penicillin resistant SA was found in 1942, first in hospitals 
and afterwards also in the community (Lowy, 2003, Rammelkamp & Maxon, 1942). In 
the late 1960 the resistance was reported to be about 80% regardless of their origin 
(i.e. hospital- or community-associated). Today still 70-80% of methicillin-sensitive SA 
(MSSA) are penicillin resistant (Chambers & De Leo, 2009). 
SA resistance against penicillin is mediated by the expression of the gene for β-
lactamase blaZ and regulated by the adjacent antirepressor blaI and the repressor 
blaR. The β-lactamase confers resistance to penicillins by inactivation of penicillin 
through hydrolysis of its β-lactam ring. 
The emergence of penicillin resistance in SA leads to the development of new 
antibiotics such as streptomycin, erythromycin and chloramphenicol in the 1950s. 
However, during clinical application SA developed resistances against these, too 
(Shanson, 1981, Udo et al., 1999). 
During the search of β-lactamase stable penicillin’s as a new treatment option, 
methicillin was introduced as first of the semisynthetic penicillinase-resistant penicillin’s 




resistance was discovered in the same year shortly after the introduction of methicillin 
(Jevons, 1961). 
The by far most important resistance mechanism in MRSA is mediated by the mec 
genes. All MRSA strains contain a staphylococcal chromosomal cassette (SCC) 
carrying the mec operon. The SCCmec harbors the already well-known methicillin 
resistance genes mecA, mecC and the in SA just recently reported mecB (Ito et al., 
2012, Becker et al., 2018). They all encode penicillin binding proteins (PBP). 
The mec genes are located within the mec operon together with its regulatory genes 
(Berger-Bachi & Rohrer, 2002). The SCCmec is a mobile genetic element originally 
acquired from other Staphylococcus species. Thus, the SCCmec is a foreign genetic 
element from whom its mechanism of acquisition and spread in SA is not completely 
understood. 
One assumption is that the SCCmec elements were acquired horizontally by SA from 
Staphylococcus fleurettii or Staphylococcus sciuri and that mecA positive, coagulase 
negative staphylococci as Staphylococcus epidermidis, may be a potential reservoir 
for the SCCmec element (Hiramatsu et al., 2013, Rolo et al., 2017, Tsubakishita et al., 
2010, Wu et al., 1996). For example, SCCmec types II and III are too large to be 
transferred by bacteriophages (Lindsay & Holden, 2004). 
Till yet 13 different SCCmec types (I to XIII) have been differentiated, five of them, 
SCCmec types I to V, are globally distributed (Baig et al., 2018). The larger SCCmec 
allotypes I, II and III are normally found in healthcare-associated (HA)-MRSA and 
harbor multiple resistance determinants. The smaller, more mobile SCCmec allotypes 
IV and V are normally associated with community-associated (CA)-MRSA and don’t 
carry multiple antibiotic-resistance genes (Baba et al., 2002, Chambers & De Leo, 
2009). However, SCCmec type IV could not be found only in CA-MRSA but also in HA-
MRSA of sequence type (ST) 22 (ST22-IV) (Otter & French, 2012). Therefore, it is not 
possible to conclude from the SCCmec type if a SA isolate is a HA- or CA-MRSA 
isolate. 
Vancomycin was increasingly used as last remaining antibiotic which MRSA were 
reliably susceptible, too (Hiramatsu et al., 1997). However, after a long period the 
increasing burden of MRSA infections worldwide with MRSA rates up to 50% in 




in the USA (Köck et al., 2010, Moran et al., 2006) leads to the first Vancomycin 
intermediately resistant SA (VISA) strains detected in 1997 (Hiramatsu et al., 1997, 
Smith et al., 1999). VISA are strains showing a reduced susceptibility to vancomycin 
through adaptive mutation (Nelson et al., 2007, Howden et al., 2014, Hanaki et al., 
1998). In Germany they were described for the first time in 1997 (Epidemiol Bulletin, 
45/97). Later, complete vancomycin resistant SA (VRSA) were found. VRSA are 
caused by conjugal transfer of the vanA operon from Enterococcus faecalis (Hu et al., 
2016). So far, still less than 20 vancomycin resistant SA strains are described 
worldwide, with most of them reported from the USA and in one case from Portugal 
(Friães et al., 2015, Limbago et al., 2014). 
Until today SA developed resistances against all big antimicrobial classes including 
macrolides (e.g. erythromycin), lincosamides and streptogramin B, aminoglycosides 
[e.g. gentamicin], tetracyclines, linezolid, mupirocin, fusidic acid, oxazolidinone, 
glycopeptides (e.g. daptomycin), lipopeptides, gyrase like gyrase-inhibitors (e.g. 
ciprofloxacin) and many other unrelated antibiotic classes. 
2.1.2 Virulence of SA 
Pathogenesis of SA is driven by different virulence factors from adhesion mediating 
virulence factors, over biofilm promoting virulence factors to virulence factors like 
cytotoxins such as enterotoxins, hemolysins and leukocidins guaranteeing the SA 
nutrition, as well as virulence factors counteracting the host’s immune system like the 
IEC (immune evasion cluster). 
The start of pathogenesis is initiated by adhesion factors of SA. The first of the both 
predominant groups of adhesion factors are the cell wall associated proteins called 
microbial surface component recognizing matrix molecules (MSCRAMMs). 
MSCRAMMs share that they are covalently anchored to the cell wall by sortase A, a 
transpeptidase that recognizes the C-terminal cell-wall sorting signal LPXTG. The key 
representatives of the MSCRAMMs are the fibronectin binding proteins (FnBPA and 
FnBPB) (Foster, 2016), the fibrinogen binding proteins clumping factor A and B (ClfA 
and ClfB) (McDevitt et al., 1994, Ni Eidhin et al., 1998), the Ser-Asp dipeptide repeat 
surface proteins (SdrC and SdrD) (Foster & Hook, 1998), the bone sialoprotein binding 
protein (Bbp) (Vazquez et al., 2011), the collagen binding protein (Cna) (Gillaspy et al., 




The second predominant group of adhesion factors are the secretable expanded 
repertoire adhesive molecules (SERAMS). These secreted adhesion proteins partially 
rebind to the bacterial cell surface (Chavakis et al., 2007, Chavakis et al., 2005, Foster 
et al., 2014). Well known structurally unrelated SERAMs are the coagulase Coa, the 
fibrinogen binding protein FbpA, von-Willebrand-factor binding protein encoded by vwb 
and the extracellular adherence protein Eap, also referred to as Map (Chavakis et al., 
2005, McAdow et al., 2012). All these adhesion genes enable SA to adhere and 
mediate the invasion of a range of different cell types (Chavakis et al., 2007, Lacey et 
al., 2016). 
After adhesion, pathogenesis may be driven by biofilm formation which plays a major 
role in foreign body infections. A biofilm consists of a complex microbial flora within a 
self-synthesized matrix. One of the advantages of biofilm growth is the increased 
resistance to host defense mechanisms and antibiotics (Arciola et al., 2012). A number 
of clinical SA isolates are able to synthesize the exopolysaccharide PIA (intercellular 
polysaccharide adhesin) also referred to as PNAG („poly-N-acetylglucosamin“). PIA 
synthesis is catalyzed by the products of the ica-operon components icaA, icaB, icaC, 
and icaD, whose expression is for example controlled by the negative regulator IcaR 
(Cue et al., 2012, Otto, 2008). Other SA isolates can form a proteinaceous biofilm 
utilizing MSCRAMMs such as FnBPs, Spa, and the staphylococcal surface protein G 
(SasG). The SA surface component Bap (encoded by bap) is also involved in biofilm 
formation, which (in comparison to PIA) promotes not only the intercellular adhesion 
between SA cells but also the attachment to inert surfaces (Cucarella et al., 2002, 
Taglialegna et al., 2016). 
Moreover, SA secretes several cytotoxins e.g. enterotoxins (Hu et al., 2008, Hu et al., 
2016, Spaulding et al., 2013) as the staphylococcal superantigen/ enterotoxin-like 
antigens (Argudin et al., 2010), toxic shock syndrome-Toxin (TSST-1) (Becker et al., 
2003) and exfoliative toxins ETA and ETB (Grumann et al., 2014, Nishifuji et al., 2008). 
These toxins are known to have potent effects on cells of the host’s immune system to 
inhibit the host’s immune responses. However, many of them have other biological 
effects, too. 
Cytotoxins such as hemolysins and leukocidins can form pores in diverse host cell 
types. The chromosomally encoded hemolysins α, β, γ and δ are responsible for the 




2012). The function of the hemolysins and leukocidins is to ensure the supply of 
nutrients by lysis of host cells. 
The best known leukocidin, Panton-Valentine leukocidin (PVL), consists of the 
subunits lukF-PV and lukS-PV (Shallcross et al., 2013). Typical clinical manifestations 
of the well-known leukocidin PVL (Shallcross et al., 2013) are chronic or recurrent skin 
and soft tissue infections (SSTI). In rare cases, PVL is also associated with severe life-
threatening diseases such as necrotizing fasciitis and pneumonia (Gillet et al., 2002, 
Lina et al., 1999). The attention of PVL arised with the detection of an epidemiological 
association between the presence of the genes lukF-PV and lukS-PV and CA-MRSA 
(Vandenesch et al., 2003). More than 75% of CA-MRSA carry the genes encoding for 
PVL (Daum et al., 2002, Naimi et al., 2003). Thus, PVL was assumed to be one of the 
criteria for definition of CA-MRSA (Otter & French, 2010). However, an increasing 
number of CA-MRSA clones do not contain the PVL encoding genes (He et al., 2018). 
Cytotoxins are causative for the invasiveness of SA and are responsible for typical 
clinical conditions. Their main function is to guarantee the nutrient supply and to 
counteract the host‘s immune system (Dinges et al., 2000, Alonzo & Torres, 2014). 
SA further secrets a number of lytic enzymes such as hyaluronate lyases, the zinc-
dependent metalloprotease aureolysin (Aur), the enzyme proteases staphopain A, B 
and P (SspA, SspB, SspP) and the serine proteases SplA, SplB and SplE (Bailey et 
al., 1997, Dubin, 2002, Redpath et al., 1991). They are mainly involved in the 
destruction of the host tissue to enable the bacteria to spread from the initial infection 
site to new sites through lysis of specific cell structures. In this way its survival and 
nutrition will be guaranteed. 
To counteract the host ‘s immune system SA possess the IEC. The IEC consists of 
three components, the immune modulator staphylococcal complement inhibitor 
(SCIN), the chemotaxis inhibitory protein of SA (CHIPS) and the plasminogen activator 
Staphylokinase (SAK) (Foster, 2005, McGuinness et al., 2016, Collen, 1998). 
Additionally, epidermal cell differentiation inhibitors (EDIN) belonging to a large group 
of virulence factors support the hematogenous spread of SA into deeper tissues 
(Lemichez et al., 2010). 
Most SA clinical isolates are also able to produce a polysaccharide capsule, which 




immune cells. Eight capsule serotypes, CP1 to CP8, can be distinguished with CP5 
and CP8 being predominant in clinical isolates (O'Riordan & Lee, 2004). 
The virulence factor synthesis of SA is regulated by a complex regulatory network. 
These regulators are influenced by different conditions like the growth phase of the 
bacteria and environmental conditions like pH-value or available nutrients. Three well 
described regulation systems of this network are the quorum sensing system Agr 
(accessory gene regulator) (Novick, 2003, Somerville & Proctor, 2009), the two 
component systems SaeRS (S. aureus exoprotein expression RS) (Novick, 2003), and 
the Sar (staphylococcal accessory regulator) family (Liu et al., 2016, Somerville & 
Proctor, 2009). 
The Agr system plays an important role in the growth phase dependent regulation of 
various virulence genes. It suppresses the transcription of several cell wall associated 
proteins such as Protein A, coagulase and the fibronectin binding proteins. It also 
activates the transcription of several exoproteins such as -toxin, -haemolysin, 
TSST-1 and leukotoxins during the post-exponential phase. There are four 
distinguishable agr allelic groups: agr-type I, agr-type II, agr-type III and agr-type IV. 
They can be distinguished based on the cross-inhibition of the agr-response by their 
different autoinducing peptides (Bronner et al., 2004, Vandenesch et al., 2012). 
A second important group are the Sar DNA binding proteins. The sar operon in SA 
comprises the three transcription units sarA, sarB and sarC encoding for the SarA 
protein. The expression of these transcripts is growth dependent (Bayer et al., 1996). 
SarA can influence the transcription of different virulence genes such as spa encoding 
for the protein A and hla encoding for the alpha haemolysin (Novick, 2003, Somerville 
& Proctor, 2009). In addition it is an important activator of the agr-system (Cheung et 
al., 1997). 
The SaeRS two-component system plays an important role in the expression of over 
twenty virulence factors such as hemolysins, leukocidins, superantigens, surface 
proteins and proteases. The Sae system doesn’t have an influence on other regulation 
systems but it is known that the transcription of the sae-operon is influenced by other 




 SA epidemiology and the need of SA typing 
2.2.1 The need of SA typing  
Characterization including typing is an essential instrument to understand the 
epidemiology of pathogens. Reports of large SA outbreaks in the 1950’s showed that 
a typing system for SA was required not only to understand individual, local outbreaks 
but also to understand transmission. Even today SA typing is the cornerstone in the 
understanding of the SA epidemiology and to investigate outbreaks especially in health 
care setting. 
Hospitalized patients still have a higher risk of infection because they usually suffer 
from comorbidities associated with an increased infection risk (Herrmann et al., 2013b, 
Cadena et al., 2016). Furthermore, a thorough hygiene management can limit the 
pathogen transmission through doctors, nurses and other healthcare workers in 
hospitals. Studies showed that transmission between patients in settings without any 
infection control precautions as e.g. patient screenings and isolation at hospital-entry 
have a 16fold higher infection risk compared to patients with contact isolation 
(Tacconelli et al., 2009). But also in the community the understanding of the 
mechanism of the successful spread SA could help to develop prevention strategies. 
The first developed typing method was the phage typing (Blair & Williams, 1961). In 
the further decades, several different methods have been developed for MSSA and 
MRSA typing, surveillance, epidemiological investigations and outbreak detection. It 
started with traditional typing systems based on phenotype, such as phage-typing. 
Later, fingerprint-based methods such as amplified fragment length polymorphism 
(AFLP) and pulsed-field gel electrophoresis (PFGE) were developed. 
Furthermore, the international spread from previous, locally successful clones showed 
that there was a need for a common language and typing methods standards for 
communication about SA infections between labs and countries with outbreaks of 
prevalent SA strains. Harmonization projects were necessary to define a common 
language (Murchan et al., 2003). However, the attempt to create internationally, inter-
lab comparable standards for fingerprint-based methods was not fully successful 
(Murchan et al., 2003). This means that PFGE still is one of the methods of choice for 





For this purpose, polymerase chain reaction (PCR) based methods were developed 
and preferentially used such as spa (SA protein A)-typing, multilocus sequencing 
typing (MLST), DNA microarrays (DNA MA) and most recently whole genome 
sequencing (WGS). For MRSA SCCmec-typing also play a major role. Additionally, 
there were several attempts to prove the applicability of mass spectrometry as SA 
typing method. 
Strictly, internationally standardized epidemiological SA typing conditions and strain 
type definitions allowed the introduction of freely accessible databases for example for 
spa-typing and MLST. However, it has to be mentioned that for spa-typing there are 
two nomenclatures from Ridom (Harmsen et al., 2003) and Kreiswirth (Koreen et al., 
2004), while there is only one nomenclature for MLST (Maiden et al., 1998, Urwin & 
Maiden, 2003). 
Actually, 17913 spa-types (www.spa.ridom.de/spatypes.shtml, 06.08.2018) and 4903 
STs (www.pubmlst.org/data, retrieved till 06.08.2018, Figure 1) were described by the 





Figure 1: Population structure of all known Staphylococcus aureus (SA) sequence types (ST). 
The figure is created by the electronic based upon repeats sequence types (eBURST) of all SA STs 
from the multilocus sequence typing (MLST) database (http://saureus.mlst.net) as of July 2018. Each 
circle represents a single ST. Clonal complexes of STs (represented by dots) differing at only one out 
of seven alleles are joined by lines. Highlighted in blue are founding genotypes. Yellow dots represent 
subgroup founders. Size of dots indicates the frequency of a specific ST within the database. 
These molecular typing methods are essential for the rapid identification of prevalent 
strains. They enhance the understanding of disease epidemiology and offers new 
insights into the evolution of SA. Molecular typing is important for their active 
surveillance to control and prevent the spread of SA in health-care settings and to act 
against their transmission, especially in outbreak situations. 
2.2.2 SA typing methods 
Today several different methods are available for differentiation of MSSA and MRSA, 
surveillance and outbreak detection. However, each of these different methods has its 
own advantages and disadvantages. They differ in their workload, accuracy, 
discriminatory power and reproducibility (van Belkum et al., 2009, Weller, 2000). These 




regarding the time, geographical scale and the objectives of a study as well as the 
available resources. 
 Phage typing 
Phage typing today is only in very limited use, however it was the cornerstone of SA 
typing for more than 30 years and thus is briefly described. 
Phage typing is based on the classification of bacterial strains according to their 
susceptibility to a set of selected phages. This means that these strains are lysogenic, 
they carry bacteriophages. These phages are able to lyse specific but not all strains of 
a bacteria species. Applying a defined set of phages allowed to recognize a 
"susceptibility pattern" and by comparison of the "susceptibility patterns" the similarity 
or dissimilarity of the examined SA strains could be determined. For phage typing of 
human SA an internationally accepted set of 23 phages is used. It is important for 
interpretation and comparability of results that internationally recommended protocols 
for propagation and maintenance of phages are followed (Marples & Rosdahl, 1997). 
The phage typing results are easy to interpret and showed a fair amount of 
discriminatory power. In addition, it is a cost-effective method. On the other hand it is 
a time consuming and technically demanding method. However, the main 
disadvantage of this method is its limitation by poor reproducibility of the results and 
the high proportion SA strains which are not typeable by this method (Archer et al., 
1983, Coia et al., 1990). 
 Amplified fragment length polymorphism (AFLP) 
The amplified fragment length polymorphism (AFLP method) is similar to phage typing 
still in limited use. However, it was one of the first fingerprint-based methods and thus 
is briefly described exemplary. 
AFLP method is based on the restriction of genomic DNA, which is cut with two 
restriction enzymes. In addition, double stranded adaptors are ligated to one of the 
sticky ends of the restriction fragments (Vos et al., 1995). This enables a selective 
amplification by PCR of the restriction fragments ending with the ligated adaptor using 
complementary primers to the adaptor sequence, the restriction site sequence and 
several additional nucleotides. It is possible to specifically co-amplificate high numbers 




labeled PCR primers. Computer-assisted analysis of high resolution banding patterns 
of AFLP analysis allowed the determination of genetic relatedness among the 
examined bacterial isolates (Mortimer et al., 2001). AFLP are reported to be as 
discriminatory as pulsed-field gel electrophoresis (PFGE) (Zhao et al., 2000). In 
comparison to PFGE it is a reproducible method which can be automated (Duim et al., 
1999). The disadvantages of this method are its working intensity and the associated 
costs. 
 Pulsed-field gel electrophoresis (PFGE) 
As one of the fingerprint-based methods PFGE is still in the most settings the gold 
standard of bacterial typing in outbreak situations. The reasons are the high 
discriminatory power and the high in-house reproducibility. In 1991 PFGE was first 
applied for epidemiological surveillance of MRSA (Prevost et al., 1991). For PFGE 
bacterial DNA is digested by a restriction enzyme that only rarely cuts within the 
chromosome, thereby generating a small number of large chromosomal fragments. 
For the low G and C species SA (harboring a DNA chromosome with fewer [G] and 
cytosine [C] nucleotides than adenine [A] and thymine [T] nucleotides), the enzymes 
SmaI (used for MSSA) and ApaI (used for MRSA) are usually used, recognizing and 
cleaving CCCGGG and GGGCCC sites, respectively. Next, the DNA fragments are 
analyzed on an agarose gel. A specific feature of the PFGE is that the electric field 
constantly changes its direction, allowing the separation of the large DNA fragments 
and causing a high resolution. 
A disadvantage of the PFGE is the low interlaboratory comparability because of its 
high susceptibility to even minor variations in the experimental settings and the 
interpretation of band marking (van Belkum et al., 1998). Therefore, it was important 
to define international standards for an epidemiological SA typing language (Murchan 
et al., 2003). However, it was not possible to create a common language or to build an 
interactive database for global analysis based on PFGE which already exist for other 
molecular typing methods such as spa-typing and MLST or will be conceivable for DNA 
MA and WGS data, respectively. Thus, PFGE is still applied for the investigation of 
outbreaks but not for epidemiological investigations. Moreover, it is a laborious and 
time-consuming method with low throughput (Hallin et al., 2007) why it is not suitable 




 Staphylococcal cassette chromosome mec (SCCmec) - typing 
For MRSA SCCmec-typing also play a major role. MRSA needs to be differentiated 
below the species level by rapid and comparable typing methods as SCCmec-typing. 
The staphylococcal cassette chromosome mec is a mobile genomic island of SA. It is 
an unique staphylococcal vector for gene transfer with tremendous variation in size 
and structure as well as of tremendous variation of genes they carry. To date 13 types 
of SCCmec elements were identified (Baig et al., 2018). All SCCmec elements have in 
common that they carry the mec gene complex encoding methicillin resistance 
(Hiramatsu et al., 2013). Thus, the acquisition of this foreign SCCmec element 
transforms MSSA to MRSA. 
All SCCmec elements share the same characteristics: i) carriage of the mec gene 
operon (mec), ii) carriage of the ccr gene complex (ccr), which are iii) flanked by 
specific nucleotide sequences, direct and inverted repeats at both ends and iv) 
integration at the so-called integration site sequence (ISS) for SCC, located at the 3'-
end of orfX or at the extremity of the SCC element v) joining regions (j-regions) other 
than mec and ccr within SCCmec (Hiramatsu et al., 2013, Ito et al., 2014, Tsubakisihita 
et al., 2010). These 13 types were classified based on the combination of their different 
mec- and ccr-types. The mec-types were classified based on the presence or absence 
of specific insertion sequences. Furthermore, J-regions can be differentiated into three 
subgroups (J1-J3) (Hiramatsu et al., 2013). 
The SCCmec typing is based on several multiplex PCRs. Several multiplex PCRs are 
needed to identify all SCCmec types. Therefore, this method needs a lot of 
optimization, is time consuming and is cumbersome to introduce in the routine 
diagnostic, too (Ghaznavi-Rad et al., 2010). 
 SA protein A – typing (spa-typing)  
spa-typing is a single locus sequencing method which is one of the methods applied 
in the investigation of outbreaks in hospitals and health care settings. 
The staphylococcal protein A is a 42kDa protein of the MSCRAMMs (section 2.1.2). 
The open reading frame of spa is about 2150bp long and encompasses different 
regions with a varying degree of conservation: the well conserved Fc-region encoding 
the N-terminal end of the protein A, which interacts with the immunoglobulins, a 




C-terminal end of the protein which is responsible for the cell wall anchorage (Guss et 
al., 1984). The polymorphic X-region was sequenced for the first time in 1984 by Uhlen 
et al. (Uhlen et al., 1984), while Frenay et al. examined the epidemiological potential 
of spa-typing for the first time in 1994 (Frenay et al., 1996). The highly polymorphic X-
region is a region consisting of a variable number of about 24bp long repeats (Uhlen 
et al., 1984) that can be used to subdivide SA isolates into different spa-types. The 
spa-types are defined by varying repeat numbers as well as by numerous strain-
specific repeat succession possibilities and changes through point mutations and 
deletions of the XR region (Figure 2) (Frenay et al., 1996). The distinctive polymorphism 
of this region is based on duplications, deletions, insertions and point mutations. 
The spa-types are defined based on the repeat succession of the polymorphic XR 
region (Figure 2). The repeats are defined by a unique base composition. Each new 
detected repeat is assigned a unique repeat code consisting of an “r” and a number for 
example r17. 
 
Figure 2: Genetic organization of the Staphylococcus aureus (SA) protein A (spa)-gene and the 
principle of spa-typing. Schematic representation of the protein A encoding spa open reading frame 
of SA. The boxes represent different gene segments encoding for the different parts of the protein A, 
with the hypervariable X-region and their repetitive elements (XR), and the cell wall anchoring segment 
(Xc) at the end. Arrows symbolize the position of the primers used to amplify the X-region utilized for 
typing. The repeat succession of an isolate determines its spa-type. The repeats are defined by a unique 
base composition, and each repeat is assigned a unique repeat code consisting of an “r” and a number.  




Spa-typing as a single locus typing method of the hypervariable X-region of Protein A 
is nowadays a routinely applied typing method in diagnostics as well as in outbreak 
situations e.g. to check if a possible transmission of a specific SA strain from one to 
another patient occurred. The success of this method is based on its ease and speed, 
its interlaboratory reproducibility as well as its objective interpretation and access to a 
global, regularly updated database (Aires-de-Sousa et al., 2006, Harmsen et al., 2003, 
Shopsin et al., 1999). This typing method is particularly suitable for the brief analysis 
of local outbreaks. However, a disadvantage of this method is that epidemiologically 
related isolates might be different due to frequent sequence changes in the X-region 
which may result in different spa-types (van Belkum et al., 2009). 
 Multi-locus-sequence-typing (MLST) 
The development of MLST started with the analysis of highly virulent Neisseria 
meningitidis isolates (Maiden et al., 1998). MLST was developed as a fast, highly 
reproducible typing method for unambiguous strain characterization. In 2000, Enright 
and colleagues first published an article on SA characterization by MLST (Enright et 
al., 2000). It is a highly discriminative method with sequencing of internal ~450bp long 
fragments of seven constitutively expressed genes, so-called housekeeping genes. 
The seven housekeeping genes used for SA MLST are arcC (carbamat kinase), aroF 
(shikimate dehydrogenase), glpF (glycerol kinase), gmk (guanylat kinase), pta 
(phosphate acetyltransferase), tpi (triosephosphat isomerase), and ygiY (acetyl 
coenzym A acetyltransferase). The sequences of each gene fragment of the different 
gene loci are compared and each allele is assigned a specific number. The assignment 
of the alleles of the seven loci and the combination of their numbers results in the allelic 
profile which defines the sequence type (ST) (Figure 3) (Aanensen & Spratt, 2005, 
Enright et al., 2000). If the allelic profiles of six out of the seven housekeeping genes 
of two individual isolates are identical, then they have the same ST. If only five of the 
seven alleles are identical, these strains have different STs but belong to the same 
clonal complex (CC). 
The sequence fragments of the housekeeping genes used in MLST are characterized 
by a slow accumulation of genetic variations. This makes it on the one hand a suitable 
method for long term and global epidemiological studies (Feil et al., 2003), but on the 
other this could lead to an insufficient discriminatory potential in epidemiologically 




of seven housekeeping genes makes MLST most suitable for long-term and global 
epidemiological studies (Feil et al., 2003). Therefore, it is necessary to examine seven 
gene fragments to achieve a sufficient discriminatory power, which (in combination with 
the high MLST stability) makes it a particularly suitable tool for the analysis of strain 
clonality in global, long-term studies (Feil & Enright, 2004, Hallin et al., 2008). 
 
Figure 3: Principle of multi-locus sequence typing. Seven housekeeping genes of Staphylococcus 
aureus are amplified and sequenced. Depending on the allele sequences are defined numbers 
assigned, which determines the allelic profile. Isolates with identical allelic profile of all seven or six 
alleles belong to the same sequence type (ST). If only five of the seven allele sequences are identical 
they belong to the same clonal complex (CC). 
 Whole genome sequencing (WGS) 
Recently, next generation DNA sequencing (NGS) made WGS possible. WGS is 
expected to change the practice of clinical microbiology and infection control because 
of the enhanced understanding of the micro-evolution of SA during long-term carriage 
and its relationship with different states of disease. The advantage of WGS is that it is 
a highly discriminative technique that can provide valuable insights into transmission 
chains. This method allows detection of single nucleotide polymorphisms as well as 
core genome MLST, among analytical approaches. WGS can be used for MRSA 
surveillance and outbreak analysis, where the conventional methods such as MLST 
and spa-typing showed an insufficient discriminatory power (Bartels et al., 2015, 
Leopold et al., 2014, Sabat et al., 2013). In addition, WGS can be applied for the 
analysis of phenotypical properties on a genotypical basis, e. g. for the determination 
of antibiotic resistance profiles (Billal et al., 2011). Advances in WGS technology and 
reduced sequencing costs to approximately 60€ per genome make this method more 




However, the detailed bioinformatic analysis and limited information technology 
structure for data storage and exchange, pose a challenge and are some of the major 
obstacles to be overcome before introduction of WGS in the routine practice. There 
are several commercial software- and web-based solutions available for the 
performance of spa-typing, MLST, analysis of epidemiologic strain evolution, strain 
relationships, transmission chains as wells as for screening for predefined genes 
based on WGS data. Consequently, there will maybe be a future technique for the 
virulence assignment of clinical isolates based on their genotypical profiles (Laabei et 
al., 2014). 
 DNA microarray (DNA MA) 
DNA MA technology has facilitated the simultaneous analysis of the presence of 
selected molecular targets based on hybridization reactions since the late 1990s 
(Bumgarner, 2013). The DNA MA is a collection of DNA probes attached to a solid 
surface. These DNA probes can be used to detect complementary nucleotide 
sequences in bacterial isolates. Studies showed that they were already successfully 
applied for the investigation of the genetic composition of predominant SA lineages 
and the evolutionary genomics of SA (Lindsay et al., 2006, Fitzgerald et al., 2001). The 
Alere Technologies DNA SA oligonucleotide microarray used in this study provides 
334 immobilized probes corresponding to 233 different genes. The different gene 
groups of the Alere Technologies DNA MA encompass SA species markers, regulatory 
genes, antibiotic resistance genes, toxin genes, adhesion genes, biofilm genes, 
immune evasion genes and other virulence-related genes. Moreover, the classification 
of the accessory gene regulator, capsule and some SCCmec types are included. 
DNA of a SA isolate is amplified via a linear PCR and labelled with biotin. In contrast 
to standard PCR, only one antisense primer per target is used. This leads to single 
stranded, labeled DNA reaction products and an amplification of a high number of 
targets but also leads to a lower sensitivity than in a standard PCR. This approach also 
diminishes the probability of a possible contamination and prevents the competition 
between probe and antisense strand during the amplification, resulting in an increased 
probability of the single stranded amplicon binding to the probe (Monecke & Ehricht, 
2005). The resulting amplicons are hybridized to the DNA MA and are made visible 




The final hybridization profiles are rather specific for different SA strains. It is possible 
to identify the strain lineage CC or ST of newly collected isolates analyzed by the DNA 
MA by automatic comparison of the obtained hybridization profiles with the 
hybridization profiles in the IconoClust (Alere Technologies) software database 
(Monecke et al., 2008). The software automatically identifies the hybridization patterns 
by means of digital pictures of the array and provides information on presence, 
absence and ambiguous signals for the different genes and classifies the strain in 
concordance with the MLST nomenclature. This method thereby combines the 
analysis of clinically relevant factors with a globally accepted, epidemiological 
classification. DNA MA results can be obtained within a day and deliver easy to 
understand results with a high reproducibility and comparability. 
In this work, DNA MA analysis was performed as a fast, commercially available, 
diagnostic panel for SA typing and as one of the molecular state of the art typing 
methods with affordable costs, convenient (laboratory) handling and a robust 
technique with a direct result output without requiring further bioinformatical analysis 
steps for interpretation. Especially the latter characteristics qualify DNA MA as a 
suitable method for microbiological laboratories in developing countries. 
 Mass spectrometry using MALDI-TOF 
The introduction of matrix-assisted laser desorption ionization - time of flight (MALDI-
TOF) as mass spectrometry technique in routine diagnostic initiated a revolution in the 
identification of microorganism grown on solid media and nowadays also in fluid blood 
cultures (Christner et al., 2010). It is a rapid, cheap, easily applicable, accepted and 
highly reliable diagnostic method which is increasingly used in routine diagnostic. 
Mass spectrometry detects the mass to charge ratio (m/z) of proteins or protein 
fragments of a bioanalyte in a few minutes. Therefore, bacteria or bacteria cell extracts 
are transferred onto single spots of a so-called target. Afterwards, the spots are 
covered with a matrix. The target with the dried spots is transferred into the mass 
analyzer (Figure 4). In the analyzer short pulses of laser flashs on the target ionizes 
the matrix molecules and the bacteria or bacteria cell extracts molecules are ionized 
by proton transfer from the matrix. After that, the ions are accelerated in an electronic 
field in a vacuum. During their flight the ions are separated by their mass to charge 




smaller time of flight. Each detected protein or protein fragment is characterized by its 
molecular mass (m), charge (z), the ratio of both and its relative signal intensity. The 
results are displayed as mass spectra with bioanalyte specific peak profiles in the 
connected data analysis software. This way, the method provides a unique fingerprint 
of the analyzed microorganism (whole bacteria cell method) or bacterial cell extract 
(protein extraction method) which can be used for bacterial identification by 
comparison of the obtained bacteria specific spectra profile against a deposited 
reference database (Jackson et al., 2005, Seng et al., 2009). 
Furthermore, there are attempts to use these fingerprint profiles for the differentiation 
of MRSA and MSSA as well as the main SA strain lineages (CC and STs) (Josten et 
al., 2013, Wolters et al., 2011). 
 
 
Figure 4: Scheme of the principle function of the matrix-assisted laser desorption time of flight. 
A bacterial colony or cell extract is applied to a target and overlaid with a matrix. The target is inserted 
into the vacuum envelope. There, a laser ionizes the bacterial molecules which are separated on their 
way from the target to the detector with respect to their mass and charge. The data from the detector 




2.2.3 SA epidemiology 
In the early 1940’s penicillin was introduced as new antibiotic treatment option. It leads 
to an improvement of the prognosis of patients with staphylococcal infections. The first 
penicillin resistant SA was found in 1942, first in hospitals and afterwards also in the 
community (Lowy, 2003, Rammelkamp & Maxon, 1942). In the 1950s the first reports 
of large SA outbreaks at maternity wards hospitals were published (Barber & 
McCartney, 1952). Penicillin resistance rapidly increased and in the late 1960s, about 
80% of all staphylococcal isolates were penicillin resistant, regardless of their origin 
(i.e. hospital- or community-associated). This pattern of resistance, first emerging in 
hospitals and then spreading to the community, is a pattern recurring with each new 
wave of antimicrobial resistance (Chambers, 2001). 
In 1961, methicillin was introduced as first of the semisynthetic penicillinase-resistant 
penicillin’s. Shortly after the introduction of methicillin the first resistant isolates were 
identified (Jevons, 1961). In the 1960’s the first wave of clonal dissemination of SA 
with different locally prevalent phage types were reported and were responsible for 
many infections (Jessen et al., 1969, Parker et al., 1970). The MRSA infections were 
primarily caused by one SA clone of the phage type 83A, today also known as the 
archaic MRSA clone ST250 (Aires-de-Sousa & De Lencastre, 2003, Enright et al., 
2002, Robinson & Enright, 2003). This so-called “archaic” MRSA clone circulated in 
hospitals only in some parts of the world as in UK, Denmark and Australia, but the rest 
of the world was largely unaffected (Crisóstomo et al., 2001, Jessen et al., 1969, 
Rountree & Beard, 1968). The ST250 MRSA descends from the MSSA ST250 
genotype, which probably evolved from the MSSA ST8 type (Deurenberg et al., 2009). 
This first archaic MRSA clone contained the SCCmecI (Chambers & De Leo, 2009). 
In the mid to the late 1970s, novel pandemic lineages of MRSA emerged, replacing 
the archaic MRSA clone ST250: ST1, ST8, ST22, ST30 and ST45 (Aires-de-Sousa & 
De Lencastre, 2003, Robinson & Enright, 2003). These MRSA clones appearing in the 
mid to late 1970 carried the new SSCmec allotypes, SCCmecII and SCCmecIII. This 
was the beginning of wave II. They started the worldwide pandemic of MRSA in 
hospitals that is still ongoing (Aires-de-Sousa & De Lencastre, 2003, Robinson & 
Enright, 2003). Although MRSA were distributed worldwide, they were still restricted to 




While the hospital environment still remains a risk factor for SA carriage and 
nosocomial infections, an increasing number of SA infections is caused by community-
associated (CA) MRSA strains (Chuang & Huang, 2013, Otter & French, 2010). This 
means, in the last two decades started the third wave of MRSA with MRSA invasion 
into the community as described before for the penicillin resistance. The first cases of 
CA-MRSA infections in patients arising in the community were published in 1982. 
However, CA-MRSA were at this time disputed as several of the patients were drug 
addicts (Saravolatz et al., 1982). The earliest reports on CA-MRSA infections were 
from Australia. Since then, CA-MRSA popped up almost simultaneously in different 
parts of the world, spread around the globe with different strain types and have become 
a major health concern, predominantly in the USA (Figure 5). The next and certain 
emergence of MRSA strains in the community came in the late 1980s in Australian 
Aboriginals in remote Western Australian communities without previous history of 
hospitalization (Udo et al., 1993). However, the real awareness came in 1999 with the 
MMWR (morbidity and mortality weekly report) of four pediatric deaths caused by CA-
MRSA infections in Minnesota and North Dakota, USA (MMWR, 1999). 
In the USA, CA-MRSA infections were first caused by the USA400 (ST1) strain MW2. 
USA400 was subsequently replaced by USA300 (ST8), which is now the predominant 
CA-MRSA clone in the United States (Chua et al., 2011, DeLeo et al., 2010, Takano 
et al., 2008). In other parts of the world other ST’s have dominated. In Europe ST80, 
which belongs to the CC80 clone is predominant in Europe. Another predominant ST 
in another part of the world is ST59 belonging to the CC59 clone, being the main 
sequence type in Taiwan. ST30 belonging to the CC30 clone predominates in Eastern 
Australia. In Germany the CA-MRSA are more heterogenous and are reported to range 
between 1% to 2%. The German CA-MRSA are mostly of CC5, CC8, CC30 and CC80 
(Köck et al., 2010, Robert Koch Institut, 2018). 
Staphylococcal strains, which are prevalent in hospital settings, are so-called hospital-
associated (HA) MRSA. HA-MRSA is represented in industrialized countries as 
Germany by a small number of clones such as CC5, CC8, CC22, CC30 and CC45 
which rarely cause infections outside the health-care setting (Chambers & Deleo, 
2009, Köck et al., 2010). During this second wave of MRSA, MRSA were reported in 
Germany for the first time in the 1970/1980s (Lenz et al., 1988, Witte et al., 1986). In 




MRSA-II (Rhine-Hesse epidemic clone), the Northern-German clone t008/ ST8-MRSA-
IV and t032/ ST22-MRSA-IV (Barnim-epidemic-strain) (Cuny & Layer, 2011, Meyer et 
al., 2014). 
 Healthcare-, community- and livestock- associated SA 
Division of SA is important to understand the different subgroups. Today the problem 
is that it is not directly obvious if a MRSA infection is caused by HA- or CA-MRSA. HA-
MRSA are characterized by their resistance to β-lactam antibiotics as well as to other 
classes of antibiotics (Berger-Bachi & Rohrer, 2002) and they are predominantly 
responsible for infections in hospitalized patients of very young or higher age with 
typical risk factors. Typical HA-MRSA risk factors are history of hospitalization, 
residence in a nursing home, skin lesion, hemodialysis as well as indwelling catheters 
and inserted or implanted foreign bodies (Schaumburg et al., 2012). 
CA-MRSA strains are the cause of infections in otherwise healthy and young people 
(Herold et al., 1998) without any typical risk factors. Phenotypic and molecular analysis 
showed that CA-MRSA differ from the major circulating MRSA clones and are different 
from country to country. The CA-MRSA strains are not closely related with common 
endemic hospital strains. They are more virulent and typically characterized by their 
susceptibility to several non β-lactam antibiotics which hospital strains are usually 
resistant to (David & Daum, 2010). Common features of outbreaks of CA-MRSA 
comprise close contact, poor hygienic conditions, shared equipment, high risk of 
superficial skin abrasions, and lack of access to medical care to treat infections. 
Moreover, more than 75% of CA-MRSA carry the genes encoding for PVL (Daum et 
al., 2002, Naimi et al., 2003). PVL is associated with chronic or recurrent skin and soft 
tissue infections (SSTI) and in rare cases also with severe life-threatening diseases 
such as necrotizing fasciitis and pneumonia (Lina et al., 1999). 
Thus, clear definitions are required to distinguish between HA- or CA-MRSA infections. 
However, there are several CA-MRSA definitions based on an epidemiologic 
approach, antibiotic susceptibility patterns and molecular typing which have been 
thought to distinguish CA-MRSA from HA-MRSA (Witte, 2009). Different definitions, 
especially based on the last-mentioned characteristics developed in parallel, based on 




An epidemiological based definition created from the centers for disease control and 
prevention is that HA-MRSA infections are all infections that occur after 48 hours 
following the patient’s admission to hospital and/or which fulfill one of the following HA-
MRSA risk factors: hemodialysis, surgery, residence in a long-term care facility or 
antibiotic treatment during the last year, presence of a permanent catheter or 
percutaneous device or previous MRSA isolation, care in ICU’s, and prolonged 
antibiotic treatment. Conversely, CA-MRSA infection is defined as any infection 
diagnosed in an outpatient within 24 or 48 hours of hospital admission which doesn’t 
fulfill any of the HA-MRSA risk factors. 
Till today, CA-MRSA outbreaks have been reported all over the world (DeLeo et al., 
2010, Figure 5). 
 
Figure 5: Global distribution of community-associated (CA) methicillin-resistant 
Staphylocococcus aureus (MRSA) sequence types (Figure copy of De Leo et al., 2010). The dotted 
lines represent possible dissemination routes of CA-MRSA strains. Colored regions indicate the 
estimated distribution area where infections caused by the main strains are known (ST1-green, ST8-
red, ST30-blue, ST80-grey hatched). “+” indicates PVL positive strains, “-“ indicates PVL negative 
strains, “±” indicates a combination of PVL positive and negative strains. 
Unfortunately, studies including data on CA-MSSA are rare, although they may 
constitute a major factor in a variety of infections, especially in developing countries. 
More recently, since the end of the 1990s, MRSA are also described to be responsible 
for a range of infections in livestock pigs, cows and companion animals such as dogs 
and horses (Huijsdens et al., 2006, Weese et al., 2005). Colonization of livestock 




especially MRSA become a major challenge on farms and the livestock environment 
(van Cleef et al., 2011, Köck et al., 2013). Zoonotic transmissions from livestock to 
farmers and people with close contact to livestock as well as a transmission from 
livestock workers to their family members are well known. In The Netherlands the 
number of LA-MRSA isolated from people increased up to 30% of all isolated MRSA 
and history of livestock contact was included as risk factor to the Dutch screening 
guidelines (Bosch & Schouls, 2015). The typical livestock MRSA strains belong to the 
most predominant clonal complexes CC398, CC9 and CC97. MRSA CC398 is 
responsible for about 2% of all human MRSA infections such as bacteremia, 
pneumonia and wound infections especially in regions with a high density of livestock. 
 SA in Sub-Saharan Africa 
To date, most epidemiological studies on SA were carried out in industrialized 
countries, although SA also plays an important role as a pathogen in developing 
countries in Sub-Saharan Africa. In comparison to typically diagnosed tropical 
diseases such as tuberculosis, malaria and parasite-associated diseases, SA 
infections are considered neglected tropical diseases. They are frequently 
underdiagnosed (Herrmann et al., 2013a), probably due to limited availability of 
microbiology laboratories in these countries. In consequence, there is a lack of 
molecular, clinical and epidemiological data for this large region. This results in 
empirical therapy strategies which might entail treatment errors, especially in septic 
patients as reflected by the high infant mortality rate through bacteremia (Berkley et 
al., 2005, Mulholland & Adegbola, 2005). Moreover, a concurrence of SA infections 
with HIV infections or malnutrition has been shown (Kraef et al., 2015, Sigauque et al., 
2009, Talbert et al., 2010) as well as a high incidence of bacteremia in African 
countries, with the highest fatality rates for SA infections (Anah et al., 2008, Mugalu et 
al., 2006, Obaro et al., 2011). 
Most of the African studies are from South African or North African countries such as 
Marocco, Tunesia, Algeria and Egypt. In contrast, only a limited number of publications 
is available on SA prevalence, genotypes and prevalence of virulence factors such as 
PVL (Ako-Nai et al., 1991, Shittu et al., 2015, Phaku et al., 2016), especially in Sub-
Saharan Africa. A recent overview article showed that data about MRSA were only 




focus on CA-MRSA or CA-MSSA in African countries comprise only small isolate 
numbers of in average up to 150 isolates (Enany et al., 2010, Ramdani-Bouguessa et 
al., 2006, Ruimy et al., 2008). 
Moreover, Schaumburg et al. showed recently that the major African MSSA clones are 
heterogenously distributed and that ST5 and ST8 MRSA as well as MSSA strains are 
geographically different distributed, despite the fact that they have the similar genetic 
background (Schaumburg et al., 2014). 
Overall, the predominant strains from the North to the South of Africa are different 
(Figure 6). ST80-MRSA is prevalent in North Africa with resistance profile differences 
between the Maghreb and Egypt (Ben Nejma et al., 2013, Djoudi et al., 2013). In 
comparison, ST8-MSSA is common in Maghreb and Nigeria (Breurec et al., 2011) 
while ST5-MSSA and ST15-MSSA are more prevalent in West Africa including 
Cameroon (Breurec et al., 2011, Ghebremedhin et al., 2009). Further, ST88-MRSA is 
common in West-, Central- and East-Africa. Additionally, ST5-MRSA, ST30, ST121 
and ST152 could frequently be detected in West- and Central-Africa while ST8-MRSA 
is abundant in Central- and South Africa. In South Africa the HA epidemic clones ST22, 
also called EMRSA-15, and ST36, also called EMRSA-16, are typical STs/CCs (van 
Rensburg et al., 2010, Oosthuysen et al., 2014). Overall, CC5 as HA strain lineage 





Figure 6: Distribution of the predominant sequence types in Africa. Text fields show the 
predominant sequence types (ST) in the different African regions such as the Maghreb region and Egypt 
in North Africa, West-, Central Africa as well as in South Africa. 
Taken together, only limited data are available on SA distribution and epidemiology, 
especially for Sub-Saharan Africa. A more detailed knowledge would help to optimize 




 Objectives of this thesis 
The objective of this thesis was a comparison of isolate characteristics of community-
associated SA isolates collected from different geographies i.e. in four different African 
geographic regions and in three federal German states, as well as of isolates obtained 
by screening (nasal swabs) and from clinical origin. Furthermore, to investigate 
whether analysis of the gene content / mass spectra could be used to predict defined 
epidemiological questions and to evaluate different bioinformatic software tools for 
DNA MA data analysis. 
The thesis consists of five different evaluations:  
 Evaluation of the potential of the DNA MA array to subtype SA of nasal isolates 
collected within a 4 week-interval during state-wide routine hospital admission 
prevalence screenings (APS) in the federal state of Saarland in comparison to 
spa-typing (study A) (Ruffing et al., PLoS One, 2012) and 
 Comparison of a standardized approach for DNA MA data analysis by three 
known bioinformatic tools (study A): splits graph, hierarchical agglomerative 
clustering (HAC), and principal component analysis (PCA) - methods which 
were frequently applied in phylogenetic analysis or in genome-wide association 
studies (Ruffing et al., PLoS One, 2012). 
 Evaluation of the suitability of the DNA MA for the analysis of African isolates 
(study B) (Shittu et al., Frontiers in Microbiology, 2015). 
 Determination of the potential of DNA MA to address epidemiological questions, 
to predict the virulence potential of SA strains and to link specific genotypes with 
infection types (study C) (Ruffing et al., Scientific Reports, 2017). 
 Evaluation of mass spectrometry for SA subtyping with regard to methicillin 
resistance geographic origin of the isolates, spa-type and CC/ST.
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3 Material and Methods 
 Material 
3.1.1 Isolate collection  
This work represents a synopsis of four studies (A-D) with the overall aim of 
epidemiological comparison of SA isolates from four different African geographic 
regions and three federal German states as well as a comparison of isolates obtained 
by screening (nasal swabs) and from clinical origin. Study A was a small study based 
on the previously performed admission prevalence screening (APS) study of the 
federal state of Saarland (section 4.1) (Herrmann et al., 2013b) funded by the German 
Ministry of Health and the State of Saarland Government and performed by the State 
wide German network for the control of MRSA, MRSAarNet (www.mrsaar.net), actually 
renamed in InfectioSaar. The aim of study A was the comparison of MRSA and MSSA 
and in advance of study C for evaluation of how to perform the DNA MA data analysis. 
Study B was an independent study for evaluation of the applicability of the chosen DNA 
MA for African isolates in advance of study C (Shittu et al., 2015). Study C was a part 
of the prospective cohort study of the African-German network on staphylococci and 
staphylococcal diseases (African-German StaphNet) during the collaborative research 
project “Infection biology and epidemiology of Staphylococci and Staphylococcal 
diseases in Africa” (DFG, PAK 296). Study D was an independent study for evaluation 
of the applicability of mass spectrometry for epidemiologic analysis of SA isolates. 
The definition of criteria for the isolate inclusion in the studies A to C (e.g. 
questionnaires, case related forms) were not part of this work. 
1. Study A: Nasal isolates of all patients with nasal SA colonization admitted to any 
of the 24 hospitals in the federal state of Saarland were collected within a 4 week- 
interval during state-wide routine hospital admission prevalence screenings 
(APS) (Herrmann et al., 2013b). For each patient clinical data were also obtained 
(Herrmann et al., 2013b). From 436 MRSA overall, a collection of 46 MRSA 
isolates from the university clinic of Saarland (one per patient) with assignable 
clinical data were identified. Additionally, 46 MSSA isolates from patients 
matched according to the following clinical data of the MRSA patients: gender, 
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age (<70 vs. ≥70 years), previous hospitalization during the last 6 months were 
also selected. The study was approved by the ethic commission of Saarland 
(registration # 127 / 10). 
2. Study B: Between March 2009 and April 2010, 52 MSSA (3 nasal and 49 clinical 
isolates of wound infections) were obtained from samples collected as part of 
surveillance activities in microbiology laboratories of six health care institutions in 
Nigeria (convenience sample) (Ado-Ekiti, Ile-Ife, Osogbo, Lagos, Ibadan, 
Maiduguri) or were included from a previous study (Shittu et al., 2015). 
3. Study C: A total of 1200 SA isolates were sampled in the prospective cohort study 
of the African-German network on staphylococci and staphylococcal diseases 
(African-German StaphNet, DFG PAK 296). From each of six medical centers/ 
hospitals, three African (Lambaréné, Gabon; Dar-es-Salaam, Tanzania; Ifakara, 
Mozambique) and three German study sites (Homburg, Saarland; Freiburg, 
Baden-Württemberg; Münster, North Rhine-Westphalia), 100 consecutive SA 
isolates from clinical specimens from patients admitted to the medical centers/ 
hospitals were collected. All specimens were taken at admission or within 24 
hours. Only one isolate per patient were included. Furthermore, each study site 
contributed with a collection of 100 isolates of randomly selected healthy 
volunteers without hospital employment or other close contact to the health care 
system. Clinical information as e.g. patient history, clinical presentation risk 
factors, antibiotic treatment, surgical treatment from all participants and healthy 
volunteers were further collected by case report forms (CRF) (Appendix, section 
6.2). One of the African study sites served as primary care center for children, 
which was not the case for the German study sites leading to some misbalance 
in the patient population. 
The 1200 SA isolates were given a unique strain identification code containing 
the study site (LG= Lambaréné, Gabon, MM= Manhica, Mozambique, IT= Ifakara, 
Tanzania, HS = Homburg, Saarland, MW= Münster, Westfalen, FR= Freiburg, 
Baden-Württemberg), the strain origin (N= nasal, B= blood culture, O= wound 
infection) and a running number e. g. 1-100. 
Ethical approvals for this study was given by the Ministry of Health and Social 
Welfare of Tanzania, the Institutional Ethics Committee of the Medical Research 
Unit of the International Foundation of the Albert Schweitzer Hospital 
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(Lambaréné, Gabon), the Comité Nationale de Bioética para a Saudé (Manhiça, 
Mozambique), the Ethics Committee of the Medical Association and Medical 
Department of the Westfälische Wilhelms-University (Münster, North Rhine-
Westfalia), the Ethics Committee of the Albert-Ludwigs-University (Freiburg, 
Baden-Wuerttemberg), and the Ethics Committee of Saarland (Homburg, 
Saarland). A written informed consent was obtained from all study subjects or 
their legal guardians. 
4. Study D: 219 SA isolates (51 MRSA, 168 MSSA) of study C (n=127, section 4.3) 
and all isolates of study A (n=92, section 4.1) were used to evaluate the potential 
of subtyping of SA by MALDI-TOF. 
3.1.2 List of all analyzed SA isolates and DNA microarray data 
All SA isolates of this work (Study A to Study D) were analyzed by DNA MA. The list 
of all DNA MA hybridization signals and more detailed analysis of the DNA MA data of 
study C are shown in the attached electronic excel file (EEF) DNA MA SA data, doctor 
thesis Ruffing U. 
Additional tables in the EEF indicate the percentages of the number of isolates with 
positive hybridization signals for all DNA MA targets of study C with comparison of i) 
African versus German isolates (sheet A2), ii) clinical versus nasal isolates (sheet A3), 
the iii) clinical isolates of African versus German origin (sheet A4), iv) nasal isolates of 
African versus German origin (sheet A5), and clinical versus nasal isolates in the v) 
African isolate group (sheet A6), vi) German isolate group (sheet A7) as well as vii) 
analysis of the absolute numbers of positive DNA MA targets of the African-German 
comparison study, overall and in the ten most predominant CCs (sheet A8). 
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3.1.3 Chemicals and consumables 
 Chemicals, media and consumables  
Table 1: List of the used Chemicals, media and consumables 
Chemicals, media, consumables Manufacturer 
Identibac® S. aureus Genotyping Kit Alere GmbH, Köln/Germany 
MagAttract HMW DNA Kit Qiagen GmbH, Hilden/Germany 
Qiagen DNeasy® Blood & Tissue Kit (250) Qiagen GmbH, Hilden/Germany 
Acetonitril Sigma Aldrich, St. Louis/USA  
Blue loading buffer PEQLAB, Erlangen/Germany 
Ethanol Sigma Aldrich, St. Louis/USA 
ROTISOLV® HPLC gradient grade water Sigma Aldrich, St. Louis/USA  
100bp DNA ladder PEQLAB, Erlangen/Germany 
HCCA portioned (matrix) Bruker, Bremen/Germany 
Nuclease-Free Water Promega, Mannheim/Germany 
PastorexTM Latex Test Bio-Rad, München/Germany 
peqGOLD Hot Start-Mix Y  PEQLAB, Erlangen/Germany 
QA-Agarose TM MP Biomedicals, Illkirch/France 
SybrGold  Invitrogen, Oregon/USA 
Trifluoroacetic acid Sigma Aldrich, St. Louis/USA 
Tris Borat EDTA buffer (10x) AppliChem, Darmstadt/Germany 
TrypticaseTM Soy Agar II (TSA) + 5% sheep Becton Dickinson, Heidelberg/Germany 
USB® ExoSAP-IT Affymetrix, Inc., Ohio/USA 
CryobankTM Mast Diagnostica GmbH, Reinfeld/Germany 
eSwab  COPAN Italia S.p.A., Brescia/Italy 
inoculation loops Sarstedt, Nürmbrecht/Germany 
pipette tips Sarstedt, Nürmbrecht/Germany 
 Oligonucleotids 
The spa-typing primers spa-1113f (TAA AGA CGA TCC TTC GGT GAG C) and spa-
1514r (CAG CAG TAG TGC CGT TTG CTT) were purchased from biomers.net GmbH 
(Ulm, Germany). The stock solution of the oligonucleotides was prepared with A. dest. 
according to the manufacturer’s instructions to obtain a concentration of 100 pmol/µl. The 
spa-typing master mix consists of 10µl A. dest.,12,5 µl peqGold Hot-Start Mix Y, 0,25µl 
forward primer and 0,25µl revers primer. The aliquoted stock solution was stored 




3.1.4 Instruments and Software 
Table 2: Used instruments and softwares 
Instrument/ Software Manufacturer/Developer 
ArrayMate Reader Alere GmbH, Köln/Germany 
Biometra UNO Thermoblock Biometra GmbH, Göttingen/Germany 
Brutschrank Heraeus, Langenselbold/Germany 
FlexCycler Analytik Jena AG, Jena/Germany 
Gel electrophoresis chamber Bio-Rad, München/Germany 
Illumina MiSeq Illumina, Cambridge/UK 
Microflex LT spectrometer  Bruker, Bremen/Germany 
MIKRO 20 Hettich Zentrifugen, Tuttlingen/Germany 
Minizentrifuge Eppendorf AG, Hamburg/Germany 
Molecular Imager® GelDoc XR+ Bio-Rad, München/Germany 
MSP 96 target polished steel BC Bruker, Bremen/Germany 
Nano DropTM 2000 PEQLAB Biotechnologie GmbH, Erlangen/Germany 
Power Pac 1000  Bio-Rad, München/Germany 
Thermomixer comfort Eppendorf AG, Hamburg/Germany 
VITEK® 2 BioMérieux, Marcy-l‘Etoile/France 
Vortex Genie Scientific Industries, New York/USA 
Acrobat Reader Adobe, Dublin/Iireland 
Bioconductor packages (Gentleman et al., 2004) 
BioNumerics Applied Maths, Sint Martens Latem/ Belgium 
Biotyper Bruker, Bremen/Germany 
Flexcontrol Bruker, Bremen/Germany 
QuickCalcs GraphPad Software Inc., California/USA 
IconoClust  Alere Technologies GmbH, Jena/Germany 
ImageLabTM Bio-Rad, München/Germany 
NanoDrop 2000/2000c PEQLAB Biotechnologie GmbH, Erlangen/Germany 
NCBI BLAST package  (Camacho et al., 2009) 
R Studio R Studio Team, 2015 (R Studio: Integrated Development for 
R. RStudio, Inx. Boston, MA; http://www.rstudio.com/) 
Ridom StaphType Ridom GmbH, Münster/Germany 
RidomTM SeqSphere+ Ridom GmbH, Münster/Germany 
SplitsTree (Huson & Bryant, 2006) 
SPSS IBM, Germany 
Stats  (Quackenbush, 2001) 
Translate (ExPasy) (Gasteiger et al., 2003) 
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Instrument/ Software Manufacturer/Developer 
Word/Excel 2010 Microsoft, Redmond/USA 
 Methods 
3.2.1 Culture, basic characterization and storage 
All isolates were cultured on TSA sheep blood agar plates according to standard 
procedures and incubated at 37°C. The species’ identity of all newly collected SA 
isolates was confirmed by MALDI-TOF of pure cultures. The presence of the mecA 
gene was determined by DNA MA by the presence of the mecA gene and the SCCmec 
cassette (see section 2.1.1). All isolates were stored in Cryobank tubesTM at -80°C 
(Mast Diagnostica GmbH, Reinfeld/Germany). 
3.2.2 DNA microarray 
 DNA-preparation 
The DNA preparation was performed according to the manufacturer’s instructions of 
Qiagen in combination with additional information from the Identibac® S. aureus 
Genotyping-Kit. 
For every single isolate, the reaction tube (A2) of the Identibac® S. aureus Genotyping-
Kit containing a lysis enhancer was centrifuged for 1 min at 13226xg to concentrate 
the pellet at the bottom of the tube. In each reaction tube (A2), 200 µl of the Identibac® 
S. aureus Genotyping-Kit lysis buffer were transferred and incubated at RT for 5 min 
to activate the lysis enhancer. Three colonies of the overnight culture were inoculated 
in the suspension. The suspension was then incubated 1 h at 37°C and 550rpm. 
Afterwards, 200 µl of lysis buffer AL and 40 µl proteinase K were added. This 
suspension was mixed and incubated for 1 h at 56°C and 550rpm. After the incubation, 
the tubes were briefly centrifuged and 200 µl of 100% ethanol were added per tube. 
The whole suspension was transferred onto the provided Qiagen Kit column and 
centrifuged at 6000xg for 1 min. The flow-through was discarded and the column 
transferred onto a new tube. Next, different washing procedures followed, beginning 
with washing of the column with 500 µl of the first washing buffer (AW1) for 1 min at 
6000xg. The flow-through was discarded. Then 500 µl of the second washing solution 
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(AW2) was applied to the column on a new tube and centrifuged at 13226xg for 3 min. 
Again, the flow-through was discarded and the column was centrifuged for 1 min at 
13226xg. The flow-through was discarded and the column was transferred onto a fresh 
reaction tube. Finally, 40 µl of elution buffer (AE) were pipetted on the column, 
incubated for 3 min at room temperature and centrifuged for 1 min at 6000xg to elute 
the DNA. 
 DNA concentration measurement 
The quality and quantity of the DNA was spectrophotometrically measured with the 
NanoDrop2000 (Quiagen GmbH, Hilden, Germany) and the previously used elution 
buffer as blank value. For the DNA MA analysis, a DNA concentration of at least 
80ng/µl and a purity ratio (OD260/OD280) of 1.8 to 2.0 were necessary. 
 DNA microarray hybridization 
The original protocol of the manufacturer‘s instructions of the Identibac® S. aureus 
Genotyping-Kits without modifications was carried out (Manual Identibac® S. aureus 
Genotyping-Kit, 2015). 
In a linear PCR, one antisense primer per target was used resulting in single stranded 
DNA amplificates. Additionally, the single stranded DNA was labeled with Biotin-d-UTP 
of the B1 Master Mix of the S. aureus Genotyping-Kit during the linear PCR with 
approximately 40-fold amplification (Manual Identibac® S. aureus Genotyping-Kit, 
2015). A master mix of 4.9 µl of labelling buffer B1 and 0.1 µl of labelling enzyme B2 
was prepared. For the linear PCR, a DNA concentration of 0.5-2 µg/ 5µl was prepared 
with RNase free H2O, and 5µl of this DNA solution mixed with 5 µl of the Mastermix. 
Linear PCR protocol:  
95°C  5 min   initial denaturation  
45 cycles: 
96°C  20 sec  denaturation  
50°C   20 sec annealing 
72°C   30 sec  elongation  
4°C  ∞  cool down 
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Following the PCR, 90 µl of the hybridization buffer C1 were pipetted into the PCR 
reaction tubes while the ArrayStrips were rinsed with 200 µl of RNase-free H2O. 
Afterwards, the ArrayStrips were incubated with 200 µl of C1 hybridization buffer at 
55°C and 550rpm for 2 min. Then, the liquid was removed from the ArrayStrips and all 
amplificates were transferred onto the ArrayStrips. The ArrayStrips were closed with 
lids and incubated for 1 h at 55°C and 550rpm. 
In parallel, for every isolate a suspension of 1 µl of the C3 horseradish-peroxidase-
conjugate and 99 µl of the C4 conjugation buffer were prepared. 
After the hybridization step, the ArrayStrips were cleared from the fluids and 
subsequently washed for three times with 200 µl of C2 washing buffer. Then 100 µl of 
the C3/C4 horseradish-peroxidase mix was transferred onto the ArrayStrips and 
incubated without caps for 10 min at 30°C and 550rpm. The C3/C4 horseradish-
peroxidase mix was removed and the ArrayStrips were washed twice with 200 µl of the 
washing buffer C5. During this incubation step, the D1 horseradish-peroxdiase 
substrate was taken out of the fridge and equilibrated to RT and subsequently 
centrifuged for 1 min at 13226xg. After 10 min incubation, 100 µl of the D1 were 
pipetted into the Arrays and incubated at RT for 5 min in darkness. Finally, the whole 
fluid was removed and the ArrayStrips were measured in the ArrayMate-Reader. The 
Reader with the Iconoclust software automatically measures the grey signals in 
comparison to the background signals, interprets the signals according to predefined 
parameters and gives an exportable output for every single examined isolate. 
The signals were interpreted as positive (=target present), negative (=target absent) or 
ambiguous. For the signal analysis, there were two ways: First ambiguous signals for 
genes without allelic variants signifies that there is no clear answer about presence or 
absence of this gene. The reason for this could be poor sample or signal quality, only 
low copy numbers of plasmids especially in the case of some resistance genes as 
aacA-aphD or gene/allele mutations which influence the hybridization. Second, for 
genes with allelic variants as e.g. bbp, clfA, clfB, fnbB, set/ssl, isaB, mprF and isdA the 
probe with the strongest signal value is regarded as positive, if it exceeded a defined 
breakpoint. All other allele-specific probes are then regarded as negative, if the signal 
is below the breakpoint and ambiguous if the signal lies in between the both 
breakpoints.  
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 DNA microarray data analysis by bioinformatic methods 
For DNA microarray data analysis five different bioinformatic methods splits graph, 
affinity propagation, principal component analysis (PCA), hierarchical agglomerative 
clustering (HAC) and silhouette plot for visualization and cluster analysis were applied. 
In advance, a latent factor model was applied for DNA MA data preparation for further 
data analysis by affinity propagation, PCA, HAC and silhouette plot analysis. DNA MA 
data preparation by latent factor model, affinity propagation, PCA, HAC and silhouette 
plot for visualization and cluster analysis in study A and study C were technically 
performed by cooperation partners. 
3.2.2.4.1 Splits graph 
Splits graphs were used to analyze and visualize the data obtained by spa-typing and 
DNA MA typing. Splits graphs were originally developed to present the evolutionary 
history of a set of taxa calculated from binary or tertiary sequence data whereby the 
tree branches have defined branch lengths representing the time of divergence. For 
the construction of a split network, aligned data sequences are required (Figure 9, 10). 
These aligned data sequences can be arranged into a two-dimensional matrix of size 
N×N. 
In our case the matrix was constructed from "distances" between N genomic 
sequences of SA strains. The distance matrix is a two-dimensional array of size N×N, 
which contains the pairwise distances of a given set of N elements. Each distance 
between two sequences was set equal to the Euclidian distances between the tertiary 
sequence data encoding the present, absent or ambiguous signals of a DNA MA. 
Based on such a matrix the distances between the chosen characteristic can be 
calculated. In mathematics Euclidean distance is the straight-line distance between 
two points in Euclidean space. This means that similarity was measured based on the 
number of differing entries (hybridization signals). For simplicity, let us assume a 
scenario with 5 probes. Sample A could yield the following hybridization signal: (0 1 1 
0 1) and sample B could yield: (1 1 0 0 1). These two samples differ in the first and 
third element (probe). Thus, their Euclidian distance is 2. 
The distance between two isolate sequences is the sum of the splits, representing the 
differences which separates them. A split is a partition of the set of e.g. hybridization 
signal sequences into two disjoint groups. Splits are the elements of phylogenetic 
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trees. Each branch divides the set, of in this case sequences into a split separating the 
sequences of the one side of the branch to the sequences of the other side. The 
number of splits represented by the different branches in an unrooted phylogeny 
contains all the branching information of the phylogeny. This is a so-called set of splits. 
In this work the distances are the sum of differences in the sequences i.e. the number 
of positions in the sequence where the hybridization signals are not identical. In this 
way, splits graphs visualize characteristic differences between the signals in larger 
data sets (Huson & Bryant, 2006). 
Splits graphs in this work were constructed based on the neighbor-net which is one of 
the most frequently applied distance-based methods for phylogenetic analyses (Bryant 
& Moulton, 2004). It constructs splits networks from inferred distance matrices and 
applies an agglomerative process to create a phylogenetic tree (Huson & Bryant, 
2006). 
 
Figure 7: Visualization of the agglomerative process of the neighbor-joining method. (A) First each 
node represents a single hybridization signal sequence. (B) Based on the selection criterion b and c 
were identified as neighbors. Additionally, e and f were identified as neighbors, too. (C) E has been 
identified as a neighbor of d and of f. (D) Because e has two neighbors, a reduction is performed, 
replacing d, e, f by x, y. Figure adapted from Bryan & Moulton, Molecular Biology and Evolution, 2003. 
The distance matrix was calculated based on the proportion of positions which were 
different between two sequences or hybridization patterns. In a binary alignment (i.e. 
an alignment with two different elements p=positive and n=negative), or tertiary 
alignment (i.e. an alignment with three different elements p =positive, n=negative, and 
a=ambiguous) every difference (e.g. a “p” instead of an “n” at the equivalent position 
in a column) leads to a split of the sequences. In the graph, one line splits up into two 
different lines at the point of difference in the alignment (Figure 8). This point of 
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separation of the line at the point of difference is named split in graphical presentations 
(Figure 8). 
 
Figure 8: Two splits graph without (A) and with (B) possible recombination event for four 
sequences as examples for explanation constructed based on the neighbor-joining method. A 
box (highlighted in blue) represents a possible recombination event. 
A difference means that there is i.e. a positive instead of a negative signal at the same 
position of two sequences in an alignment as shown in Figure 9 for gene 4 of isolates 
one and two. 
 
 
Figure 9: Presentation of a tertiary alignment. An alignment with three different kinds of hybridization 
signals is shown, with “a” as symbol for an ambiguous hybridization signal, “p” for a positive hybridization 
signal and “n” for a negative signal. All splits in the alignment are highlighted by a bar. Columns represent 
different hybridization signals and rows represent different isolates. 
As mentioned before, the evolutionary distance equals the sum of the length of the 
branches along the way from e.g. hybridization signal 1 to hybridization signal 4. If 
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there is no possible recombination event, splits are connected by the shortest direct 
connection line, named branch (Figure 8A). Possible events of recombinations are 
represented as boxes (Figure 8B, highlighted in blue). Graphically these are parallel 
lines in the splits graph. 
In this work, splits graphs were applied for comparison of DNA MA analysis (study A) 
to spa-typing analysis as reference method routinely used in microbiology labs (section 
4.1) and for analysis of DNA MA data of a small selection of Nigerian SA isolates (study 
B, section 4.2). 
The splits graphs were created based on the DNA MA data organized as alignments 
as shown exemplary in Figure 9 and 10. For analyzing the DNA MA data by splits 
graphs, the hybridization signals (e.g. positive/negative hybridization signal of a 
gene/allele) were organized in a matrix. This means that the DNA MA hybridization 
signals of all analyzed SA isolates were aligned like SA sequences to obtain the 
required data matrix (Figure 10). 
The SplitsTree software (Huson & Bryant, 2006) was used to analyze the similarities 
between the hybridization patterns of 46 MRSA and 46 MSSA isolates of study A 
(shown in section 4.1), and of 52 Nigerian MSSA isolates (study B, shown in section 
4.2). The DNA MA results were imported into the SplitsTree software (Huson & Bryant, 
2006) as alignments in a FASTA format and the DNA MA hybridization results were 
converted into a “pseudo” nucleotide code consisting of the three symbols “g” (negative 
hybridization signal), “a” (ambiguous) and “c” (positive hybridization signal) (Figure 10). 
 
Figure 10: Part of a tertiary alignment in a FASTA format of the DNA microarray hybridization 
sequences after conversion into a pseudo” nucleotide code consisting of the three symbols “g” 
(negative hybridization signal), “a” (ambiguous) and “c” (positive hybridization signal). 
The splits graphs were constructed using SplitsTree versions 4.10 (Figure 15, 17) and 
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4.11.3 (Figure 20) with default settings (characters transformation, uncorrected P; 
distance transformation, neighbor-net; variance, ordinary least squares). 
Additionally, splits graphs were automatically constructed by the software SplitsTree 
(Huson & Bryant, 2006) based on the spa-typing data of the 46 MRSA and 46 MSSA 
(Figure 14) and the 43 CC5 SA isolates (Figure 16) obtained from study A. First a 
cost/distance matrix (Figure 11) was calculated by the based upon repeat pattern 
(BURP) algorithm of the Ridom StaphType software (Ridom, Münster, Germany) 
based on the spa-typing data. This cost/distance matrix was transferred via an 
automatically link of the Ridom StaphType spa-typing software to SplitsTree. 
 
Figure 11: Part of the cost/distance matrix calculated by the based upon repeat pattern (BURP) 
algorithm of the Ridom StaphType software (Ridom, Münster, Germany) based on spa-typing 
sequence data of 92 Staphylococcus aureus isolates. 
Next, the software SplitsTree calculated the splits and constructed the graph based on 
the computed export cost/distance matrix (Figure 12) from Ridom StaphType. 
 
Figure 12: Part of the calculation of the splits based on a previously computed cost/distance 
matrix. 
3.2.2.4.2 Imputing ambiguous data points with Latent factor model (LFM) 
As described in section 3.2.2.3, the DNA MA hybridization pattern reader automatically 
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categorized the signals in “absent“, “present“ or “ambiguous” hybridization signal. In 
our case, "absent" entries were represented as 0 values and "present" entries as 1. 
"Ambiguous" values are those with ambiguous hybridization signals represented as “-“. 
As described below, DNA MA data were processed with methods for dimensionality 
reduction such as affinity propagation, HAC and PCA. The aim was to identify those 
hybridization probes (genes) distinguishing rather homogeneous groups of samples. 
Before doing this, we had to deal with the “ambiguous” values that typically represent 
about 5% of the measured data points. One possible strategy of dealing with the 
ambiguous values is to replace these values by an intermediate value i.e. 0.5. 
However, this would mean that we would treat these values with a definite level of 
certainty which may be inappropriate because there may exist many different reasons 
why these values were returned as ambiguous. Another strategy is to filter out all 
hybridization probes (genes) or samples that contain at least one ambiguous value. 
However, in our case this would reduce the number of probes or samples to a fairly 
small number. Finally, we decided on a strategy whereby ambiguous values are 
replaced by binary “positive” or “negative” values based on a prediction model using 
Latent Factor Models (LFM) applied by the bioinformatic collaborator Ruslan Akulenko. 
In the area of data sciences, this type of task is referred to as “data imputation” and is 
typically solved by predictions based on the values of the remaining data. 
LFM are popular methods in predicting missing data for example in image 
reconstruction, see e.g. (Candès & Recht, 2012, Koren et al., 2009). The mathematical 
details of the LFM method are described by the collaborators (Akulenko et al., 2016). 
Briefly, the LFM method is able to complete missing data points in a matrix by 
constructing two accessory matrices that, when multiplied with each other, closely 
match the known values of the original matrix. The accuracy of the LFM prediction was 
tested by random deletion of 5% of the (known) positive (1) and negative (0) entries. 
Next, these missing entries were predicted by LFM and the calculated results were 
compared with the original data. This reconstruction of known data had an accuracy of 
97%. Thus, it can be assumed that also the predicted values that replace the 
ambiguous values will have a similar accuracy. As mentioned before, the 5% 
percentage of deleted entries corresponded with the number of ambiguous signals 
detected in the DNA MA experiments.  
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3.2.2.4.3 Affinity propagation 
Affinity propagation was applied for DNA MA data analysis of study C. Affinity 
propagation is a sophisticated clustering algorithm (Frey & Dueck, 2007), which 
identifies exemplars and clusters. As with any other clustering method, a “cluster” 
contains a group of samples that are more homogeneous to each other than to the 
remaining samples. Exemplars are members of the given data set that are 
representatives for the identified clusters. For each cluster, affinity propagation outputs 
one exemplar. Affinity propagation uses a measure of similarity between pairs of data 
points as input (here the similarity of DNA MA hybridization profiles of the isolates). In 
contrast to other clustering algorithms affinity propagation does not need the number 
of clusters to be determined or to be estimated for starting the algorithm. The number 
of clusters is automatically determined by the algorithm in an optimal way. 
3.2.2.4.4 Principal component analysis (PCA) 
The Principal component analysis (PCA) is essentially a method for dimension 
reduction to extract relevant information from large complex data sets. The method 
was used in three studies of this work (study A, section 4.1, study C, section 4.3 and 
study D, section 4.4). In study A and C, it was applied for more detailed SA DNA MA 
data analysis. In study D it was applied for the evaluation of the subtyping potential of 
SA based on their total mass spectra. 
For this, PCA transforms (projects) the original data onto a new set of uncorrelated, 
orthogonal basis vectors (principal components). The first principal component (PC) is 
directed along the direction with largest variance in the data, the second PC is 
orthogonal to the first PC and points along the direction of second-largest variance and 
so forth. In our case, the dimensionality of the original data is equal to the number of 
DNA MA target sequences. The variance in this data reflects the differences between 
the binary hybridization signals of the probes. An important property of PCA is that – 
by way of construction – the first few PCs describe most of the variance in the data 
(Marques et al., 2008). Thus, the full data set can be projected on the first two or three 
PCs and visualized in a 2D- (e.g. Figure 18, 24) or 3D-plot (e.g. Figure 25, 26) without 
losing too much information. This data compression captures most of the variation 
among the samples and visualizes similarities and differences in a readily accessible 
fashion. In our case, the PCs will point along those DNA MA probes that show the 
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largest variation of hybridization among the samples. Samples with similar DNA MA 
hybridization profiles are arranged closer to each other in the 2D/3D plot compared to 
samples with larger differences (Caddick et al., 2006). 
For the PCA, in study A and study C the data were preprocessed basically as for the 
cluster dendrogram. Again, all probe IDs containing ambiguous results were replaced 
by LFM. This was done for all DNA MA data of the 92 isolates of study A and for all 
1200 African and German SA isolates of study C. The main PC vectors identified by 
PCA have the largest coefficients in the fields corresponding to those MA probes were 
the samples differ most. In this case, we focused our analysis on projections along the 
first two PC. The PCs were computed by the R function prcomp in the package „stats“. 
3.2.2.4.5 Hierarchical agglomerative clustering dendrogram (HAC) 
HAC was applied for DNA MA data analysis of study A (Figure 19). This method 
constructs a dendrogram, a branching tree diagram which represents the hierarchy of 
clusters based on the degree of similarity or number of shared characteristics of the 
data. The method was applied in our study with 43 CC5 SA isolates of study A using 
DNA MA hybridization data (Figure 19). The distance along the tree from one element 
to the next one represents the relative degree of similarity, while short distances 
representing high similarities. In this bottom-up approach every character (e.g. 
hybridization signal or isolate) represents an individual cluster at the beginning. Then, 
at each step the most similar elements (e.g. isolates with the most similar hybridization 
pattern) are pooled into a new larger cluster until all entries are connected (Figure 13). 










Figure 13: Presentation how a dendrogram is constructed by the hierarchical agglomerative 
clustering algorithm. As indicated by the name, this type of clustering proceeds in a bottom-up fashion. 
Initially, every element (sample) is considered as a single cluster (shown at the top). Then, the pairs 
with smallest pairwise distance are connected to each other. In this example, elements (1) and (2) are 
connected at this step, as well as (4) and (5). Subsequently, element (3) is merged with the cluster 
containing elements (1) and (2) because its distance to these elements is smaller than to the other 
elements. In this way, step by step, smaller clusters are merged into larger clusters until one large cluster 
remains in the end. One important decision during this clustering procedure is to decide at which 
distance threshold the clustering should be halted. This then determines the final number of obtained 
clusters. 
In our case, similarity was measured by the Euclidian distance of the DNA MA 
hybridization profiles. In mathematics Euclidean distance is the straight-line distance 
between two points in Euclidean space. This means that similarity was measured 
based on the number of differing entries (hybridization signals) between two vectors 
holding the hybridization signals of two samples. For simplicity, let us assume a 
scenario with 5 probes. Sample A could yield the following hybridization signal: (0 1 1 
0 1) and sample B could yield: (1 1 0 0 1). These two samples differ in the first and 
third element (probe). Thus, their Euclidian distance is 2. 
Before hierarchical clustering, all probe identifications with ambiguous results were 
replaced by imputed values predicted with LFM method as described in section 
3.2.2.4.2. Thereafter, each isolate contains only negative (0) or positive (1) values. 
Next, the phylogenetic–like analysis was performed with the HAC algorithm of the 
program R suite (version 2.13.1) (Ihaka & Gentleman, 1996, R Development Core 
Team, 2008), together with Bioconductor packages (Gentleman et al., 2004) as well 
as the software package Stats. Stats computes a Euclidean distance matrix to measure 
the similarity of the target sequence hybridization profiles in the different SA isolates 
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with the software tool „dist“ (distance) function in the software package „Stats“ (R, 
version, 2.13.1). Then, the cluster dendrogram was constructed using the HAC method 
and the “hclust” function of „Stats“ based on Ward’s method (Pryer et al., 2001, 
Quackenbush, 2001). 
3.2.2.4.6 Silhouette plot for clustered data 
The silhouette plot was applied in study C to confirm, if the subjectively assigned 
isolates to clusters, really belong to these cluster based on a dispassionate 
mathematical evaluation. 
Here, data (e.g. isolates/hybridization signals) is clustered by the K-means clustering 
algorithm. At the beginning, this algorithm arbitrarily selects a given number of K data 
points (single isolates of the isolate set) as centers of K clusters. All remaining data 
points are assigned to the closest one of these cluster centers. These “clusters” will 
initially not be very homogeneous. Then for each cluster, a new central data point is 
determined that is really in the center of its current members. Afterwards, all data points 
are again assigned to the cluster with the closest center point. For some points, nothing 
will change. Other points may now be assigned to a different cluster. This procedure 
is iterated until the cluster centers remain stable. 
One open point in this is to choose the optimal number K for the number of clusters. 
This depends on the data set. As optimality criterion the so-called silhouette analysis 
uses the silhouette value. The silhouette value compares how close each data point 
(e.g. isolate) of a cluster is to the other points (e.g. isolates) in the same cluster relative 
to its distance to points in neighboring clusters. In our case distances reflect the 
Euclidean distance as explained before. Basically, this method measures the strengths 
of a cluster or how good the assignment of a point (e.g. isolate/hybridization signal) to 
a cluster (e.g. African isolate group, or adhesion gene group) is. The values range from 
[-1, 1]. That way, it can be controlled by PCA if a subjectively recognized isolate group 
or the amount of recognized isolate groups is correct. If the silhouette coefficients are 
close to 1, the point/isolate is located far away from the next cluster. A value close to 
0 indicates that this isolate is close to or is lying on the threshold value between two 
adjacent clusters. Negative values indicate that these isolates are possibly assigned 
to the wrong cluster. 
The silhouette analysis was performed with the software “R”, version 3.2.2, function 
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silhouette and package “cluster” version 2.0.3 based on default parameters. 
Afterwards, K is selected that yields a maximal silhouette value. 
3.2.3 MALDI-TOF analysis 
 Culture and MALDI-TOF performance 
For the MALDI-TOF analysis of the SA isolates of the fourth study, freshly streaked 
blood agar plates were prepared from one-day old blood agar plate cultures. Applying 
the whole cell measurement method, one bacterial colony was picked with a toothpick 
and transferred onto the predefined spot of the MALDI target plate. For each isolate, 
eight colonies were streaked on eight individual spots of the target plate. The 
measurement was repeated on three different days. The dried spots were covered with 
1 µl of the matrix (Table 1). The target plate with the different isolates was analyzed in 
a Microflex LT spectrometer (Bruker Daltonics) using the preinstalled AutoXecute 
method as soon as every single spot covered with matrix was dried. 
 Mass spectra analysis 
Mass spectra analyses were performed in study D using the mass spectra tools as well 
as mathematical and statistical methods of the software BioNumerics, version 7.5. The 
spectra data files of all 219 measured SA isolates were imported into BioNumerics. 
Then all MALDI TOF spectra and the DNA MA data were assigned to the individual 
isolates using the isolates’ unique identifier. 
Additionally, all available information of geographic origin, spa-type and CC were 
imported as a table into BioNumerics. The data of the single isolates could be 
connected by the isolates’ unique identifier. 
3.2.3.2.1 Mass spectra preprocessing and PCA 
All mass spectra were preprocessed for further analysis. For this, smoothing and 
baseline subtraction of the uploaded isolate spectra as well as a peak matching were 
performed. This consists of a background subtraction using a rolling disc algorithm, a 
noise removal with a Kaiser window and peak detection with a continuous wavelet 
algorithm (Vranckx et al., 2017). These steps prepare the spectra for application of 
similarity coefficients such as Pearson correlation coefficient as well as PCA. These 
steps are necessary to obtain the same basic level on the y axis of all single spectra 
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and to order peaks of the same mass to charge ratio at the same position on the x-
axis. This step eliminates the “background noise”. Next, different comparisons were 
performed with the BioNumerics software where the mass spectra of SA isolates of 
different spa-types, different CCs, methicillin-susceptible and methicillin-resistant SA 
and of different geographic origin were compared using PCA. 
3.2.3.2.2 Mass spectra identification projects with Support Vector Machine 
With a Support Vector Machine (SVM) so called identification projects were performed 
(Vranckx et al., 2017). The SVM predicted if the mass spectra were true positively, 
false negatively or false positively assigned or not assigned to the known, predefined 
subgroup of the SA isolates (e.g. spa-types, CCs, MRSA or MSSA). 
A SVM is a specific mathematical algorithm for pattern recognition, also called 
classifier. It performs an identification or classification. This means the algorithm 
assigns biological samples or mass spectra to user defined classes e.g. CC or spa-
type using their mass spectra based on the mass spectra of a training set, for example 
SA isolates with already known CC or spa-type. The information about e.g. CC or spa-
type were previously imported as well as the mass spectra profiles into BioNumerics 
and could be assigned by the isolates’ unique identifier. 
First the classifier was trained with a training set of mass spectra from isolates with 
known classes. After training of the classifier, a cross validation analysis was 
performed. In a cross-validation analysis k mass spectra are removed from the training 
set, treated as unknown and their class is predicted by the classifier using the 
remaining k-1 mass spectra of the training set. This is done for a specified percentage 
of the training set, typically 100% as in this work. The number of false and true positives 
and false and true negatives as well as unassigned isolates are reported to evaluate 
the performance of the identification which led to a confusion matrix (error matrix). In 
the confusion matrix each predefined group e.g., geographic origin is represented as 
column and the predicted group e.g., African or German as row. This can provide 
additional information about the identification and help to identify groups that cannot 
be differentiated from each other but can be differentiated from the remaining groups. 
This is an internal validation as the complete training set has been used to train the 
classifier. If enough isolates are available, at least 10% can be left out of training and 
the classifier can be applied to this 10% and the results can be compared to the true 
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classes. This external validation was not performed due to an insufficient size of the 
groups in our study. 
3.2.3.2.3 Identification project or pairwise comparisons 
Detailed pairwise comparisons or so-called identification projects were performed 
between two entries of mass spectra of the comparison data sets or in this case the 
mass spectra subgroups and defined groups (spa-type, clonal complexes, resistance 
group, geographic origin) from the database with previously imported isolate data. The 
aim was to determine if they were correctly assigned to the previously defined groups. 
The respective results were displayed as percentage of similarity for all pairwise 
comparisons. 
Then the classifier, in this work the Support Vector Machine (SVM), is chosen. A cross 
validation analysis was performed as described in section 3.2.3.2.2 for the classifier 
training but without removing of any mass spectra which led to a confusion matrix (error 
matrix). The confusion matrix provides the results, the objective estimation of the 
classifier’s performance. In this study it means if the SA isolates were correctly 
assigned to the predefined categories geographic origin, methicillin resistance, spa-
type and CC. 
3.2.3.2.4 Statistical analysis of peak intensities 
Statistical analysis was performed on the peak intensities with the aim to identify 
characteristic peak classes of different CCs. First, a cluster analysis was performed 
using Pearson correlation and UPGMA (unweighted pair group with arithmetic mean) 
as statistical tests. Next, the intensities of the peak classes of the spectra were 
compared using the Mann-Whitney test with Bonferroni procedure for correction of 
multiple testing. Peaks with significant values for a specific CC were considered 
potential discriminative peak candidates. Furthermore, randomly selected spectra of 
different CCs were visually compared at the identified peak values. These peaks were 
assumed to be potentially mutated proteins or differentially expressed proteins. To 
determine which proteins were represented by these peaks, an in-silico databank 
search was carried out with the ExPASy software tool “Translate” provided by the 
Swiss Institute of Bioinformatics. The identified peak mass values were entered in the 
ExPASy software tool and potential proteins for this value were identified according to 
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a predefined range. 
3.2.4 Spa-typing 
The DNA was extracted by inoculation of 5 colonies from freshly streaked blood agar 
plates into 200 µl A. dest and incubated for 10 min at 95°C and 550rpm. Next, the 
tubes were centrifuged for 3 min at 13226xg to sediment cell debris. Then the following 
master mix was prepared for the spa-PCR (per isolate): 10 µl H2O, 12.5 µl PCR–Mix 
(peqGOLD Hot-Start-Mix Y), 0.25 µl forward primer spa-1113f and 0.25 µl reverse 
primer spa-1514r. Finally, 2.5 µl of the DNA-containing supernatants were added. 
spa-PCR protocol: 
95°C  5 min   initial denaturation 
35 cycles: 
94°C   45 sec denaturation 
60°C  45 sec annealing 
72°C   90 sec  elongation  
96°C  20 sec  denaturation  
72°C   90 sec  final elongation  
4°C  ∞  cool down 
After the PCR, the amplificate was digested to cut off the primer sequences. To this 
end, 5 µl of the enzyme ExoSAP-IT and 5 µl of the amplificate were mixed, centrifuged 
and incubated for 15 min at 37°C and then for 15 min at 80°C. For the PCR control, 
3 µl of the amplification product were visualized on a 1% TBE agarose gel. The 
amplification products were separated on a 1% agarose gel together with a ladder, a 
negative and a positive control at 150V for 35 min. 
Amplificates were sent to GATC Biotech AG (Konstanz) for sequencing of the gene 
spa. Sequence files of spa were downloaded and analyzed using the semiautomatic 
Ridom StaphType software for spa-sequence analysis. 
3.2.5 Multi locus sequence typing (MLST) 
MLST analysis (Enright et al., 2000) of 12 SA isolates of study C for CC determination 
was carried out by our cooperation partners in Münster. 
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3.2.6 Whole genome sequencing for DNA MA concordance analysis and 
analysis of nucleotide sequences of three genes (panD, rpmG, and rpmD) 
The accuracy of the DNA MA was validated by WGS analyses of 154 representative 
isolates (Strauss et al., 2016). A motivation for WGS was that the DNA MA technique 
does not enable distinction between allelic variants or gene polymorphisms, which are 
not represented on the array as suspected for the SA adhesion gene map/eap in study 
C. 
Additionally, analysis of nucleotide sequences of the two ribosomal genes rpmG, rpmD 
and the aspartate 1 decarboxylase panD to determine potential sequence mutations 
was performed in cooperation with the Institute for Hygiene, UKM, Münster using 
RidomTM SeqSphere+, as described by Strauss et al., 2016. 
3.2.7  Statistical methods  
 Chi square test 
Univariate analysis of patient data and of gene distribution in MSSA vs. MRSA of study 
A (section 4.1) were performed using GraphPad QuickCalcs Web site (GraphPad 
Software Inc.) (http://graphpad.com/quickcalcs/contingency1/). 
P-values of CC and gene distribution of study C with 1200 African and German SA 
(section 4.3) were calculated by Chi-square tests with Hommel correction for multiple 
testing using R Studio Team (2015) (R Studio: Integrated Development for R. RStudio, 
Inx. Boston, MA; http://www.rstudio.com/). 
 Median of age 
Median ages of volunteers and patients of the African and German SA study 





4.1 Determination of clonal lineages and gene distribution of MRSA and 
matched MSSA by DNA MA 
Using a collection of 46 MRSA and 46 matched MSSA the MRSA and MSSA clonal 
lineages of community-associated SA isolates of the federal state of Saarland were 
analyzed. Further, it was analyzed which one of three different bioinformatic methods 
(splits graph, hierarchical agglomerative clustering [HAC], and principal component 
analysis [PCA]) is the most appropriate DNA MA data analysis method. In comparison 
to DNA MA data analysis by splits graph, spa-typing data were also analyzed by splits 
graph. Furthermore, the presence of resistance and virulence gene distribution in 
MRSA in comparison to MSSA were regarded. 
4.1.1 DNA MA and spa-typing data of stem collection 
The spa-typing and DNA MA analyses identified in total 13 different spa-types 
belonging to 5 CCs among the MRSA isolates and 33 spa-types belonging to 13 CC 
types among the MSSA isolates (Table 3 and 4). CC5 (n=41, 89.1%), the so-called 
Rhine-Hesse epidemic strain was the predominant strain type among the MRSA with 
30 (78%) isolates belonging to t003 (Table 3). In the MSSA group spa-types t012 (n=6, 
13%) and t015 (n=5, 10.9%) were most commonly found (Table 4). CCs being present 
in both the MRSA as well as in the MSSA isolate group were the epidemic CCs CC5, 
CC8, CC22, CC45 and the zoonotic lineage CC398. CCs only found in the MSSA 
group were CC1, CC7, CC15, CC30, CC78, CC97 and CC101. No MRSA specific CCs 
were detected. The three spa-types t002, t008 and t015 were found in the MRSA as 
well as in the MSSA group. 
DNA MA analysis showed furthermore that 38 (83%) of the MRSA isolates belonged 
to SCCmec type II, four isolates (9%) belong to SCCmec type IV and one isolate (2%) 
belong to SCCmec type. However, the SCCmec type of three isolates (7%) could not 




Table 3: List of the CCs, spa- and SCCmec types of the 46 MRSA collected during the admission 
prevalence screening of the federal state of Saarland. List is sorted according to CC and spa-
type. na=not available 
Isolate CC/ST spa-type SCCmec type  numbers 
R11 CC5 t002 II 1 
R1, R2, R3, R6, R9, R10, R12, R13, R15, R16, 
R19, R20, R24, R25, R27, R30, R31, R32, R33, 
R34, R35, R36, R37, R38, R39, R40, R41 
CC5 t003 II 27 
R21, R22, R23 CC5 t003 na 3 
R5 CC5 t010 II 1 
R14 CC5 t045 II 1 
R29 CC5 t481 II 1 
R4, R8, R17, R18 CC5 t504 II 4 
R7 CC5 t887 II 1 
R26 CC5 t1079 II 1 
R28 CC5 t3195 II 1 
R42, R43 CC8 t008 IV 2 
R46 CC22 t022 IV 1 
R45 CC45 t015 IV 1 





Table 4: List of the CCs and spa-types of the 46 MSSA collected during the admission prevalence 
screening of the federal state of Saarland. List is sorted according to CC and spa-type. 
Isolate CC spa-type Numbers 
S40 CC1 t8864 1 
S42 CC5 t002 1 
S43 CC5 t493 1 
S41, S44 CC7 t091 2 
S28 CC8 t008 1 
S38 CC15 t018 1 
S34, S37 CC15 t084 2 
S36 CC15 t306 1 
S35 CC15 t8786 1 
S26 CC22 t005 1 
S24 CC22 t310 1 
S25 CC22 t625 1 
S27 CC25 t078 1 
S2, S3, S5, S6, S7, S10 CC30 t012 6 
S4 CC30 t019 1 
S8 CC30 t273 1 
S1 CC30 t584 1 
S9 CC30 t8831 1 
S13, S16, S17, S19, S22 CC45 t015 5 
S23 CC45 t026 1 
S11 CC45 t040 1 
S18 CC45 t050 1 
S14 CC45 t073 1 
S21 CC45 t339 1 
S15 CC45 t620 1 
S12 CC45 t1689 1 
S20 CC45 t2239 1 
S39 CC88 t8863 1 
S29 CC97 t131 1 
S31, S32, S33 CC97 t267 3 
S30 CC97 t8830 1 
S45 CC101 t4044 1 
S46 CC398 t571 1 
4.1.2 Cluster analysis of total stem collection 
Splits graph (Huson & Bryant, 2006) were evaluated for visualization of the spa-typing 
data and for the capability of the DNA MA array to further differentiate the 46 MRSA 




4.1.2.1 Splits graph of 46 MRSA and 46 MSSA based on spa-typing data 
Splits graph of the spa-typing data scattered the isolate set into nine different isolate 
groups (cluster 1, 2, 4, 5, 6, 7, 8, 10, 12), and five single isolates (cluster 3, 9, 12, 13, 
14) (Figure 14, Table 5) and indicated how the individual groups are placed in relation 
to each other. 
 
Figure 14: Spa-typing data-based diversity analysis of 46 MSSA (S1-S46) and 46 MRSA (R1-R46) 
isolates. Splits graphs were constructed based on spa-typing data and a calculated cost distance matrix 
by direct data transfer from Ridom StaphType to splits tree (Huson & Bryant, 2006). The predominant 
spa-types of this study, t003 (grey circles), t012 (purple circles) and t015 (orange circles) are highlighted. 
Isolates of the same clonal complexes (CC) are framed by tetragons. All isolates groups were numbered 
(1-14). Figure adapted from Ruffing et al., PLoS One, 2012. 
Based on the Ridom database 61 isolates of 17 spa-types could be assigned to a CC 




Splits graph analysis of the spa-typing data allowed to assign 19 more isolates to the 
following CC/ST isolate groups: CC5 (n=9), CC22 (n=1), CC30 (n=3), CC45 (n=5), 
ST15/ST18 (n=1). 
In both cases most isolates were assigned to the CC5 group (n=43, 47%) (Table 5). 




CC/ST assignment described by 
Ridom spa server database 
Additional assignment 
by splits graph 
Isolate 
1 43 t002 CC5  R11, S42 
t003 CC5  R1, R2, R3, R6, R9, R10, 
R12, R13, R15, R16, R19, 
R20, R21, R22, R23 R24, 
R25, R27, R30, R31, R32, 
R33, R34, R35, R36, R37, 
R38, R39, R40, R41 
t010 CC5  R5 
t045 CC5  R14 
t306 na CC5 S36 
t481 na CC5 R29 
t504 na CC5 R4, R8, R17, R18 
t887 na CC5 R7 
t1079 na CC5 R26 
t3195 na CC5 R28 
2 4 t005 CC22 CC22 S26 
t022 CC22 CC22 R46 




3 1 t1689 na 
 
S12 
4 2 t091 ST7 
 
S41, S44 
5 3 t084 ST15, ST18 
 
S34, S37 
t8786 na ST15, ST18 S35 
6 2 t011 na  R44 
t571 na  S46 
7 11 t012 CC30 CC30 S2, S3, S5, S6, S7, S10 
t018 CC30 CC30 S38 
t019 CC30 CC30 S4 
t584 na  S1 
t8831 na  S9 
t8864 na  S40 
8 13 t015 CC45  R45, S13, S16, S17, S19, S22 
t026 CC45  S23 




t073 na CC45 S14 
t339 na CC45 S21 
t620 na CC45 S15 
t2239 na CC45 S20 
9 1 t8863 na  S39 
10 6 t131 na  S29 
t267 na  S31, S32, S33 
t8830 na  S30   
t273 na  S8 
11 3 t008 CC8  R42, R43, S28 
12 1 t493 na  S43 
13 1 t078 ST-26  S27 




4.1.2.2 Splits graph of 46 MRSA and 46 MSSA based on DNA MA data 
Splits graph analysis (Huson & Bryant, 2006) based on the DNA MA hybridization 
profiles identified 13 clusters with the most frequent ones being CC5 (n=43), CC45 
(n=14), CC30 (n=9), CC15 (n=5) and CC97 (n=5) (Figure 15, Table 6). 
Splits graph based on DNA MA data presented in detail how the single isolates are 
placed in relation to each other and that isolates of the same CC as S12 of CC45 and 
S43 of CC5 build one common group (Figure 15, Table 6). 
 
Figure 15: DNA microarray (MA) data-based diversity analysis of 46 MSSA (S1-S46) and 46 MRSA 
(R1-R46) isolates. Splits graphs were constructed based on the DNA MA hybridization profiles in 
FASTA format on default settings using splits tree. The positive, negative and ambiguous hybridization 
results represented as 1 (present), 0 (absent) and “-“ (ambiguous) in the DNA MA results presentation 
were converted into a nucleotide code: 1=c, 0=g, “-“=a. Columns represented the target sequences and 
the rows represent the isolates. Isolates of the same clonal complexes (CC) are framed by tetragons. 
CCs with the largest isolates numbers (e.g. CC5 [blue], CC45 [red] and CC30 [green]) are encircled by 
coloured tetragons. The predominant spa-types of this study, t003 (grey circles), t012 (purple circles) 





Table 6: List of the CC groups and assigned isolates based on the DNA MA data derived splits 
graph analysis. 
CC group numbers Isolate 
CC1 1 S40 
CC5 43 
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, 
R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R24, 
R25, R26, R27, R28, R29, R30, R31, R32, R33, R34, R35, 
R36, R37, R38, R39, R40, R41, S42, S43 
CC7 2 S41, S44 
CC8 3 R42, R43, S28 
CC15 5 S34, S35, S36, S37, S38 
CC22 4 S24, S25, S26, R46 
CC25 1 S27 
CC30 10 S1, S2, S3, S4, S5, S6, S7, S8, S9, S10 
CC45 14 
R45, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, 
S21, S22, S23 
CC88 1 S39 
CC97 5 S29, S30, S31, S32, S33 




4.1.2.3 Comparison of the splits graph of 46 MRSA and 46 MSSA based on spa-
typing and DNA MA data 
Comparison of both splits graphs revealed a different assignment of five MSSA isolates 
in the two splits graphs for S8, S12, S36, S38, and S43 (Table 7). Based on the spa-
typing data S12 and S43 were singletons whereas DNA MA data grouped S12 with 
CC45 and S43 with the CC5 isolate group, respectively. Isolate S8 was assigned to 
CC97 by spa-typing data but to CC30 by DNA MA data. Similarly S36 were assigned 
to CC5 by spa-typing data but to CC15 based on DNA MA data, and S38 was assigned 
to CC30 based on spa-typing data but to CC15 based on DNA MA data. 
Table 7: Comparison of the assignment of five MSSA isolates in splits graphs based on spa-
typing and DNA MA data. 
Isolate spa-type DNA MA CC 
Assignment in splits graph 
based on spa-typing data to 
cluster of CCx isolates  
Assignment in splits graph 
based on DNA MA data to 
cluster of CCx isolates 
S8 t273 CC30 CC97 CC30 
S12 t1689 CC45 no assignment CC45 
S36 t306 CC15 CC5 CC15 
S38 t018 CC15 CC30 CC15 




Further, comparison of the splits graphs based on spa-typing and DNA MA data 
showed a different order and number of clusters in the splits graphs as well as of single 
isolates. Splits graph based on spa-typing yielded 9 clusters and six singletons. Splits 
graph based on DNA MA generated 13 clusters with four singletons. Singletons S27, 
S39 and S45 are identical in both splits graphs. Only isolate clusters of CC7 and CC15 
or CC30 and CC45 were in both splits graphs in direct neighborhood to each other. All 
other isolate clusters showed an incomparable order with different CCs assembling in 
both splits graphs, as neighbours as could be seen for example for the CC30 and 
CC398 clusters. 
4.1.3 Cluster analysis of 43 CC5 isolates by splits graphs based on spa-typing 
and DNA MA as well as by PCA and HAC based on DNA MA 
Isolates belonging to CC5 dominated the isolate collection. Splits graph analysis of the 
whole collection of 92 isolates allowed only a rough isolate group assignment. In order 
to increase the resolution within this CC, splits graphs as well as to two further 
bioinformatical methods, i.e. PCA and HAC were next used to evaluate isolates 
belonging to CC5 only. 
4.1.3.1 Splits graph of 43 CC5 isolates based on spa-typing data 
Splits graph analysis of the 43 CC5 isolates (MRSA R1-41 and MSSA S42, S43) based 
on the spa-typing data yielded in spa-type specific subgroups of isolates of spa-type 





Figure 16: DNA microarray subclassification analysis of the 43 CC5 isolates, R1-41 (MRSA) and 
S42, S43 (MSSA). Splits graph based on spa-typing data and cost distance matrix calculated by direct 
data transfer from Ridom StaphType to splits tree (Huson & Bryant, 2006). The MRSA spa-types t003 
(blue circle), t504 (green square), t010 (red hexagon) and t002 (orange, pentagon) which were detected 
more than once, are highlighted. Figure adapted from Ruffing et al., PLoS One, 2012. 
4.1.3.2 Splits graphs of 43 CC5 isolates based on DNA MA data 
Splits graph analysis based on the DNA MA hybridization profiles of the 43 CC5 
isolates subdivided the CC5 isolates into a number of different groups. However, only 
for the group of isolates R22, R23, and R24 there was a clear denominator visible – 
these isolates were the only isolates being positive for the genes encoding the ACME 
locus (Figure 17). For the remaining isolates the grouping could not be assigned to a 
single denominator. 
Isolates of the predominant spa-type t003 (Figure 17, isolates marked by blue circles) 
were found in all tree branches, while isolates of spa-type t504 (Figure 17, isolates 





Figure 17: DNA microarray (MA) subclassification analysis of the 43 CC5 isolates, R1-41 (MRSA) 
and S42, S43 (MSSA). Splits graph based on DNA MA hybridization profiles in FASTA format on default 
settings using splits tree. The MRSA spa-types t003 (blue circles), t504 (green squares), t010 (red 
hexagons) and t002 (orange, pentagons) which were detected more than once, are highlighted. Three 
isolates carrying the ACME locus as specific feature were highlighted. Adapted from Ruffing et al., PLoS 
One, 2012. 
4.1.3.3 Comparison of the splits graphs based on spa-typing and DNA MA data of 
43 CC5 isolates 
4.1.3.3.1 DNA MA data analysis of 43 CC5 MRSA/MSSA with PCA 
PCA (Figure 18A) based on the hybridization profiles of the 43 CC5 isolates scattered 
the isolates into two clusters with 30 isolates (70%) grouping together in cluster I and 
9 isolates in cluster II (20.9%), respectively, while four isolates (R40, R41, S4 and S43; 
9.1%) were displayed individually. 
A subsequent PCA of the 30 CC5 isolates, assembled as cluster 1 in the first PCA 
(Figure 18B) identified four subgroups (Figure 18B, Ia-Id). Subgroup Id isolates 






Figure 18: Principal component analysis (PCA) of 43 CC5 isolates, R1-41 (MRSA) and S42, S43 
(MSSA). PCA was conducted based on the hybridization profiles of the 334 target sequences of each 
Staphylococcus aureus isolate yielded by DNA microarray analyses. (A) Two clusters I (green) and II 
(blue) within the 43 CC5 isolates were identified by PCA. (B) A higher resolution PCA plot of the 30 
MRSA isolates of cluster I (green) identified four subclusters (Ia-Id). Subcluster Id was characterized by 
the presence of the ACME locus. Adapted from Ruffing et al., PLoS One, 2012. 
In total, five different PCA clusters (Ia to Id, II) and four unassigned isolates could be 
identified by PCA. 
4.1.3.3.2 DNA MA data analysis of 43 CC5 isolates with HAC and bioinformatic 
methods’ data analysis comparison 
DNA MA hybridization pattern analysis of the CC5 SA isolates (Figure 19) by HAC 
showed five isolate clusters (I-V). The HAC provides a high resolution and it is very 




which isolates are very similar and which not. 
 
Figure 19: Hierarchical agglomerative clustering (HAC) of 43 CC5 isolates, R1-41 (MRSA) and 
S42, S43 (MSSA). HAC was conducted based on the hybridization profiles of the 334 target sequences 
of each Staphylococcus aureus isolate yielded by DNA microarray analyses. Five clusters I to V were 




4.1.3.3.3 Comparison of cluster analysis of 43 CC5 isolates with splits graph, PCA 
and HAC based on DNA MA data 
The comparison of all three different bioinformatical analyses methods showed that 12 
isolates were assigned to two identical isolate groups of R22-R24 (n=3) and R25-R33 
(n=9). All other 31 CC5 isolates (R1, R2, R34-R41, S42, S43) were assigned to 
different subgroups (Table 8). 
Table 8: Correlation of CC5 Staphylococcus aureus spa-typing results with subgroups identified 
based on the DNA microarray (MA) data analysis using three different bioinformatic methods. 
The DNA MA subgroup analyses were performed with principal component analysis (PCA, 3nd column), 
splits graph (4rd column) and hierarchical agglomerative clustering (5th column) based on the DNA MA 
hybridization results. 
Isolate spa-type 
MA PCA cluster 
(arbitrary group) 
MA Splits graph cluster 
(arbitrary group) 
MA Cluster dendrogram 
(arbitrary group) 
R22 t003 I d 1 I 
R24 t003 I d 1 I 
R23 t003 I d 1 I 
R39 t003 I a 4 II 
R38 t003 I a 4 II 
R1 t003 I b 6 II 
R35 t003 I b 3 II 
R36 t003 I b 3 II 
R16 t003 I b 8 II 
R37 t003 I b 3 II 
R2 t003 I b 6 II 
R34 t003 I b 3 II 
R18 t504 I c 9 III 
R19 t003 I c 9 III 
R20 t003 I c 9 III 
R21 t003 I c 9 III 
R11 t002 I c 7 III 
R17 t504 I c 9 III 
R14 t045 I c 7 III 
R13 t003 I c 7 III 
R15 t003 I c 8 III 
R3 t003 I c 7 III 
R5 t010 I c 7 III 
R6 t003 I c 7 III 
R4 t504 I c 7 III 
R12 t003 I c 7 III 
R10 t003 I c 7 III 
R9 t003 I c 7 III 
R8 t504 I c 7 III 
R7 t887 I c 7 III 
R25 t003 II 2 IV 
R26 t1079 II 2 IV 
R27 t003 II 2 IV 
R29 t481 II 2 IV 
R30 t003 II 2 IV 
R28 t3195 II 2 IV 
R31 t003 II 2 IV 
R33 t003 II 2 IV 
R32 t003 II 2 IV 
R40 t003 others 4 V 
R41 t010 others 5 V 
S42 t002 others 5 V 
S43 t493 others 5 V 
Comparison of the three applied bioinformatic methods showed that each model may 




an almost unlimited number of isolates. Yet, simple assignment of each point in the 
graph to the corresponding isolate is difficult because of the very close up to 
overlapping presentation of the samples. For good resolution you need a digital format 
which allow to zoom in the figure. HAC reveals a more detailed isolate relationship with 
direct assignment to each isolate and the corresponding isolate cluster. However, HAC 
is only useful for analysis of up to one hundred isolates. The problem is that for more 
isolates it is not possible to present the dendrogram on a A4 page with sufficient 
resolution. Again, for good resolution you need a digital format which allow to zoom in 
the dendrogram as described before for the PCA. Thus, splits graph seems to be the 
most appropriate method for cluster analysis for a high number of isolates. Additionally, 
splits graph is easy to apply. 
4.1.4 Gene repertoire analysis  
The gene repertoire of the 46 MRSA and 46 MSSA isolates was analyzed for individual 
genes associated with e.g. antibiotic resistance, toxin production, adhesion, and 
immune evasion. 
The SA species markers (rrn, gapA, katA, coa, nuc1, spa) were all positive in the entire 
strain set. Consequently, species identification of the DNA MA was confirmed. 
The analysis of the accessory gene regulator (agr) genes, a master regulatory system 
of virulence regulation in SA (Novick, 2003), showed that all CC5 MRSA isolates (n=41, 
89.1%) belonged to agr-type II (Table 9). The remaining 5 (10.9%) MRSA isolates were 
associated with agrI (Table 9). 21 MSSA isolates of CC7, CC8, CC22, CC45, CC97, 
CC101, and CC398 (45.7%) belonged to agr-type I, too. Ten MSSA isolates of CC1, 
CC30, and CC88 harbored agr-type III (21.7%) and 6 MSSA of CC5 and CC15 were 
positive for agr-type II (15.2%). Identification of the agr-type of nine MSSA isolates was 




Table 9: Comparison of the agr-type distribution in the clonal complexes (CC) of methicillin- 
resistant Staphylococcus aureus (SA) and methicillin-susceptible SA and of the Staphylococcal 
cassette chromosome(SSC)mec types in MRSA. 
 CC agr type I, 
n (%) 
agr type II, 
n (%) 
agr type III, 
n (%) 
SCCmec 
type I, n 
(%) 
SCCmec 
type II, n 
(%) 
SCCmec 
type IV, n 
(%) 
SCCmec 
type V, n 
(%) 
MRSA CC5 0 (0) 41 (89.1) 0 (0) 0 (0) 41 (89.1) 1 (2.2) 0 (0) 
 CC8 2 (4.3) 0 (0) 0 (0) 0 (0) 0 (0) 1 (2.2) 0 (0) 
 CC22 1 (2.2) 0 (0) 0 (0) 0 (0) 0 (0) 1 (2.2) 0 (0) 
 CC45 1 (2.2) 0 (0) 0 (0) 0 (0) 0 (0) 1 (2.2) 0 (0) 
 CC398 1 (2.2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (2.2) 
  5 (10.9) 41 (89.13) 0 (0) 0 (0) 41 (89.1) 4 (8.7) 1 (2.2) 
MSSA CC1 0 (0) 0 (0)0 1 (2.2) na na na na 
 CC5 0 (0) 1 (2.2) 0 (0) na na na na 
 CC7 2 (4.3) 0 (0) 0 (0) na na na na 
 CC8 1 (2.2) 0 (0) 0 (0) na na na na 
 CC15 0 (0) 5 (10.9) 0 (0) na na na na 
 CC22 3 (6.5) 0 (0) 0 (0) na na na na 
 CC30 0 (0) 0 (0) 0 (0) na na na na 
 CC45 8 (17.4) 0 (0) 0 (0) na na na na 
 CC88 0 (0) 0 (0) 0 (0) na na na na 
 CC97 5 (10.9) 0 (0) 0 (0) na na na na 
 CC101 1 (2.2) 0 (0) 0 (0) na na na na 
  CC398 1 (2.2) 0 (0) 0 (0) na na na na 
    21 (45.7) 6 (15.2) 10 (21.7)         
SCCmec-type analysis (Table 9) showed that 41 MRSA isolates (89.1%), possessed 
a SCCmec-type II-cassette while the other MRSA isolates harbored a SCCmec type 
IV cassette (n=4, 8.7%) or a SCCmec-type V-cassette (n=1, 2.2)%). The SCCmec 
types of three MRSA could not be determined by DNA MA. 
The β-lactamase operon with the three genes blaZ, blaI and blaR were detected in the 
majority of the MRSA (n=39, 84.8%) and MSSA isolates (n=29, 63%) (Table 10). The 
gene erm(A) conferring resistance against macrolides, lincosamides and 
streptogramins (MLSB) was found in significantly more MRSA (n=41, 89.1%) than 
MSSA isolates (n=3, 6.5%) (p<0.001) (Table 10). The putative marker gene for 
fosfomycin and bleomycin resistance, fosB, was also detected significantly more often 
in the MRSA isolates (n=43, 93.5%) than in MSSA isolates (n=20, 43.5%) (p<0.001) 
(Table 10). Most of the isolates were positive for the sdrM gene (n=82/92, 89%). Other 
resistance genes were only detected in single isolates (Table 10). In general, MRSA 




Table 10: Comparison of the DNA microarray target recognition of selected resistance genes of 
methicillin-susceptible Staphylococcus aureus (SA) and methicillin-resistant SA. 
gene  MSSA, n (%) MRSA, n (%) p-value  
blaZ/I/R 29 (63) 39 (84.8) <0.05 
ermA 3 (6.5) 41 (89.1) <0.001 
ermC 1 (2.2) 0 (0) ns 
fosB 20 (43.5) 43 (93.5) <0.001 
tetK 2 (4.3) 0 (0) ns 
tetM 0 (0) 1 (2.2) ns 
qacA 0 (0) 1 (2.2) ns 
qacC 0 (0) 1 (2.2) ns 
sdrM 40 (87) 42 (91) ns 
p-values were calculated by Chi-square test using GraphPad Quick Calcs Web site (GraphPad Software 
Inc.) (http://graphpad.com/quickcalcs/contingency1/); ns=not significant 
The ACME gene cluster was found in three MRSA isolates of the strain lineage ST2 
(6.5%). Analysis of the leukocidin hybridization results shows that none of the isolates 
were positive for the Panton-Valentine leukocidin (PVL) encoding genes (lukF-/lukS-
PV) (Table 11). The tst1 (encoding toxic shock syndrome toxin 1) was mainly found in 
MSSA of CC30 (n=8, 17.4%). Outside CC30 tst1 was only found in one isolate of CC45 
(2.2%). 
The hybridization patterns of the enterotoxin gene cluster (egc) genes seg, sei, sem, 
sen, seo, and seu showed that these genes were significantly more frequently detected 
in MRSA (n=43, 93.5%) compared to MSSA (n=29, 63%) (p<0.001) (Table 11). 
Moreover, the egc genes were only detected in four CCs, namely CC5, C22, CC30, 
and CC45. 
The coding sequence of the metalloprotease aureolysin (aur) was identified 
significantly more often in MRSA (n=43, 93.5%) than in MSSA (n=30, 65.2%; p<0.001) 
(Table 11). The same result was visible for the serine protease genes splA and splB, 
which were predominantly detected in MRSA isolates of the CCs CC1, CC5, CC7, 
CC8, CC15 and CC97. 
Most MRSA isolates carried the genes encoding factors for capsule type 5 biosynthesis 
(n=44, 96%) in contrast to MSSA isolates (n=15, 32%) (Table 11). Only one MRSA 
isolate (2.2%) was positive for the genes of capsule type 8, while the majority of the 
MSSA isolates harbored the capsule type 8 encoding genes (n=31, 74%) (Table 11). 




(MSCRAMM) encoding gene cna (collagen-binding protein) was detected with a higher 
rate in the MSSA group (n=26, 57%) compared to the MRSA group (n=3, 7%) (Table 
11). In the MRSA group, the SERAM (secretable expanded repertoire adhesive 
molecules) encoding genes fib (encoding a 19kDa fibrinogen-binding protein; n=38, 
83%), and sasG (encoding the cell-wall anchored surface protein SasG; n=43, 93%) 
were identified more often (Table 11). Additional MSCRAMM encoding genes (Table 
11) and two further SERAM genes were found in most of the isolates (≥83%), without 
methicillin resistance specific differences. 
Table 11: Comparison of the DNA microarray target recognition of selected toxin and adhesion 
genes of of methicillin-susceptible Staphylococcus aureus (SA) versus methicillin-resistant SA. 
gene/ gene cluster MSSA, n (%) MRSA, n (%) p-value 
lukF/S-PV 0 (0) 0 (0) ns 
tst1 9 (19.5) 0 (0) <0.01 
egc 29 (63) 43 (93.5) 0.001 
aur 30 (65.2) 43 (93.5) <0.01 
splA 19 (41.3) 42 (91.3) <0.001 
splB 20 (44.3) 43 (93.5) <0.001 
cap5 15 (32) 45 (98) <0.001 
cap8 31 (74) 1 (2.2) <0.001 
cna 26 (57) 3 (6.5) <0.001 
bbp 42 (91) 43 (94) ns 
clfA 46 (100) 46 (100) ns 
clfB 43 (94) 46 (100) ns 
ebh 42 (91) 44 (96) ns 
eno 46 (100) 46 (100) ns 
ebps 46 (100) 46 (100) ns 
fnbA 45 (98) 44 (96) ns 
fnbB 37 (82) 45 (98) ns 
sdrC 46 (100) 46 (100) ns 
fib 20 (44.3) 38 (83) <0.001 
sasG 19 (41.3) 43 (93.5) <0.001 
map/eap 42 (91) 43 (94) ns 
vwb 46 (100) 46 (100)  ns 
p-values were calculated by Chi-square test using GraphPad Quick Calcs Web site (GraphPad Software 




4.2 Characterization of Nigerian SA isolates by DNA MA analysis 
Analysis of the strain lineages and the gene repertoire of 52 Nigerian MSSA isolates 
by DNA MA showed that they belonged to 12 different CCs: CC1 (n=6, 11.6%), CC5 
(n=9, 17.3%), CC7 (n=1, 1.9%), CC8 (n=4, 7.7%), CC15 (n=7, 13.5%), CC25 (n=2, 
3.8%), CC30 (n=8, 15.4%), CC45 (n=2, 3.8%), CC80 (n=1, 1.9%), CC97 (n=1, 1.9%), 
CC121 (n=8, 15.4%), and CC152 (n=3, 5.8%). More than half of the 52 MSSA 
belonged to CC1, CC5, CC8, CC30, and CC45. 
As shown in Figure 20, isolates of CC7, CC8, CC25, CC45, CC97, and CC152 (n=13, 
25%) were associated with agr-type I while 16 isolates of CC5 and CC15 (30.2%) 
belonged to agr-type II and 15 isolates of CC1, CC30 and CC80 belonged to agr-type 
III. Combined signals for agr-type I and type-IV were observed for one, three and four 





Figure 20: Similarity analysis of 52 Nigerian methicillin-susceptible SA isolates. Splits graph are 
constructed based on the DNA microarray (MA) hybridization profiles on default settings by splits tree 
(Huson & Bryant, 2006). The hybridization results were arranged in a matrix in a FASTA format. The 
present, absent and ambiguous hybridization results represented as 1 (present), 0 (absent) and “-“ 
(ambiguous) in the DNA MA results presentation were converted into a nucleotide code: 1=c, 0=g, “-
“=a. Columns represented the target sequences and the rows represent the isolates. Clonal complexes 
(CC) and agr-types as well as genes (blue) which were present in all isolates of a CC are indicated. 
Adapted from Shittu et al., Front Microbiol, 2015. 
The detection rates of selected resistance and virulence genes were shown in Table 
12. The predominant resistance genes in the Nigerian SA isolates were sdrM, encoding 
for a multidrug efflux channel (n=52, 100%) and fosB, encoding for fosfomycin 




Table 12: Detection rates of selected resistance and virulence genes in 52 Nigerian methicillin-
susceptible Staphylococcus aureus isolates. 
genes n, (%) 
sdrM 52 (100) 
fosB 39 (75) 
blaZ/I/R 36 (69) 
aur 30 (65.2) 
tetK/tetM 13 (25) 
lukF/S-PV 27 (52) 
tst1 3 (6) 
etA 2 (4) 
etB 0 (0) 
etD 3 (6) 
cap8 33 (64) 
cap5 19 (37) 
icaA 50 (96) 
icaC 49 (94) 
icaD 50 (96) 
fnbA 52 (100) 
clfA 52 (100) 
ebh 52 (100) 
eno 52 (100) 
ebps 52 (100) 
fnbA 52 (100) 
cna 27 (52) 
The lukF- and lukS-PV genes encoding the Panton-Valentine leukocidin (PVL) were 
detected in 27 (52%) isolates belonging to seven CCs (CC1 [n=4, 8%], CC5 [n=5, 
10%], CC15 [n=1, 2%], CC30 [n=5, 10%], CC80 [n=1, 2%], CC121 [n=8, 15%], and 
CC152 [n=3, 6%]; EEF, sheet A1). 
The gene tst1 (the toxic shock syndrome) was found in three isolates of CC1 (n=1, 
1.9%) and CC45 (n=2, 3.8%). Presence of the genes etA, etB and etD, encoding 
exfoliative toxins, was observed in a total of five isolates of CC15 (n=2, 4%), CC25 
(n=2, 4%), and CC80 (n=1, 2%). Almost two-third of the analyzed isolates carried the 
genes encoding for capsule type 8 (n=33, 63.5%; Table 12). The remaining 19 isolates 
carried capsule type 5 encoding genes (36.5%; Table 12). 
Biofilm-associated genes icaA (n=50, 96%), icaC (n=49, 94%) and icaD (n=50, 96%) 
(intracellular adhesion genes) were found in almost all isolates (Table 12). The 
MSCRAMM encoding genes clfA (clumping factor A), ebh (cell wall-associated 
fibronectin-binding protein), eno (enolase binding protein), ebps (cell surface elastin 




isolates (Table 12; EEF, sheet A1). In contrast, cna (collagen binding adhesin) was 
only found in isolates of CC1 (n=6, 52%), CC30 (n=8, 15%), CC121 (n=8, 15%) and 
CC152 (n=3, 6%; EEF, sheet A1). 
4.3 Characterization and comparison of African and German SA isolates  
4.3.1 Collection of African and German SA isolates 
The data of all participants were documented in case related forms (CRFs) (see 
Appendix, section 6.2) and checked of fulfilling the requirements for inclusion into the 
study cohort. Characteristics of African and German healthy volunteers and patients 
are shown in the Appendix, section 6.3. 
4.3.2 Clonal complexes and sequence types analyses 
The DNA MA data assigned 1,185 isolates of the 1,200 isolates to 32 known CCs and 
three STs based on the hybridization profiles. For the remaining 15 isolates, CC 
grouping could be resolved for three of the isolates (0.25%) by affinity propagation of 
the DNA MA data, whereas for 12 isolates assignment by DMA MA data was not 
possible. A subsequent MLST analysis (Enright et al., 2000) was carried out by our 
cooperation partners in Münster. The 12 isolates were assigned to five different STs 
(ST2370, ST2678, ST2733, ST2735, and ST2744)  that  had not been described so 
far. 
4.3.2.1 Analysis of clonal complexes with African or German SA origin 
A comparison of the CC distribution in the African and German study sites is shown in 
Figure 21 and Table 13. The comparison identified several significant differences in 
CC representations between the African and the German study sites. Four CCs were 
either exclusively found in Africa (CC80 and CC88) or in Germany (CC50 and CC398), 
all other CCs were detected both in Africa and in Germany. Furthermore, significant 
geographic differences were identified for 15 of the 40 detected CCs and STs between 
the African and German study sites (Figure 21). The 22 (55%) most common CC’s 
were statistically, mainly present either in Africa or in Germany (Figure 21, Table 13). 
On the other hand isolates of CC5, CC8, CC9, CC25 as well as CC707 were observed 





Figure 21: Comparison of the frequencies of the 22 most prevalent clonal complexes (CCs) of 
community-associated Staphylococcus aureus isolates in the African and German study sites. 
CCs and sequence types (STs) with less than six isolates were summarized as group others. The CCs 
on the y-axis were ordered according to the total number of identified isolates. Prevalence of clinical 
(red) and nasal (grey) isolates in the African (left side) and German group (right side) is shown. Statistical 
analyses for association of CCs with African or German origin were performed by Chi square test with 
Hommel correction for multiple testing using the program R Studio; *: p<0.05, **: p<0.01, ***: p<0.001. 
Figure adapted from Ruffing et al., 2017. 
Predominant African CCs were CC80 (n=13, 100%, p<0.001), CC88 (n=28, 100%, 
p<0.001), CC152 (n=79, 98%, p<0.001), and CC121 (n=105, 81%, p<0.001) (Figure 
21, Table 13). The main CCs in Germany were CC398 (n=22, 100%, p<0.001), CC22 
(n=37, 90%, p<0.001), CC7 (n=57, 97%, p<0.001), CC30 (n=75, 87%, p<0.001,) and 




Table 13: Clonal complex distribution in Africa and Germany with total numbers and percentages 
of isolates found in African and German study sites for each CC group. 
  Total [n] Africa [n] African isolates [%] Germany [n] German isolates [%] p-value* 
CC1  48 38 79 10 21 <0.001 
CC5  95 44 46  51 54 ns 
CC6  20 17 77 3 23 0.03 
CC7  59 2 3 57 97 <0.001 
CC8  101 48 4 53 53 ns 
CC9  29 15 52 14 48 ns 
CC12  21 2 9 19 91 <0.01 
CC15 166 109 66 57 34 <0.001 
CC22  41 4 10 37 90 <0.001 
CC25  28 13 46 15 54 ns 
CC30  86 11 13 75 87 <0.001 
CC45  139 51 37 88 63 0.01 
CC50   6 0 0 6 100 ns 
CC59  13 2 15  11 85 ns 
CC80  13 13 100 0 0 <0.001 
CC88 28 28 100 0 0 <0.001 
CC97  13 1 92 12 8 <0.05 
CC101  21 3 14 18 86 0.05 
CC121  130 105 81 25 19 <0.001 
CC152 81 79 98 2 2 <0.001 
CC398  22 0 0 22 100 <0.001 
CC707 6 5 83 1 17 ns 
others 34 10 29 24 71  ns 
sum  1200 600   600     
 
Statistical analyses were performed by Chi square test with Hommel correction for multiple testing using 





4.3.2.2 Association analysis of clonal complexes with clinical or nasal isolate origin 
In addition to the analysis of the CC distribution in the African and German study sites, 
the CC distribution within the clinical and nasal isolate groups were compared (Figure 
22). CC121 (p<0.01) and CC152 (p<0.01) were identified significantly more often in 
clinical isolates, whereas CC45 (p<0.05) were significantly more often detected in 
nasal isolates (Figure 22). The other CC’s did not show any predominance for isolates 
of either nasal or clinical origin. 
 
Figure 22: Comparison of the prevalence of the nasal and clinical community-associated 
Staphylococcus aureus isolates in the 22 most prevalent clonal complexes (CCs). CCs and 
sequence types (STs) with less than six isolates were summarized as group others. The CCs on the y-
axis were ordered with respect to the total number of identified isolates from the bottom to the top. 
Prevalence of German (black) and African (blue) isolates in the clinical (left side) and nasal group (right 
side) is indicated. Statistical analyses for association of CCs with clinical or nasal isolate origin were 
performed by Chi square test with Hommel correction for multiple testing using R Studio; *: p<0.05, **: 
p<0.01, ***: p<0.001. 
Comparison of the DNA MA data of 300 clinical and 300 nasal African strains (Figure 
22, Table 14) revealed also for the African isolates alone that a significantly larger 
proportion of CC121 (yellow section, p<0.001) and CC152 (black, p<0.001) isolates 
were of clinical origin. In contrary, isolates of CC8 (orange, p<0.05) and CC45 (red, 




(Figure 23A, second and fourth column) CC15 were found significantly more frequent 
in the nasal isolate group (dark blue section, p<0.05). 
Table 14: Comparison of the clonal complex (CC) distribution of community-associated 
Staphylococcus aureus in the individual African and German study sites with differentiation of 
the clinical or nasal isolate origin. The study sites were represented by abbreviations: IT= Ifakara, 
Tanzania; LG= Lambaréné, Gabon; Manhiça, Mozambique; FR=Freiburg, Baden-Württemberg; 
HS=Homburg, Saarland; MW= Münster, Nordrhein-Westfalen. 
 clinical isolates nasal isolates 
 Africa Germany Africa Germany 
 IT LG MM FR HS MW IT LG MM FR HS MW  
CC15 5 27 19 3 9 7 17 24 16 11 11 16  
CC45  0 0 4 13 12 21 10 35 2 13 12 17  
CC121  24 7 42 6 4 4 6 4 23 4 2 5  
CC8  4 6 6 8 11 7 14 6 12 12 6 9  
CC5  9 8 6 11 15 6 11 6 4 5 10 4  
CC30  4 2 2 10 7 14 2 1 0 18 11 15  
CC152 13 38 4 2 0 0 0 14 11 0 0 0  
CC7  0 0 2 10 14 9 0 0 0 5 13 6  
CC1  9 9 3 2 2 2 6 1 10 0 4 0  
CC22  0 0 0 10 5 9 1 0 3 8 0 5  
CC9  7 1 0 1 2 1 6 1 0 2 4 4  
CC25  2 0 3 5 2 2 1 0 7 2 2 2  
CC88 10 1 4 0 0 0 7 1 5 0 0 0  
CC398  0 0 0 3 5 3 0 0 0 5 4 2  
CC12  0 0 0 2 4 2 0 0 2 3 6 2  
CC101  0 0 0 1 1 3 2 1 0 3 8 2  
CC6  3 1 2 1 0 1 9 1 1 1 0 0  
CC59  0 0 1 2 2 1 1 0 0 2 4 0  
CC80  6 0 2 0 0 0 3 0 2 0 0 0  
CC97  1 0 0 5 0 3 0 0 0 0 2 2  
CC50   0 0 0 1 0 0 0 0 0 2 0 3  
CC707 0 0 0 0 0 0 0 4 1 0 0 1  
others 3 0 0 4 5 5 4 1 1 4 1 5  
sum 100 100 100 100 100 100 100 100 100 100 100 100 
The analysis of the relative CC frequencies of isolates of clinical (Table 14; Figure 23A) 
or nasal origin (Table 14; Figure 23B) identified the following: Within the Ifakara 
(Tanzania, IT) isolate group, CC121 (yellow, p<0.001) and CC152 (black, p<0.001) 
were significantly more often identified in the group of clinical origin, while CC8 
(orange, p<0.001), CC15 (dark blue, p<0.05) and CC45 (red, p<0.001) were found 
more often in the group of nasal isolates. In the clinical strain group of Lambaréné 




dominating, while CC45 isolates (red, p<0.001) were only detected among isolates of 
nasal origin. In Manhiça (Mozambique, MM) isolates of CC121 (yellow, p<0.01) were 
observed more often in the clinical isolate group, similar to the situation visible for 
Ifakara. Compared to the African study sites, the relative frequencies of CC’s in the 
clinical and nasal German groups as well as in-between the three German institutions 
were more homogenous. Only isolates of CC15 (blue, p<0.05) were found more often 
in the nasal isolates than in the clinical isolates sampled in Freiburg (FR) (Figure 23). 
In addition, the distribution of CCs in the African clinical and African nasal isolate group 
was more diverse than in the German isolate groups. 
 
Figure 23: Relative distribution of the 22 most prevalent clonal complexes (CC) of community-
associated Staphylococcus aureus. The percentage distribution of the individual African and German 
study sites with discrimination of (A) clinical isolates and (B) nasal isolates are shown. CCs and 




4.3.2.3 Antibiotic resistance and virulence-related gene presence as a function of 
geographical origin and clinical significance of SA isolates 
The following paragraphs summarize the comparisons of the hybridization results of 
selected DNA MA targets of regulatory SA genes (Table 15), resistance genes (Table 
16), toxin and virulence genes (Table 17), and adhesion genes (Table 18) with respect 
to the geographic or clinical/nasal isolate origin. 
The SA species markers rrn, gapA, katA, coa, nuc1, spa, and sbi were positive in 
virtually all isolates tested in this work (≥99.8%), thus providing an internal quality 
control for the species identification and for the performance of the DNA MA (Table 
15). 
The genes encoding for major regulatory factors of the virulence factor synthesis in SA 
such as SarA, SaeS and the sensor protein VraS, a member of the two-component 
regulatory system VraS/VraR, were detected in all except of two isolates (Table 15). 
The accessory gene regulator-type I (agrI) locus was more prevalent in German 
isolates (n=331 [55%] vs. n=209 [35%], p<0.001), while the accessory gene regulator-
type IV (agrIV) encoding genes were detected more often in African isolates (n=221 
[37%] vs. n=38 [6%], p<0.001). 
Table 15: Comparison of the DNA microarray target recognition of community-associated 
Staphylococcus aureus genes encoding regulatory factors with respect to the geographic or 
clinical isolate origin. 

















sarA 600 599  ns 300  300  ns 300 299 ns 
saeS 600 600 ns 300  300  ns 300  300  ns 
vraS 599 600 ns 300  300  ns 299 300 ns 
agrI total. 209 331  <0.001 99  179 <0.001 110 152 ns 
agrII.total 161 151 ns 78  68 ns 83 83 ns 
agrIII.total 93 84 ns 50  36 ns 43 48 ns 
agrIV total 221 38 <0.001 128  20 <0.001 93 18 <0.001 
*p-values were calculated by the Chi-square test with Hommel correction for multiple testing using R 
Studio; ns= not significant 




and clinical cohort is shown, respectively. 
Screening for the staphylococcal methicillin resistance gene cassette SCCmec, 
carrying the methicillin resistance gene mecA, revealed that a total of 40/1200 (3%) 
strains were found to carry this cassette. MRSA strains were equally distributed in 
isolates from Africa (n=17, 3%) and from Germany (n=23, 4%; Table 16). In Africa the 
MRSA isolates were equally distributed between clinical (n=9, 3%) and nasal isolates 
(n=8, 3%), whereas in Germany significantly more MRSA isolates could be identified 
in clinical (n=21, 7%) than in nasal isolates (n=2, 1%; p<0.0001) (Table 16). 
The erythromycin resistance genes erm(A) and erm(C) were detected in isolates 
belonging to 12 different CCs (n=43, 4%) and 21 CCs (n=134, 11%), respectively. 
Erm(A) was more often observed in German isolates than in African isolates (n=40 
[7%] vs. n=3 [1%], p<0.001; Table 16) both for clinical isolates (n=24 [8%] vs. n=2 [1%], 
p<0.001) and for nasal isolates (n=16 [5%] vs. n=1 [0,3%], p<0.001). On the other hand 
erm(C) was identified in higher numbers in the African isolate set than in the German 
isolate set (n=91 [15%] vs. n=43 [7%], p<0.001); Table 16). This was again visible both 
for the clinical subgroup (n=41 [14%] vs. n=24 [8%], p<0.05) and for the nasal 
subgroup (n=50 [17%] vs. n=19 [6%], p<0.001; Table 16). The tetracycline resistance 
gene tet(K) was found in all CCs in Africa except for CC30. In Germany it was detected 
occasionally in CC5 (n=1/51), CC7 (n=3/57), CC8 (n=1/53), CC15 (n=4/57), CC97 
(n=1/12), CC121 (n=1/25), CC188 (n=1/5), and CC398 (n=3/22). A significantly larger 
proportion of tet(K) and tet(M) was detected in African isolates irrespective of their 
clinical or nasal origin (n=211 [35%] vs. n=15 [3%] for tet(K), and n=47 [8%] vs. n=7 
[1%] for tet(M); p<0.001; Table 16). A high prevalence for the fosfomycin resistance 
gene fosB was identified in African and German clinical/nasal isolates (n=193 [64%] 
vs. n=158 [53%] for African and German clinical isolates, and n=181 [60%] vs. n=185 




Table 16: Comparison of the DNA microarray target recognition of selected resistance genes of 
community-associated Staphylococcus aureus isolates with respect to the geographic or 
clinical/nasal origin. 

















mecA 17 23 ns 9 21 ns 8 2 ns 
erm(A) 3 40 <0.01 2 24 ns 1 16 ns 
erm(C) 91 43 <0.001 41 24 <0.01 50 19 ns 
tet(K) 211 15 <0.001 113 9 <0.001 98 6 <0.001 
tet(M) 47 7 <0.001 29 7 ns 18 0 <0.05 
fosB 374 343 ns 193 158 ns 181 185 ns 
qacA 0 4 ns 0 4 ns 0 0 ns 
qacC 
(total) 
7 16 ns 2 10 ns 5 6 ns 
sdrM  594 558 <0.001 299 273 ns 295 285 ns 
*p-values were calculated by the Chi-square test with Hommel correction for multiple testing using R 
Studio; ns= not significant 
The distribution of selected virulence genes encoding for toxins, leukocidins, capsule 
syntheses factors and adhesins in African and German isolates was examined (Table 
17). 
A major difference between African and German isolates was observed for the Panton-
Valentine leukocidin (PVL) encoding genes (lukF-/lukS-PV). Overall, lukF-PV and 
lukS-PV were found in 287/1200 (24%) isolates belonging to 13 different CCs, of which 
272 (45%) were detected in Africa and only 15 (3%) in Germany (EEF, sheet A1). On 
the CC level, most lukF-PV and lukS-PV positive isolates belonged to the following 
CCs: CC15 (n=28), CC88 (n=20), CC121 (n=94), and CC152 (n=78). Statistical 
analysis revealed a significant association of the PVL encoding genes with clinical vs. 
nasal origin (n=202 [34%] vs. n=85 [14%], p<0.0001; Table 17). Occurrence of lukF-
/lukS-PV was highly associated in CC5 with African origin (13/44 [30%] vs. 0/51 [0%] 
for African vs. German isolates, p<0.0001) and a similar situation was seen for CC15 
(27/109 [25%] vs. 1/57 [2%], p<0.0001), CC22 (3/4 [75%] vs. 1/37 [3%], p<0.0015), 
CC30 (8/11 [73%] vs. 2/75 [3%], p<0.0001), and CC121 (87/105 [83%] vs. 7/25 [28%], 




Table 17: Comparison of the DNA microarray target recognition of selected community-
associated Staphylococcus aureus virulence genes with respect to the geographic or 
clinical/nasal isolate origin. 

















tst1 36 67 ns 12 23 ns 24 44 ns 
sea 92 68 ns 44 28 ns 48 40 ns 
seb 114 45 <0.001 72 23 <0.001 42 22 ns 
sec 49 92 <0.05 19 57 <0.01 30 35 ns 
sed 21 52 <0.001 9 35 <0.05 12 17 ns 
seh 34 26 ns 18 12 ns 16 14 ns 
sej 25 41 ns 10 27 ns 15 14 ns 
sek 56 27 ns 27 14 ns 29 13 ns 
sel 50 92 <0.05 20 57 <0.01 30 35 ns 
egc 
total 
253 332 <0.01 120 173 <0.001 133 159 ns 
seq 56 27 ns 27 14 ns 29 13 ns 
ser 20 37 ns 8 24 ns 12 13 ns 
lukF.PV 272 15 <0.001 187 15 <0.001 85 0 <0.001 
lukS.PV 273 15 <0.001 188 15 <0.001 85 0 <0.001 
etA 39 24 ns 19 9 ns 20 15 ns 
etB 21 7 ns 12 4 ns 9 3 ns 
etD 21 17 ns 10 9 ns 11 8 ns 
cap5 237 224 ns 107 126 ns 130 98 ns 
cap8 362 376 ns 193 174 ns 169 202 ns 
*p-values were calculated by Chi-square with Hommel correction for multiple testing using R Studio; ns= 
not significant 
Analysis of the capsule gene distribution revealed that the type 5 capsule genes (cap5) 
were associated with CC5 (n=92/95, [97%]), CC8 (n=101/101, [100%]), CC22 
(n=39/41, [95%]) and CC152 (n=79/81, [98%]), while all other CCs, except CC1, 
carried type 8 capsule genes (cap8) (EEF, sheet A8). The capsule type for CC1 
isolates was found to be inhomogeneous, with 38 of 48 (79%) isolates being cap8-
positive and the remaining 10 isolates (21%) being cap5-positive (EEF, sheet A8). In 
nasal samples, the capsule type 5 encoding genes were predominant in isolates from 
African volunteers compared to isolates from German volunteers (n=130/238, [54%] 
vs. n=98/224, [44%], p<0.01). In comparison, cap8 harboring isolates were more 
frequent among nasal samples collected in Germany in comparison to nasal samples 
in Africa (n=202/376, [54%] vs. n=169/362, [47%], p<0.01; Table 17). 
For other genes such as fib (encoding a fibrinogen binding protein; n=448, 75% vs. 




n=594, 99% vs. n=553, 92%), fnbB (encoding a fibronectin binding protein; n=587, 
98% vs. n=522, 87), and sasG (SA surface protein G; n=370, 62% vs. n=253, 42%) 
higher frequencies were detected in African compared to German isolates (p<0.001 
for all comparisons; Table 18). In contrast, the map (major histocompatibility complex 
class II analog protein) gene, also referred to as eap (extracellular adhesion protein), 
which is exclusively found in SA, was more often identified in German isolates than in 
African isolates (n=582, 97% vs. n=494, 82%; Table 18). In detail, 18% (n=106) of the 
map/eap negative isolates belong to the African cohort and only 3% (n=18) to the 
German cohort. Notably, all CC152 isolates (n=82, with 80 isolates of African origin 
and only 2 isolates of German origin) lacked a map/eap specific signal, pointing 
towards the possibility that the eap nucleotide sequence of CC152 isolates might not 
match with the map/eap target sequence provided by the DNA MA. A limited number 
of map/eap positive isolates was also observed among African CC1 isolates (n=16, 
42%), while the map/eap recognition in the other CCs approached 100% irrespective 
of the isolate origin. 
Table 18: Comparison of the DNA microarray target recognition of selected adhesion genes of 
community-associated Staphylococcus aureus with respect to the geographic or clinical isolate 
origin. 















fib 448 372 <0.001  231 184 ns 217 188 ns 
ebh 594 553 <0.001 299 270 ns 295 283 ns 
fnbB 587 522 <0.001 294 262 ns 293 260 ns 
sasG 370 253 <0.001 161 134 ns 209 119 <0.001 
map/eap 494 582 <0.001 233 290 ns 261 292 ns 
*p-values were calculated by Chi-square with Hommel correction for multiple testing using R Studio; ns= 




4.3.3 Isolate cluster analysis 
The combination of 2D-PCA and silhouette analysis identified nine isolate clusters 
(labelled 1 to 9, Figure 24) that correspond with the CC attribution of the isolates. In 
addition to the nine identified isolate clusters, a heterogeneous isolate group 
comprising isolates of different CCs was seen on the left side, in the center of the plot. 
Further, the silhouette analysis showed that each isolate’s position in the PCA plot 
matched well within the identified cluster areas with a silhouette value of 0.59. A 
silhouette coefficient close to 0 means that this isolate is close or on the threshold 
value between two adjacent clusters. 
Three of the nine clusters (#1, 2, and 3) were located on the left plot side of the PCA 
panel and six separate isolate clusters (#4-9) on the right side. The clusters on the left 
plot side preferentially consisted of ‘African’ isolates (clusters #1 [CC8], #2 [CC15], #3 
[CC121]). In comparison, the clusters on the right side of the plot were prevalently 
formed by isolates of ‘German’ origin (clusters #5 [CC22], #6 [CC398], and #9 [CC30]). 
The CC121 cluster (#3) was closely associated with the heterogeneous group in the 
central part of the two-dimensional PCA plot. Remarkably, the PCA separated the 
CC45 isolates into two distinct clusters (cluster #7 and cluster #8) of which cluster #8 
include isolates of African and German origin (Figure 24A), while cluster #7 consisted 






Figure 24: Two-dimensional principal component analysis (PCA) of (A) 600 African and 600 
German or (B) 600 clinical and 600 nasal community associated Staphylococcus aureus isolates. 
PCA is based on the presence or absence of hybridization profiles of the 334 target sequences of each 
isolate determined by DNA microarray. (A) Each black diamond represents an African isolate and each 
grey square represents a German isolate. (B) Clinical isolates were denoted by black triangles and nasal 
isolates by grey circles. Clonal complex (CC) isolate clusters are indicated and numbered. Close 






4.3.4 DNA MA and whole genome sequencing concordance analysis 
WGS was performed because DNA MA technique can’t detect allelic variants or gene 
polymorphisms, which are not represented on the array by the sequence targets and 
thus resulting in false negative results. The existence of such an allelic variant was 
assumed for the gene map/eap because previous studies indicated map/eap to be 
present in the clear majority of SA. A lack of map/eap target recognition was observed 
in 124/1200 isolates, with 18% (n=106) map/eap negative isolates in the African cohort 
and 3% (n=18) in the German cohort. Absence of an eap/map signal was especially 
recognized for CC152 isolates, which all were negative for this signal. Therefore, WGS 
was performed for exemplary isolates of the CC152. An aberrant map/eap gene were 
identified in this CC type, which lacked the DNA region represented on the DNA MA 
(Strauss et al., 2016). 
However, when results of WGS were compared with the DNA MA data, it was found 
that both techniques were highly (but not fully) reliable with respect to the gene/allele 
identification (with 1.7% WGS errors and 1.8% MA errors) (Strauss et al., 2016). 
4.4 Subtyping of SA isolates by MALDI-TOF  
To test if it is possible to subtype SA strains based on their mass spectra with regard 
to methicillin resistance, geographic origin of the isolates, spa-type and strain lineage 
(CC), the mass spectra profiles of 219 SA isolates (51 MRSA, 168 MSSA) of the 
African-German-StaphNet (study C; n=127, section 4.3) and the admission prevalence 
screening of Saarland (study A; n=92, section 4.2) were compared. 
4.4.1 Evaluation of correct assignment of SA based on their total mass spectra 
to methicillin resistance, geographic origin, spa-type and strain lineage 
(CC/ST)  
The 219 isolates belonged to 20 different CCs with the predominant CCs being CC5 
(n=58, 26:5%), CC8 (n=20; 9:1%), CC15 (n=17; 7:8%), CC30 (n=11, 5%), CC45 (n=28, 
12.8%), as well as CC121 (n=26, 11.9%). Further, the isolates were of 108 different 
spa-types, dominated by spa-types t003 (n=29, 13.2%) and t002 (n=11, 5.0%) (Figure 
25A). For 6 spa-types only three isolates, for 12 spa-types only two isolates and for 77 




Table 19: Number of different spa-types and assigned Staphylococcus aureus isolates. 
spa-type 
number of different 
spa-types 
number of isolates for 
each spa-type 
t003 1 29 
t002 1 11 
t084, t015 2 9 
t012, t272 2 6 
t701, t1476 2 5 
t008, t314, t504, t645, t939 5 4 
t148, t267, t304, t311, t1849, t4499 6 3 
t026, t085, t091, t131, t159, t346, t714, t941, 
t4198, t5122, t11586, t12385 12 2 
t005, t010, t011, t018, t019, t021, t022, t040, t045, 
t050, t065, t073, t078, t098, t127, t197, t237, t273, 
t279, t306, t310, t339, t435, t437, t451, t481, t493, 
t571, t584, t620, t625, t630, t690, t702, t711, t729, 
t887, t934, t940, t2393, t2720, t2771, t3092, t3195, 
t3772, t4044, t4333, t5562, t6172, t6208, t6431, 
t8786, t8830, t8831, t8863, t8864, t10333, t10419, 
t1079, t1081, t1114, t1171, t2164, t2239 t1510, 
t1579, t1689, t1991, t11282, t11311, t11312, 
t11313, t11314, t11318, t11375, t11583, t11584  77 1 
To analyze if the total mass spectra-based isolate clusters correspond with spa-type 
(Figure 25A), CC (Figure 26), resistance profile (MRSA/MSSA) (Figure 25B) or 






Figure 25: Three-dimensional principal component analysis (PCA) of mass spectra of 219 African 
and German methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant 
Staphylococcus aureus (MRSA) isolates. PCA based on the mass spectra profiles of 219 
Staphylococcus aureus genotypically well characterized isolates, projected onto the three principal 
components PC1, PC2 and PC3. Each spot represents an individual isolate that is highlighted according 
to (A) the spa-type, (B) the resistance profile (MSSA or MRSA) (C) the geographic origin (African or 
German). The PCA clustering pattern reflect the similarity between isolates. Higher similarity is 
represented by a higher proximity of the isolates. 
The PCA showed that isolates of the same spa-type (Figure 25A) or carrying methicillin 
resistance (Figure 25B) were not separated into different groups based on their mass 
spectra. Separation into different groups would mean that in the PCA dots of the same 
colour, representing isolates of the same group, build separate clusters. 
In addition, PCAs were performed to identify if the SA mass spectra correspond with 
the CCs they belong to (Figure 26). The results of the PCA identified that there were 
no CC5, CC8, CC45 or CC88 specific isolate groups based on the isolates’ mass 
spectra profiles (Figure 26B/C, 26E/F). Mass spectra profiles of these four CCs could 
not be distinguished from mass profiles of all other CCs. However, a different picture 
emerged for the mass spectra of the CC121 isolates. The spectra of the CC121 
isolates formed a separate group (Figure 26D, red) in comparison to the mass spectra 
of the isolates of all other CCs. This strongly suggests that CC121 isolates can be 
identified based on their mass spectra profile, while there is no possibility to identify 





Figure 26: Three-dimensional principal component analysis (PCA) of 219 Staphylococcus aureus 
(SA) mass spectra with color codes highlighting different clonal complexes (CCs). The PCA was 
projected onto the first three principal components (PC1, PC2 and PC3) that separates the data set. (A) 
Clustering of the SA mass spectra with color codes for 15 different CCs contributing at least two isolates, 
and three single isolates summarized as group “others”. (B-F) Clustering of the mass spectra of specific 
CCs (red), (B) CC5, (C) CC8, (D) CC121, (E) CC45 and (F) CC88 in comparison to all other isolates 
(green). 
The PCA results were confirmed in single identification projects for each of the four 
previous mentioned categories (Table 20). Results are shown as performance of the 
classifier support vector machine for the four predefined groups in the four identification 




Table 20: Collected results of the performance of the classifier support vector machine for the 
four predefined groups in the four identification projects. The table shows the results of the 
objective estimation of the classifiers performance for calculation of the likelihood of correct or incorrect 
assigned Staphylococcus aureus (SA) isolates to the predefined groups (geographic origin 
[African/German)] resistance profile [methicillin resistant/susceptible SA {MRSA/MSSA}], spa-type [t003 
vs. all other spa-types] and clonal complex [CC121 vs. all other isolates]). True positive assigned 
isolates are e.g. German isolates correctly assigned to the German group. False negative assigned 
isolates are e.g. German isolates which were assigned to the African group. False positive assigned 












Geography 219 90.87 9.13  
Germany 103 90.29 9.71 9.71 
Africa 116 91.38 8.62 8.62 
Resistance 219 84.93 15.07  
MRSA 168 89.29 10.71 8.93 
MSSA 51 70.59 29.41 35.29 
spa-types 219 89.04 10.96  
 t003 29 62.07 37.93 44.83 
 others 190 93.16 6.84 5.79 
 Clonal complexes 219 97.72 2.28  
 CC121 26 92.31 7.69 11.54 
 others 193 98.45 1.55 1.04 
#The right column shows the percentages of additional isolates the algorithm had assigned to the 
different classes i.e. 9.7% of the African isolates were judged to be of German origin. 
Total mass spectra analysis of African versus German isolate origin indicated a 
tendency of geographically dependent isolate clustering with true positive assignment 
of about 90% of the German SA isolates and 91% of the African SA. A high number of 
MSSA isolates was misclassified (29% false negative and 35% false positive), while 
89% of MRSA isolates were assigned to the correct group based on their total mass 
spectra. A substantial part of the predominant spa-type t003 isolates were also 
misclassified with 38% false negative and 45% false positive (Table 20). In the 
assignment analysis of total mass spectra isolates of CC121 versus total mass spectra 
belonging to all other CCs in the study showed a tendency of true positive assignment 




In conclusion, the identification projects identified no reliable correspondence of the 
SA isolates’ clusters based on the total mass spectra with the geographic origin, 
methicillin resistance profile or spa-type. However, a positive tendency for correct 
assignment of CC121 isolates were detected. 
4.4.2 Analysis of potential CC121 specific total mass spectra peaks 
Next, it was examined if there are characteristic mass spectra peaks discriminating 
CC121 mass spectra from all other SA mass spectra by visual comparison (Figure 27). 
Therefore, the mass spectra profiles of four randomly selected CC121 isolates and 
four other isolates of CC8 (n=1), CC30 (n=1) and CC45 (n=2) (Figure 27) were 
regarded. The visual comparison showed that all four CC121 isolates showed three 
peak shifts in comparison to the spectra obtained from non-CC121 isolates from a 
mass to charge ratio (m/z) of m/z 2760.32 to m/z 2774.32, from m/z 5525.53 to m/z 5552.28 
and from m/z 6552.50 to m/z 6581.18 (Figure 27). This let assume that these peaks are 
potentially characteristic CC121 peak shifts (p<0.001). 
These potentially characteristic CC121 peak shifts were statistically confirmed as 
significantly characteristic CC121 peaks (p<0.001) with the Mann-Witney test and 
Bonferroni correction for multiple correction based on the total mass spectra peak list 





m/z= mass to charge ratio 
Figure 27: Mass spectra sections of three CC121 specific peak shifts. Comparison of four CC121 
(red) isolates and four isolates of three other clonal complexes (CCs), namely CC8 (n=1), CC30 (n=1) 
and CC45 (n=2), (black). The mass to charge ratio (m/z) of three peaks were shifted in the CC121 
isolates. 
A web based in-silico database search was performed to identify the corresponding 
proteins to these peaks. The best hits with the highest probabilities were the 
aspartate 1 decarboxylase PanD (~2806Da), and the two ribosomal proteins RpmG 
(5375Da) and RpmD (6554Da), respectively. In order to evaluate if the peak shifts 
might be caused by mutations, the nucleotide sequences of the corresponding genes 
panD, rpmG, and rpmD of the CC121, CC45, CC30 and CC8 SA isolates (data not 
shown) were compared by our cooperation partners in Münster. However, this 
comparison showed no nucleotide alterations in any of the three genes so that 
mutations in these genes can be excluded as reason for the differences in the CC121 






5.1 Differentiation of closely related SA strains of a hospital admission 
prevalence screening study in Saarland by DNA microarray 
In this study of a SA cohort of the tertiary care university hospital of Saarland (section 
4.1), the DNA MA platform of Identibac® (Alere Technologies GmbH, Jena, Germany) 
was applied as a state-of-the-art genotyping method with affordable costs and 
technical robustness for genotyping of matched nasal MSSA and MRSA isolates 
collected upon patient admission. The obtained DNA MA data of this small study were 
used to evaluate three bioinformatic methods to analyze which is the most appropriate 
DNA MA data analysis method in comparison to spa-typing as reference method. 
Further, the MRSA and MSSA clonal lineages of community-associated SA isolates of 
the federal state of Saarland and the resistance and virulence gene distribution in 
MRSA in comparison to MSSA were evaluated. 
The analysis of the MRSA and MSSA revealed that the MSSA cohort revealed a large 
CC diversity (n=12) in comparison to the analysis of the MRSA isolate set displaying a 
limited number of CCs (n=5). The MRSA cohort further showed a high prevalence for 
spa-type t003 in CC5. Overall higher diversity of MSSA compared with MRSA has 
been described in previous studies (Deurenberg & Stobberingh, 2008, Ghasemzadeh-
Moghaddam et al., 2011, Goering et al., 2008). 
The low CC diversity, the predominance of CC5 within the MRSA strain set might be 
considered at first sight as a limitation of this study. However, it might also be regarded 
as a strength, as the discrimination of such closely related strains is a major challenge 
when analyzing HA-MRSA isolate cohorts of geographically restricted studies. Such 
high-resolution strain differentiation is of special importance to confirm potential 
outbreak situations from accumulated MRSA detections to identify the starting point 
and to interrupt the responsible transmission routes. 
The DNA MA from Alere Technologies (Jena, Germany) provides information for a 
comprehensive number of genetic loci that are associated with resistance formation 
and infectivity of SA. The chip contains 334 gene fragments of genes encoding for 
virulence factors, resistance genes as well as regulatory elements, and hybridizing 




in this isolate. The hybridization pattern can be furthermore used to assign the isolate 
to a known CC or ST (based on the image of the microarray, analyzed by the 
designated reader and iconoclust software provided by Alere Technologies GmbH, 
Jena). A major advantage of this method is that isolates with identical spa-types and/or 
CCs/STs might be further distinguishable, when strains differ in the genes tested by 
this array. However, due to the large amount of data that is generated by this method, 
this information is not easily visible and often requires advanced bioinformatic 
evaluation methods, especially if a larger set of isolates should be compared. 
This study suggested that this method is particularly well suited in answering detailed 
questions related to SA typing, infection control and SA epidemiology when the DNA 
MA data is analyzed by appropriate software tools, for example to investigate if two SA 
isolates are genetically identical or how they differ and/or if they are from the same 
strain lineage. While splits graph and HAC are bioinformatic methods typically used in 
phylogenetic analyses, PCA is a dimension reduction model that is especially used in 
genome wide association analyses. Based on this evaluation, an analysis algorithm 
has been developed in this work for further DNA MA genotyping projects for analysis 
and best approach for result presentation. 
Additionally, splits graph based on DNA MA provided a better resolution based on the 
high number of analyzed loci with a more detailed view how the single isolates or 
isolates groups are placed in relation to each other compared to splits graph based on 
spa-typing data. 
This means, that it is easy to evaluate or recognize in outbreak situations if isolates/ 
isolate groups belong to the same strain or give a hint that isolates even not being 
totally identical, but may descend from the same mother strain. This allowed in 
potential outbreak situations to decide if there is a real outbreak situation to handle 
with or if the observed accumulation in fact represents different introductions. 
Furthermore, DNA MA data can be used to select isolates where further typing is 
necessary i.e. WGS. 
Comparison of the both splits graph based on spa-typing and DNA MA for the 
predominating isolates of CC5 showed that the splits graph based on DNA MA has a 
much higher resolution. It reveals several isolates subgroups not presented by splits 
graph based on spa-typing data and how each single isolate is placed in relation to the 




Splits graph based on spa-typing data allowed a correct assignment of five more 
isolates  (S36 of spa-type t306, R4, R8, R17 and R18 of spa-type t504) to CC5 than 
described till yet by the Ridom spa-server database but as described before in literature 
(Deurenberg et al., 2009, Cuny et al., 2015).  
Comparison of splits graph based on spa-typing and DNA MA showed that splits graph 
based on DNA MA was able to assign two more isolates to a isolate group CC (S12 to 
CC45 and S43 to CC5 cluster) than splits graph based on spa-typing data. 
These findings showed, that splits graph presentation of DNA MA data make it 
relatively easy to see how isolates may be related even without knowledge of an expert 
and can thus be an important tool for infection control nurses. 
Further, DNA MA data seemed to overcome some of the limitations of spa-typing as 
established SA typing system. 
MLST still proved the framework for epidemiological understanding. However, MLST 
is expensive and laborious because of the higher number of analyzed genes. MLST is 
based on the sequencing of fragments of seven housekeeping genes that, in 
evolutionary terms, slowly accumulate genetic variations (Aanensen & Spratt, 2005). 
This could attribute to an insufficient discriminatory potential in epidemiologically 
unrelated strains because of the low or missing number of differences in the analyzed 
genes. In this case epidemiologically unrelated strains might falsely be assigned to the 
same ST or CC. MLST is unsuitable for the direct tracking of fast changes. This is the 
reason why MLST is not suited for outbreak analysis – but provide reliable information 
as a basis for SA epidemiology and is the method of choice for larger epidemiological 
studies. 
In comparison, spa-typing is based on the sequencing of a single gene. It is a relatively 
cheap method, which could be transferred and directly applied in other labs leading to 
identical, unambiguous results. A remarkable degree of spa gene repeat 
polymorphisms within specific clonal lineages often provides a higher discriminatory 
power of this method if compared to MLST (Strommenger et al., 2006). However, a 
disadvantage of spa-typing is the risk of evolutionary convergence, reflecting 
homoplasies because of the high mutation rate of the spa-locus. This may not allow a 
correct discrimination or may lead to incorrect assignment of isolates to clones as it 




analysis (Basset et al., 2012, Harris et al., 2010, Nübel et al., 2011, Nübel et al., 2008). 
Reason could be the exchange or deletion of spa-repeats leading to spa-types typically 
not found and described in literature for isolates of these CCs. In literature, spa-type 
t273 were found in SA isolates of CC1, spa-type t306 were described in CC5 isolates, 
t018 in CC30 isolates and t493 in CC182 isolates (Boswihi et al., 2016, Krupa et al., 
2015, Nulens et al., 2008, Rijnders et al., 2009) while in this study isolates of these 
spa-types clustered with isolates of other CCs. Thus, in this single locus typing method 
evolutionary convergence may lead to indifferent clustering of these isolates by spa-
typing in comparison to the DNA MA analyzing more loci. 
Another disadvantage is that only one gene region is analyzed and that putative 
changes in other regions are not detectable by this method. Genetic changes may 
accidently blur the picture. Although spa-typing showed a high mutation rate, the 
resolution of this method is not discriminatory enough when single clones as t003 
dominated as seen this work. Thus, spa-typing is a highly useful method for MSSA but 
only with minor extent for monitoring spreads of MRSA because in MRSA cohorts 
single spa-types dominate often (Ruffing et al., 2012, Witte et al., 2008). In these cases 
additional methods are often needed. 
In comparison to splits graph based on DNA MA data, you need to be an expert to 
understand how similar spa-types based on one single gene are for the correct 
interpretation of splits graph based on spa-typing data. The resolution of splits graphs 
is too low. You must be able to understand how similar the single repeat sequences 
are to see if they are closely related to each other. That means you need to know if 
there is only a single nucleotide mutation or if they are totally different repeat patterns 
resulting in another spa-type. 
Although, as could be seen, the higher number of analyzed loci by DNA MA provided 
a better resolution in comparison to spa-typing. Analysis of the whole isolate cohort of 
92 isolates by splits graph based on DNA MA showed limitation for the resolution of 
the CC5 isolates. Therefore, it was needed to perform an analysis only of the CC5 
isolates separately by three selected bioinformatic methods, splits graph HAC, PCA 
for better resolution and to determine which method provides the best result 
presentation. 
Notably, the analysis of the DNA MA results obtained with the closely related CC5 




bioinformatic methods. This is a critical point. The selection of the applied method could 
influence the result interpretation. The reason could be the different mathematical 
algorithm of the different methods which are based on different weightings of 
differences (splits graph, PCA) or similarities (HAC) of the analyzed isolates. 
Splits graphs in this work were constructed based on the neighbour-joining method 
(Saitou & Nei, 1987) which is one of the most frequently applied distance-based 
methods for phylogenetic analyses. It constructs splits networks from inferred distance 
matrices and applies an agglomerative process to create a phylogenetic tree (Huson 
& Bryant, 2006). The distance matrix was calculated based on the proportion of 
positions which were different between two sequences or hybridization patterns.  
In the PCA the full data set can be projected on the first two or three PCs without losing 
too much information. The data compression captures most of the variation among the 
samples and visualizes similarities and differences. In this work, the PCs will point 
along those MA probes that show the largest variation of hybridization among the 
samples. Samples with similar DNA MA hybridization profiles are arranged closer to 
each other in the 2D/3D plot compared to samples with larger differences (Caddick et 
al., 2006). 
HAC constructs a dendrogram or branching tree diagram representing the hierarchy of 
clusters based on the degree of similarity or number of shared characteristics of the 
data. The distance along the tree from one element to the next one represents the 
relative degree of similarity, while short distances representing high similarities. 
Thus, it has to be kept in mind that independent of the chosen method the obtained 
result must not reflect the total reality but shows a potential structure for a better 
understanding of the data. 
Additionally, it could be seen that each model may have its specific strengths and that 
the number of analyzed samples and their degree of diversity should be considered to 
choose the optimal method. For larger numbers of isolates, PCA appeared as the best-
suited method for a direct sample overview visualized in 2- or 3-dimensional graphs. A 
disadvantage in this case was that closely related isolates are overlapping in the 
presentation of all isolates so that is was difficult to identify isolates in a group. 
However, it is possible to zoom in the figure with the disadvantage that not all isolates 




detailed relationship of the isolates and a directly visible high-resolution subgrouping. 
This is also the disadvantage of this method because the high-resolution needs a large 
amount of space for presentation. This makes it an inappropriate method for 
construction of figures for publications with a size of maximally a DIN A4 page. 
Splits graph analysis seemed to be the most appropriate method for diversity analysis 
in this study because of its easy applicability, direct assignment of each isolate to the 
branched subgroups in a 2-dimensional graph, and its free availability as open source 
software tool (Huson & Bryant, 2006). Moreover, also for a large amount of analyzed 
isolates it is possible to construct a figure which could be easily included in 
publications. 
DNA MA revealed substantial differences in the genetic repertoires of MRSA isolates 
in comparison to the MSSA isolates, which were related to antimicrobial resistance 
genes, agr- and capsule-types, and virulence genes. Specifically, the β-lactamase 
operon was detected in 21% more MRSA (39, 84.8%) than MSSA isolates (29, 63%). 
This implies that 37% of MSSA are penicillinase susceptible. Practically, this means 
that for a high number of MSSA penicillin could be a treatment alternative. Moverover, 
the MRSA cohort was characterized by a significantly higher number of virulence 
genes of the leukocidin-, enterotoxin-, hemolysin-, protease- and adhesion gene 
families. However, the highly prevalent German epidemic MRSA clone (Rhine-Hesse) 
dominated the genetic profile of the MRSA cohort, which might have caused some 
bias. Therefore, evaluation of the conclusions in other studies is needed. Certainly, it 
may also suggest that this Rhine-Hesse virulence gene repertoire is of relevance for 
the successful epidemic spreading of this specific MRSA clone. Yet, since all examined 
study isolates were of nasal origin, no association of virulence genes and disease could 
be drawn. 
The findings of this study indicate that implementation of the DNA MA in routine 
microbiological diagnostics might be a useful first line analysis tool for outbreak 
surveillance in an easy and fast interpretable way. Further, it is an alternative to WGS 
that requires both advanced hardware and software as well as complex bioinformatic 
post processing of the sequencing results (Strauss et al., 2016). By using DNA MA 
analysis, the number of isolates requiring WGS (e.g. in case of an outbreak) could be 
reduced to a small number of closely related isolates with identical DNA MA profiles 




5.2 Characterization of Nigerian SA isolates by DNA MA 
A substantial amount of information exists for prevalent SA lineages circulating in the 
Western hemisphere and this information was utilized to define the gene regions that 
are used by the DNA MA for identification. In contrary, only very little information on 
the gene composition of African isolates was available at the time of the study. 
Therefore, it could not be excluded that the sequence targets provided by the DNA MA 
were not functional with African isolates. In order to address this question, a small 
Nigerian (Sub-Saharan African) cohort of 52 SA isolates (49 MSSA, 3 MRSA) were 
investigated by DNA MA. Most of the isolates were of clinical origin but a clear 
distinction between hospital/community-associated strains could not be made. Based 
on the results of a previous study, splits graph analysis was chosen for a subgroup 
analysis given the small study size. 
The analysis showed that DNA MA appeared to be an adequate tool for molecular 
characterization and analysis of the clonal distribution also of African SA showing a 
heterogeneous and divergent nature of the examined Nigerian isolates. Nevertheless, 
attribution of CCs by the DNA MA software is based on the specific isolate hybridization 
pattern on the DNA MA rather than gene sequencing. ST/CC hybridization pattern that 
is not included in the database, could not be detected or differentiated from other 
STs/CCs by the DNA MA. This was the case for ST2427 which could not be 
discriminated from ST8. Thus, the DNA MA hybridization pattern database 
continuously needs to be updated to detect all known and new STs/CCs. 
The identified heterogeneous and divergent nature of the examined Nigerian MSSA 
isolates corresponds to the overall higher diversity of MSSA compared with MRSA as 
described in previous studies (Blomfeldt et al., 2013, Deurenberg & Stobberingh, 2008, 
Ghasemzadeh-Moghaddam et al., 2011, Goering et al., 2008, Rasmussen et al., 2014, 
Ruffing et al., 2012). 
The potential for individual statistical comparisons was limited due to the low number 
of isolates included. However, as the isolates were obtained from patients of various 
medical institutions in Nigeria it enables us to observe some tendencies. 
PVL-positive isolates were identified in half of the isolates (52%) and seven of the 12 
CCs. The high prevalence of PVL correspond to the high numbers of soft and deep 




Schaumburg et al., 2014, Sina et al., 2013). In contrast, an association of toxin 
encoding genes such as the enterotoxin genes and tst1 was only seen for clonal types 
such as CC30. This is in agreement with previous investigations showing that tst1 has 
a strong linkage with CC30 and that the enterotoxin gene cluster egc is often 
associated with CC5, CC22 and CC45 (Holtfreter et al., 2007, Monecke et al., 2008). 
Summarizing, the data showed that DNA MA is an adequate tool for molecular 
characterization and analysis of the clonal distribution of African SA. The easiness of 
use of the DNA MA make this method a possible technique for outbreak investigation 
in labs without access to advanced molecular technologies. Further, the study also 
showed the need for further trials employing well-controlled, prospectively collected 
clinical isolates and clinical data to delineate the virulence gene repertoire of Sub-
Saharan African SA in conjunction with the clinical disease presentation. 
5.3 Genotypic characterization and comparison of Sub-Saharan African and 
German isolates 
SA or rather MSSA are a ubiquitous worldwide distributed, opportunistic pathogen. 
However, epidemiological and molecular data on SA derived from infections and nasal 
isolates are rare for developing countries such as in Sub-Saharan Africa. This study 
provides a comprehensive data set on molecular bacterial characteristics of strictly 
non-nosocomial SA isolates of volunteers/patients. The isolates were collected under 
controlled conditions in three Sub-Saharan African and three German study centers 
with Germany as a representative for industrialized countries of a temperate climate 
zone. The data of all participants were documented in case related forms (CRFs) (see 
Appendix, section 6.2) and checked of fulfilling the requirements for inclusion into the 
study cohort. The criteria for the isolate collection was not part of this work. 
The DNA MA based CC and ST distribution analyses showed that the cluster 
distribution among African and German isolates was inhomogeneous with certain CCs 
being more prevalent among either African or German patients or volunteers. As there 
was some heterogeneity in population age and comorbidities between the German and 
African cohorts this may, however, have distorted the ‘true’ distribution of clones and 
genes between isolates from the different geographic regions. 




derived from the spa-types of SA isolates that were recovered from patients with 
invasive disease in 2006/2007 in Europe (Grundmann et al., 2010). Approximately one 
half of the 565 MSSA isolates was attributed to the following CCs (in descending 
order): CC45, CC5, CC15, CC7, CC30, CC8, CC22 and CC12. In a strictly population-
based survey from Germany, SA was recovered from 85 out of 389 participants (5 of 
them MRSA). The most prevalent MSSA clones belonged to CC5, CC8, CC1, CC15, 
and CC30 (Holtfreter et al., 2016, Mehraj et al., 2014). In a population-based study in 
the Northeast of Germany the most common SA lineage was CC30, followed by CC45, 
CC15, CC8 and CC22. In line with these observations, the same CCs were also 
prevalent in our study, with similar distributions of CC5, CC8, and CC45 in the African 
and German isolate groups. They also belong to the 10 most prevalent CCs in this 
study. 
The population structure of major MSSA clones in Africa has been described in a 
recent review (Schaumburg et al., 2014) as well as in individual studies (Breurec et al., 
2011, Conceicao et al., 2015, Ruimy et al., 2008). They show that CC5, CC15 and 
CC30 are largely distributed in Africa and Europe. In line with this, these three CCs 
also belonged to the 10 most prevalent CCs of this study. However, CC15 isolates 
were more prevalent in the African cohort and CC30 isolates were almost exclusively 
found in the German group. In comparison, CC8 MSSA were mainly reported from 
Maghrebian regions, whereas CC8 MRSA were predominantly detected in Central and 
South Africa and CC121 was more frequently found in Sub-Saharan countries 
(Schaumburg et al., 2014). MSSA-CC80 has more often been identified in North Africa, 
while the CA MRSA clone ST80 is prevalent in Europe (Otter & French, 2010, Stegger 
et al., 2014). In this study all CC80 isolates were of African origin. 
According to Schaumburg et al. CC88 isolates are typically methicillin-resistant and 
isolates of this CC were almost exclusively detected in West, Central and East African 
regions. Because of this, the cluster was given the acronym ‘African clone’ 
(Schaumburg et al., 2014). In accordance with Schaumburg and colleagues 
(Schaumburg et al., 2014), CC88 was only detected at African study sites. However, 
in contrast to Schaumburg and colleagues in this study CC88 isolates were in most 
cases MSSA (75%). 
CC152, which was almost exclusively found among African isolates in this study, has 




2007; Egyir et al. 2014). It is presumed that this strain lineage originates from African 
MSSA, which first spread through central Europe and then acquired methicillin 
resistance (Okon et al., 2009, Otter & French, 2010). A study from Mali showed that 
CC152 was the second most frequent MSSA lineage isolated from healthy carriers and 
that all tested isolates were PVL positive. Similar results were found in a study of PVL 
positive MSSA infections of Eritrean and Ethiopian asylum seekers in Switzerland, 
where 7 out of 15 infections were caused by PVL positive CC512 isolates (Jaton et al., 
2016). When summarizing the results of different studies, CC152 can be considered 
as the major PVL positive CC in Sub-Saharan Africa (Ruimy et al., 2008, Schaumburg 
et al., 2014), which is also supported by the findings presented in this thesis. 
Previous reviews indicate that there are “typical” CC clusters, such as CC5, CC15 and 
CC30, which are prevalent in Europe as well as “typical” African strain lineages i.e. 
CC80-MSSA, CC88 or CC152 (Abdulgader et al., 2015, Schaumburg et al., 2014). 
These observations correspond with the results of this study for the “African” clones 
CC80-MSSA, CC88 and CC152. In comparison, the typical in Europe prevalent CC5 
was almost equally distributed in the African and German isolate groups, while CC15 
isolates also reported to constitute a typical European CC and were more often found 
in the African group at all three study sites. 
Clear-cut studies allowing for frequency comparison between European and African 
clusters are lacking. A case study from travelers returning from Africa demonstrated 
that SA of African origin may have a different genetic background and/or harbor 
virulence determinants that are atypical for European isolates (Zanger et al., 2012). 
This is shown by African resistance data and the unexpected presence of atypical 
virulence factors such as the Panton-Valentine leukocidin, as could be seen in this 
study, too (Zanger et al., 2012). 
Taken together, in this comparative study, certain CCs were found to be significantly 
enriched (CC15, CC121, CC152) or even specific (CC88, CC80) for the African cohort. 
In the German cohort, CCs such as CC45, CC30, CC7 and CC22 were found 
significantly more often, and CC398 and CC50 were only found at German sites, 
although the overall numbers of the latter two CCs were comparably low. Additionally, 
compared to the African study sites, the relative frequencies of CC’s in the clinical and 





Regarding the agr subtypes, agr-type IV was identified with an over-representation in 
African and agrI in German isolates. In comparison, agr-type II (about 25%) and agr-
type III (14%) were found in similar amounts in the German and African isolates. This 
is consistent with previous studies demonstrating that agr-type IV is the predominant 
agr-type in African CC121 isolates (Kolawole et al., 2013, Oosthuysen et al., 2014). 
Similarly, capsule types 5 and 8 were found to be prevalent in Africa and Germany to 
a different extent (Budimir et al., 2010, Lattar et al., 2009, Melles et al., 2008). In African 
nasal isolates capsule type 5 was predominant, while capsule type 8 was predominant 
in German nasal samples. A previous study on remote African pygmies showed similar 
results with respect to the capsule type distribution compared to data from European 
studies (Schaumburg et al., 2011). 
The previously reported differences in carriage rates of the PVL encoding genes were 
clearly confirmed in this study. Significantly more African SA, almost half of the African 
isolates (45%) and only single German isolates (3%), carried the PVL encoding genes. 
Previous African field studies showed that Africa is a PVL-endemic region with high 
rates of PVL, both in pandemic CA-MRSA- and CA-MSSA-lineages ranging from 17 to 
74% (Breurec et al., 2011, Campbell et al., 2008, Okon et al., 2009, Ruimy et al., 2008, 
Schaumburg et al., 2011, van der Meeren et al., 2014). In clear contrast, in developed 
regions the PVL prevalence rates in MSSA have been reported to be between 1 to 5% 
(Lowy, 1998, Monecke et al., 2009, von Eiff et al., 2004). 
Remarkably, the MRSA prevalence in our study was very low in comparison (1-3%) to 
an admission prevalence screening in Germany of the EUREGIO MRSA-net with a 
MRSA prevalence of 6.5% (n=762 MRSA out of 23566 SA isolates) and a state wide 
admission prevalence screening study of Saarland with 12% of all collected SA 
(n=3558) being MRSA (Herrmann et al., 2013b, Köck et al., 2009). Unfortunately, no 
publications of African SA admission studies were available. The prevalences reported 
in this thesis probably better reflect the situation seen in the community in Africa and 
Germany, as this is the only study including isolates from healthy volunteers or from 
community-associated disease and strictly excluding isolates of hospital-associated 
infections. 
We found a significant enrichment of the tetracycline encoding genes tet(K) and tet(M) 
in African isolates. This is in accordance with data of other studies from African 




al., 2013, Phaku et al., 2016). A likely reason for this might be the use of these 
antibiotics as first line treatment, self-medication, incorrect dosage and unavailable 
and/or expensive alternative antibiotics as second line treatment because of their 
higher costs, after first line treatment failure (Fasehun, 1999). 
In this study the fosfomycin resistance gene fosB was frequently detected in African 
isolates (62%). In comparison, a recent review compared the antibiotic susceptibility 
profiles of MRSA in Africa and showed that 84-99% of the MRSA isolates were 
fosfomycin susceptible (Falagas et al., 2013). These results are the opposite of the 
findings of the present thesis. The discrepancy might be driven by the fact that in this 
thesis almost exclusively MSSA isolates (97%) were analyzed. This finding might also 
indicate that fosB is more distributed in African CA-MSSA than in African CA-MRSA 
isolates. An alternative explanation might be that fosfomycin, as an old antibiotic used 
for the treatment of uncomplicated urinary tract infections, is frequently used in the 
community setting in the context of increasing fluoroquinolone resistances (Abubakar 
et al., 2018, Popovic et al., 2010). Unfortunately, no literature of fosfomycin resistance 
in African MSSA and no data about treatment guidelines, antibiotic stewardship or 
investigations of typical genetic resistance mechanisms detected in Sub-Saharan 
African countries were found to confirm the latter hypothesis. 
The observed distribution differences of the adhesion genes can be explained by the 
CC distribution of the isolates. This means, for example, that CC121 and CC152 were 
mainly found in the African group, while CC50 and CC398 were only found in the 
German group as well as that single adhesion genes were not recognized in specific 
CCs (missing fib gene recognition in CC22, comprising 37 German and only 4 African 
isolates and missing eap gene recognition in CC152, comprising 79 African and only 
2 German isolates). The missing recognition might be caused by DNA mutations, allelic 
variants or polymorphisms that prevented a hybridization with the DNA MA sequence 
target albeit of the fact that the respective gene is present (as shown for example for 
map/eap). The lack of fib in CC22 influenced the overall results towards larger fib 
positivity among African isolates. Similarly, the higher ratio of map/eap positive isolates 
in the German group is most likely caused by the inability of the CC152 eap variant to 
hybridize with the respective target sequence presented on the DNA MA, as nearly all 
CC152 isolates were of African origin (80/82). Previous studies indicated map/eap to 




al., 2008), and that different versions of this gene may exist (Joost et al., 2009). 
Individual gene detection by DNA MA analysis and their comparison between 
clinical/nasal and African/German origin of isolates was informative but a more 
complex analysis was needed to address potential correlations of the hybridization 
patterns and the isolate origin. PCA gave an overall impression of the hybridization 
patterns of the 1200 isolates, which could partly be related to isolate characteristics 
such as geographic origin or clinical significance. PCA allowed the presentation of a 
combination of all SA specific markers assessed by DNA MA, thus avoiding multiple 
comparisons of single target recognition. This way, the clustering of the ‘predominant 
African’ isolates of CC8, CC15, CC121 and CC152 and the ‘German’ clusters CC22, 
CC398 and CC30 were shown. Such an association analysis of isolates with different 
geographic origin to CCs has not been performed before. A further significant cluster 
attribution to the ‘clinical’ versus ‘nasal’ subgroup was found for three CCs (CC45, 
CC121 and CC152). 
Previous studies already examined the association of CCs and genes with specific 
clinical presentation (Fowler et al., 2007, Nienaber et al., 2011, Tristan et al., 2012, 
Nethercott et al., 2013). Given the major importance of such an association for 
clinicians, this was one of the main objectives of this study, too. However, this attempt 
failed. One reason was that the numbers of specific clinical presentations in the African 
and German patient group were to small, especially for a comparison of the African 
and German differences, or similarities regarding e.g. HIV infection. A second reason 
might be the inequal CC distribution in the different disease type groups to be 
compared. This failure somehow reflects the literature for this topic which is a kind of 
contradictive, as some studies report an association of CCs with specific clinical 
presentation (Fowler et al., 2007, Nienaber et al., 2011, Nethercott et al., 2013) while 
other failed to do so (Feil et al., 2003, Tristan et al., 2012). 
In conclusion, the DNA MA analysis of the prospectively collected, community-
associated SA isolate set obtained from volunteers and patients demonstrates clear 
and significant differences between German and Sub-Saharan African localizations 





5.4 Potential of MALDI-TOF as strain differentiation method 
The mass spectrometric method MALDI-TOF allows the differentiation of bacteria to 
the species level in routine microbiology laboratories, fulfilling the criteria of 
standardization, low turn-around time, convenience in handling, and low costs (Lasch 
et al., 2014, Dingle & Butler-Wu, 2013, Benagli et al., 2011). However, in outbreak 
situations the report to the species level do not inform on the association of a given 
isolate to the outbreak. Molecular subtyping methods such as PFGE, spa-typing, 
MLST, DNA MA and WGS are relatively time-consuming, laborious and very often 
unavailable for routine diagnostic laboratories as well as in part still connected with 
high costs. Therefore, MALDI-TOF based subtyping methods could be of paramount 
clinical value in outbreak situations for fast analysis and calculation of the transmission 
risk potential of specific strains through the knowledge of the ST or CC they belong to. 
Earlier work demonstrated a successful subtyping by MALDI-TOF up to the subspecies 
level for different bacterial species such as Streptococcus pneumoniae and 
Streptococcus agalactiae (Williamson et al., 2008, Lartigue et al., 2009), Salmonella 
enterica (Dieckmann et al., 2008), Listeria monocytogenes (Barbuddhe et al., 2008), 
and Francisella tularensis (Seibold et al., 2010). One major goal of SA subtyping is not 
only the identification up to the subspecies level but also the differentiation between 
MRSA and MSSA strains, for example to prevent MRSA transmission in the clinical 
setting by prevention strategies such as isolation of MRSA patients. However, the 
effectiveness of SA subtyping by MALDI-TOF is still a matter of debate. The present 
literature is dominated by studies with low isolate numbers and differential methods for 
MRSA identification reporting contradictive results (Du et al., 2002, Edwards-Jones et 
al., 2000, Josten et al., 2013, Lasch et al., 2014, Szabados et al., 2012, Wang et al., 
2013, Wolters et al., 2011). Altogether, a differentiation of SA strains based on their 
mass spectra in MSSA or MRSA could not be achieved in the majority of studies (Wang 
et al., 2013, Sparbier et al., 2013, Edwards-Jones et al., 2000, Bernardo et al., 2002). 
However, two studies reported successful discrimination between MRSA and MSSA 
mass spectra. First, success was achieved by incorporation of nonradioactive isotopes 
into newly synthesized proteins during cell growth and functional testing in the 
presence of antibiotics (oxacillin) (Sparbier et al., 2013) and second based on the 
selection of MRSA specific peaks in combination with the commercially available 




Version 3.02, ClinPro Tools Version 2.2) (Ueda et al., 2015). In this study similarity of 
mass spectra between two isolates can be directly compared by head-to-head analysis 
of the individual peak lists. In comparison to this work, in a recent study a support 
vector machine classification using Flex analysis 3.0 (Bruker Daltonics) was performed 
leading to identification rates of 93.3% for MSSA and 86.7% for MRSA (Sogawa et al., 
2017). This latter approach was similar to the approach in this work analyzing the whole 
mass spectra and peaks with bioinformatical standardized statistical analysis as 
support vector machine for MRSA identification by the commercially available software 
BioNumerics (Applied Maths) and MRSA identification of 89.3% and MSSA of 70.6%. 
MRSA identification was not 100% successful in both studies and thus not applicable 
in routine. Maybe further refinements of the methods and databases could lead to 
applicability in clinical routine. 
A second major goal of SA subtyping is the differentiation of strains into known 
genotypes such as CC/STs or spa-types. This objective was investigated in a number 
of recent studies (Bohme et al., 2012, Camoez et al., 2015, Josten et al., 2013, Lasch 
et al., 2014, Ostergaard et al., 2015, Wolters et al., 2011, Zhang et al., 2015) and 
different lineage-related peaks were identified as markers of the established CCs or 
spa-types (Ostergaard et al., 2015, Zhang et al., 2015). These studies demonstrated 
that MALDI-typing was more or less successful for the discrimination between a couple 
of typical outbreak strains such as CC1, CC5 and CC22, and more recently also for 
the LA-MRSA CC398 (Bohme et al., 2012, Josten et al., 2014, Wolters et al., 2011, 
Ostergaard et al., 2015, Monecke et al., 2010, Sauget et al., 2016). All studies had in 
common that they looked for strain lineage-specific peaks of CCs and spa-types as 
biomarkers. If identified, these peaks were subsequently used for the identification of 
the CC or spa-type of newly collected isolates. However, most studies worked with 
limited isolate numbers derived from a single center, which might have caused a 
certain isolate selection bias. Another drawback of these studies was that different 
strategies and software tools were used to accomplish their task, which restricts the 
comparability of these studies. 
In this thesis, a high variety of genotypes from six different study sites located in two 
continents were examined. The primary aim of this study was to determine whether it 
was possible to establish an automated software tool for MALDI-typing that can be 




evaluation of different users. Automated software (BioNumerics, Applied Maths) was 
used for statistical analysis and grouping of MALDI-types by PCA for previously defined 
SA groups [CC, spa-type], resistance profile [MRSA, MSSA] or geographic origin 
[African, German]). 
By using the automated universal approach of this study, it was not possible to correctly 
identify spa-types or CCs based on the SA mass spectra, except for CC121. 
Remarkably, isolates of the latter CC formed a distinct MALDI-type subgroup. 
Statistical analysis by Mann-Whitney-U test over all spectra identified a significant 
association of three peaks (m/z 2774, m/z 5552 and m/z 6581) to the CC121 MALDI-
TOF spectra. Two of the identified characteristic CC121 peaks with a mass to charge 
ratio of m/z 2774 and m/z 5552 had not previously been described. In contrast, the 
single peak m/z 6580/1 was described before as biomarker for CC130 in two studies 
(Josten et al., 2013, Ostergaard et al., 2015). In the present study, CC130 isolates 
were not included and the question of similarity between CC121 and CC130 MALDI-
TOF spectra remains to be addressed in future studies. These findings let suggest that 
MALDI-TOF analysis may be a potential method for specific CCs in local outbreaks. 
However, it has to be considered that not only single peaks but rather a combination 
of peak patterns should be regarded for a correct CC identification or CC differentiation. 
The reason is that till yet the available data are limited and thus a high risk of 
misidentification is given. 
5.5 Conclusion 
The data shown in this thesis demonstrate that DNA MA is an adequate tool for SA 
characterization of German as well as of African SA. It allows the detection of antibiotic 
resistance cassettes, virulence genes and molecular epidemiological analysis of SA 
isolates. Major advantages of the DNA MA application are the fast-available results 
(within 6 h), the objective result interpretation and the easy to understand results 
(automated read out of signals). In addition, the comparison of spa-typing and DNA 
MA showed a higher subtyping potential of the DNA MA especially for closely related 
strains as SA CC5 isolates. 
However, a disadvantage is that DNA MA can only detect what is covered by the 
sequence targets on the DNA MA, which can result in false negative results. 




analysis of the DNA MA results revealed different isolate subgroups by the different 
bioinformatic methods. This is a critical point. The selection of the applied method and 
its mathematical algorithm has to be taken into account in the result interpretation. 
Thus, in the future a fast, detailed and standardized strain comparison with 
bioinformatic analysis tools is required for DNA MA as well as WGS data. Especially 
with regard to the growing amount of molecular and clinical data the development of 
fast, easy to handle and easy to understand software tools are necessary for data 
evaluation and interpretation. 
Testing a comprehensive set of SA isolates with MALDI-TOF revealed that it was not 
possible to determine the methicillin resistance profile, geographic origin or the strain 
lineage of SA isolates based on their mass spectra profiles with one exception. Only 
CC121 isolates could be correctly identified. Together with findings of previous studies 
this show that general identification of methicillin resistance and strain lineages based 
on mass spectra is not possible, however by applying homemade rules it can be used 
to identify specific strain types and even particular CC types, which may be an 
advantage for routine laboratories in situations with local outbreaks.  
In the future, fast and reliable SA characterization data may help to close the white 
spots of missing SA data of low- and middle-income countries, may allow a better 
traceability of SA transmission and a better understanding of the success of specific 
SA strains. DNA MA and/or WGS may become the leading molecular techniques for 
isolate differentiation and characterization in diagnostics with regard to dropping costs 
of WGS and the development of automatic data analysis systems. However, to be 
really effective, a compilation of DNA MA/WGS data in a large database will be needed 





6.1 Manufacturer information of Alere Technologies to the DNA microarray 
targets 
Table 21: List of all DNA microarray target groups with written out of the manufacturer information of 
Alere Technologies. 
Gene group Gene abbreviation Gene encoding for 
SPECIES 
 MARKER 
rrnD1 (S. aureus) Domain 1 of 23S-rRNA 
gapA glyceraldehyde 3-phosphate dehydrogenase, locus 1 
katA katalase A 
coA Coagulase 
nuc1 thermostable extracellular nuclease 1 
spa  staphylococcal protein A 




sarA staphylococcal accessory regulator A 
saeS histidine protein kinase, sae locus 
vraS sensor protein 












agrIV (total) accessory gene regulator allele IV 
agrB-IV  
agrC-IV  






mecA alternate penicillin binding protein 2, defining MRSA 
delta_mecR truncated signal transducer protein MecR1 
ugpQ 
glycerophosphoryl diester phosphodiesterase, 
associated with mecA 
ccrA-1 cassette chromosome recombinase genes A-1 
ccrB-1 cassette chromosome recombinase genes B-1 
plsSCC (COL) plasmin-sensitive surface protein 
Q9XB68-dcs hypothetical protein from SCCmec elements 
ccrA-2 cassette chromosome recombinase gene A-2 
ccrB-2 cassette chromosome recombinase gene B-2 









kdpB-SCC potassium-transporting ATPase B, chain 1 
kdpC-SCC potassium-translocating ATPase C, chain 2 
kdpD-SCC sensor kinase protein 
kdpE-SCC KDP operon transcriptional regulatory protein 
mecI methicillin-resistance gene regulatory protein 
mecR mecA repressor 
xylR 
homolog of xylose repressor, associated with 
SCCmec-elements 
ccrA-3 cassette chromosome recombinase gene A-3 
ccrB-3 cassette chromosome recombinase gene B-3 
merA 
mercury resistance gene operon, Hg(II) 
reductase 
merB 
mercury resistance gene operon, alkylmercury 
lyase 
ccrAA (MRSAZH47)_probe 1 
cassette chromosome recombinase gene 
(hypothetical) 
ccrAA (MRSAZH47)_probe 2 
cassette chromosome recombinase gene 
(hypothetical) 
ccrC (85-2082) cassette chromosome recombinase gene C 
ccrA-4 cassette chromosome recombinase gene A-4 




blaZ beta-lactamase gene 
blaI beta-lactamase repressor (inhibitor) 






rRNA methyltransferase associated with 
macrolide/lincosamide resistance 
erm(B) 
rRNA methyltransferase associated with 
macrolide/lincosamide resistance 
erm(C) 
rRNA methyltransferase associated with 
macrolide/lincosamide resistance 
lnu(A) lincosaminide nucleotidyltransferase (=linA) 
msr(A) macrolide efflux pump 
mef(A) macrolide efflux protein A 
mph(C) macrolide phosphotransferase II (=mpbBM) 
vat(A) virginiamycin A acetyltransferase 
vat(B) acetyltransferase inactivating streptogramin A 
vga(A) 
ABC transporter conferring resistance to 
streptogramin A and related compounds 
vga(A) (BM 3327) vga(A) allele from strain BM 3327 









aminoglycoside adenyltransferase  
(neo-/ kanamycin, tobramycin) 
aphA3 








 GENOTYPE : 
MISCELLANEOUS 
GENES 
sat streptothricin acetyltransferase 
dfrS1 
dihydrofolate reductase mediating trimethoprim 
resistance (=dfrA) 
far1 fusidic acid resistance gene (= far1) 
fusC (Q6GD50) fusidic acid resistance gene (= Q6GD50) 
mupA 
isoleucyl-tRNA synthetase associated with 
mupirocin resistance (=mupR) 
tet(K) tetracycline efflux protein 
tet(M) 
ribosomal protection protein associated with 
tetracycline resistance 
cat (total) chloramphenicol acetyltransferase 
cat (pC221)  
cat (pc223)  
cat (pMC524/pC194 ) 
cat (pSBK203R)  
cfr 
23S rRNA methyltransferase (phenicols, 
lincosamides, oxazolidinones, pleuromutilins, 
streptogramin A ) 
fexA chloramphenicol/florfenicol exporter 
fosB metallothiol transferase 





quaternary ammonium compound /  
multidrug efflux protein C 
qacC (total) 
quaternary ammonium compound /  
multidrug efflux protein A 
qacC (consensus)  
qacC (equine)  
qacC (SA5)  
qacC (Ssap)  
qacC (ST94)  




vanA vancomycin resistance gene 
vanB 
vancomycin resistance gene from enterococci and 
Clostridium 


















sea enterotoxin A (=entA) 
sea (320E)  enterotoxin A, allele from strain 320E 
sea (N315) / sep enterotoxin A, allele from strain N315 = enterotoxin P 
seb enterotoxin B (=entB) 
sec enterotoxin C (=entC) 
sed enterotoxin D (=entD) 
see enterotoxin E (=entE) 
seg enterotoxin G (=entG) 
seh enterotoxin H (=entH) 
sei enterotoxin I (=entI) 
sej enterotoxin J (=entJ) 
sek enterotoxin K (=entK) 
sel enterotoxin L (=entL) 
selm enterotoxin-like gene/protein M (=sem, entM) 
seln (consensus) 
enterotoxin-like gene/protein N (=sen, entN), consensus 
probe 
seln (other than  
RF122) 
 
selo enterotoxin-like gene/protein O (=seo, entO) 
egc (total) 
enterotoxin gene cluster, consisting of  
seg, sei, selm, seln, selo, selu 
seq enterotoxin Q (=entQ) 
ser enterotoxin R (=entR) 
selu enterotoxin-like gene/protein U (=seu, entU) 
ORF CM14_ probe1 enterotoxin-like protein ORF CM14 
ORF CM14_ probe2 enterotoxin-like protein ORF CM14 
VIRULENCE: 
 HLG AND 
LEUKOCI-
DINS 
lukF haemolysin gamma / leukocidin, component B (F) 
lukS haemolysin gamma / leukocidin, component C (S) 
lukS (ST22+ST45) 
haemolysin gamma / leukocidin, component C (S), 
allele from ST22 and ST45 
hlgA haemolysin gamma, component A 
lukF-PV Panton-Valentine leukocidin F component 
lukS-PV Panton-Valentine leukocidin S component 
lukF-PV (P83) F component of leukocidin from ruminants 
lukM S component of leukocidin from ruminants 
lukD leukocidin D component 
lukE leukocidin E component 
lukX 
leukocidin/haemolysin toxin family protein (= lukB or 
lukG) 
lukY  
leukocidin/haemolysin toxin family protein (= lukA or 
lukH) 
lukY (ST30+ST45) 
leukocidin/haemolysin toxin family protein (= lukA or 








hl putative membrane protein 
hla haemolysin alpha 
hlⅢ (consensus) putative membrane protein 
hlⅢ (other than RF122) 
hlb_probe 1 haemolysin beta 
hlb_probe 2 haemolysin beta 
hlb_probe 3 haemolysin beta 






chp chemotaxis-inhibiting protein (CHIPS) 




etA exfoliative toxin serotype A 
etB exfoliative toxin serotype B 






edinA epidermal cell differentiation inhibitor A 
edinB epidermal cell differentiation inhibitor B 
edinC epidermal cell differentiation inhibitor C 
VIRULENCE: 
 ACME LOCUS 
ACME (total) Arginine Catabolic Mobile Element 
arcA-SCC ACME-locus: arginine deiminase 
arcB-SCC ACME-locus: ornithincarbamoyltransferase 
arcC-SCC ACME-locus: carbamatkinase 
arcD-SCC ACME-locus: arginine/ornithine-antiporter 
VIRULENCE: 
 PROTEASES 
aur (consensus) Aureolysin 
aur (other than MRSA252) 
aur (MRSA252)  
splA serinprotease A 
splB serinprotease B 
splE serinprotease E 
sspA glutamylendopeptidase 
sspB staphopain B, protease 
sspP (consensus) staphopain A (staphylopain A), protease 











staphylococcal exotoxin-like protein/SAg gene 
homolog, SAUSA300_0370 


























ssl01/set6 (RF122)  
ssl01/set6 (other alleles) 
ssl02/set7 staphylococcal superantigen-like protein 2 
ssl02/set7 (MRSA252) 
ssl03/set8_probe 1 staphylococcal superantigen-like protein 3 
ssl03/set8_probe 2  
ssl03/set8 (MRSA252,  
SAR0424) 
ssl04/set9 staphylococcal superantigen-like protein 4 
ssl04/set9 (MRSA252,  
SAR0425) 
ssl05/set3_probe 1 staphylococcal superantigen-like protein 5 
ssl05/set3 (RF122,  
probe-611) 
ssl05/set3_probe 2 (612) 
ssl05/set3 (MRSA252) 
ssl06/set21 staphylococcal superantigen-like protein 6 
ssl06 (NCTC8325+MW2) 
ssl07/set1 staphylococcal superantigen-like protein 7 
ssl07/set1 (MRSA252) 
ssl07/set1 (AF188836) 
ssl08/set12_probe 1 staphylococcal superantigen-like protein 8 
ssl08/set12_probe 2 
ssl09/set5_probe 1 staphylococcal superantigen-like protein 9 
ssl09/set5_probe 2  
ssl09/set5 (MRSA252) 
ssl10/set4 staphylococcal superantigen-like protein 10 
ssl10 (RF122)  
ssl10/set4 (MRSA252) 






staphylococcal exotoxin-like protein, second 
locus 
setB3 (MRSA252)  
setB2  
setB2 (MRSA252)  









cap 1 (total) Capsule type 1 
capH1 capsular polysaccharide synthesis enzyme 
capJ1 O-antigen polymerase 
capK1 capsular polysaccharide biosynthesis protein 
cap 5 (total) Capsule type 5 
capH5 capsular polysaccharide synthesis enzyme 
capJ5 O-antigen polymerase 
capK5 capsular polysaccharide biosynthesis protein 
cap 8 (total) Capsule type 8 
capH8 capsular polysaccharide synthesis enzyme 
capI8 capsular polysaccharide biosynthesis protein 
capJ8 O-antigen polymerase 
capK8 capsular polysaccharide biosynthesis protein 
icaA intercellular adhesion protein A 
icaC intercellular adhesion protein C 
icaD biofilm PIA synthesis protein D 
bap surface protein involved in biofilm formation 
ADHAESION 














bbp (total) bone sialoprotein-binding protein 
bbp (consensus)  
bbp (COL+MW2)  
bbp (MRSA252)  
bbp (Mu50)  
bbp (RF122)  
bbp (ST45)  
clfA (total) clumping factor A 
clfA (consensus)  
clfA (COL+RF122)  
clfA (MRSA252)  
clfA (Mu50+MW2)  
clfB (total) clumping factor B 
clfB (consensus)  
clfB (COL+Mu50)  
clfB (MW2)  
clfB (RF122)  
cna collagen-binding adhesin 
ebh (consensus) cell wall associated fibronectin-binding protein 
ebpS (total) cell surface elastin binding protein 
ebpS_probe 612  
ebpS_probe 614  
ebpS (01-1111)  





















fib fibrinogen binding protein (19kDa) 
fib (MRSA252)  
fnbA (total) fibronectin-binding protein A 
fnbA (consensus)  
fnbA (COL)  
fnbA (MRSA252)  
fnbA (Mu50+MW2)  
fnbA (RF122)  
fnbB (total) fibronectin-binding protein B 
fnbB (COL)  
fnbB (COL+Mu50+MW2) 
fnbB (Mu50)  
fnbB (MW2)  
fnbB (ST15)  
fnbB (ST45-2)  
map (total) 
major histocompatibility complex class II analog 
protein (=Extracellular adherence protein, eap) 
map (COL)  
map (MRSA252)  
map (Mu50+MW2)  
sasG (total) Staphylococcus aureus surface protein G 
sasG (COL+Mu50)  
sasG (MW2)  
sasG (other than MRSA252+RF122) 
sdrC (total) 
Ser-Asp rich fibrinogen-/bone sialoprotein-binding 
protein C 
sdrC (consensus)  
sdrC (B1)  
sdrC (COL)  
sdrC (Mu50)  
sdrC (MW2+ 
MRSA252+RF122) 
sdrC (other than MRSA252+RF122) 
sdrD (total) 
Ser-Asp rich fibrinogen-/bone sialoprotein-binding 
protein D 
sdrD (consensus)  
sdrD (COL+MW2)  
sdrD (Mu50)  
sdrD (other)  
vwb (total) von Willebrand factor binding protein 
vwb (consensus)  
vwb (COL+MW2)  
vwb (MRSA252)  
vwb (Mu50)  







 ANTIGEN B 
isaB immunodominant antigen B 









isdA (consensus) transferrin-binding protein 
isdA (MRSA252)  




lmrP (other than RF122)_probe1 
hypothetical protein, similar to integral 
membrane protein LmrP 













type I site-specific deoxyribonuclease 
subunit, 1st locus 
hsdS2 (Mu50+N315+COL+USA300 
+NCTC8325) 
type I site-specific deoxyribonuclease 
subunit, 2nd locus 
hsdS2 (MW2+MSSA476) 
hsdS2 (RF122)  
hsdS2 (MRSA252)  
hsdS3 (all other than RF122+ 
MRSA252) 
type I site-specific deoxyribonuclease 




hsdS3 (CC51+ MRSA252) 
hsdS3 (MRSA252)  
hsdSx (CC25) 
type I site-specific deoxyribonuclease 
subunit, unknown locus 
hsdSx (CC15)  





hypothetical protein, located next to serine 
protease operon 
Q2YUB3 unspecific efflux/transporter 




hysA1 (MRSA252) hyaluronate lyase, first / second locus 
hysA1 (MRSA252+RF122)  
and/or hysA2 (consensus) 
hysA1 (MRSA252+RF122)  
and/or hysA2 (COL+USA300) 
hysA2 (all other than MRSA252) hyaluronate lyase, second locus 
hysA2 (COL+USA300+NCTC8325) 
hysA2 (all other than COL+USA300+ 
NCTC8325) 
hysA2 (all other than COL+USA300+ 
NCTC8325),1 





6.2 Case report forms 
Figure 28: Case report form of Staphylococcus aureus (SA) isolates of nonbacteremic infection. 
The case report form defined the isolate number of the collected SA isolate of a nonbacteremic infection, 
collected general patient information, inclusion criteria to exclude SA isolates of hospital acquired 





































Figure 29: Case report form of Staphylococcus aureus (SA) isolates bloodstream infection. The 
case report form defined the isolate number of the collected SA isolate of a bloodstream infection, 
collected general patient information, inclusion criteria to exclude SA isolates of hospital acquired 
















































Figure 30: Case report form of Staphylococcus aureus (SA) isolates of nasal carriage. The case 
report form defined the isolate number of the collected SA isolate of a nasal swab of a healthy volunteer, 
collected general patient information, inclusion criteria to exclude SA isolates of hospital acquired 





























6.3 Characteristics of African and German healthy volunteers and patients  
Table 22: Characteristics of African and German healthy volunteers with respect to the 
standardized questionnaire from whom nasal Staphylococcus aureus isolates were obtained. 
Only participants were included without hospitalization, antibacterial and antituberculous treatment 
within the last 4 weeks. 
 Total Africa (n=300) Germany (n=300) p-value* 
Median# age (range), yrs 22 (0-89) 18 (0-61) 23 (0-89) <0.001 
Male gender, n (%) 280 132 (44%) 148 (49%) ns 
History of hospital admission 6 months 14 (2%) 1 (<1%) 13 (4%) <0.01 
Known HIV infection 15 (3%) 15 (5%) 0 <0.001 
History of AIDS 7 (1%) 7 (2%) 0 0.02 
History of peripheral vascular disease 6 (1%) 0 6 (2%) 0.03 
History of connective tissue disease 8 (1%) 0 8 (3%) 0.01 
Known diabetes 8 (1%) 0 8 (3%) 0.01 
*p-values were calculated by Chi-square corrected for multiple testing using R Studio 




Table 23: Characteristics of African and German patients from whom clinical community-
associated Staphylococcus aureus isolates of wound infections and blood cultures were 
obtained. 





Age (yrs), median (range) 29 (0-98) 3 (0-71) 53 (0-98) <0.001 
Male gender, n (%) 348 (58%) 160 (53%) 188 (63%) ns 
History of hospital admission between 6 months and 
4 weeks prior to to sampling 
157 (26%) 29 (10%) 128 (43%) <0.01 
Healthcare contact in the past 4 weeks 129 (22%) 36 (12%) 93 (31%) <0.001 
Continuous residency in a nursing home before 
sampling  
4 (<1%) 2 (<1%) 2 (<1%) ns 
Antibiotic treatment in the past 4 weeks 133 (22%) 55 (18%) 78 (26%) ns 
Tuberculosis in the past 6 months  4 (<1%) 4 (1%) 0 ns 
Antituberculous drugs in the past 4 weeks 1 (<1%) 1 (<1%) 0 ns 
Risk factors for staphylococcal disease     
History of intravenous drug abuse 7 (1%) 0 7 (2%) 0.02 
Intravenous catheter in place 23 (4%) 0 23 (8%) <0.001 
Other intravascular devices in place 28 (5%) 0 28 (9%) <0.001 
Non-vascular foreign body/device in place 73 (12%) 3 (1%) 70 (23%) <0.001 
Known HIV infection 26 (4%) 26 (9%) 0 <0.001 
Charlson comorbidity score, median (range) 0 (0-12) 0 (0-0) 1 (0-12 ns 
History of AIDS 8 (1%) 8 (3%) 0 0.01 
History of myocardial infarction 37 (6%) 0 37 (12%) <0.001 
History of congestive heart failure 26 (4%) 0 26 (9%) <0.001 
History of peripheral vascular disease 65 (11%) 0 65 (22%) <0.001 
History of cerebral vascular disease 65 (11%) 0 65 (22%) <0.001 
Dementia 7 (1%) 0 7 (2%) 0.02 
Chronic obstructive lung disease 19 (3%) 2 (<1%) 17 (6%) <0.001 
History of connective tissue disease 30 (5%) 0 30 (10%) <0.001 
History of peptic ulcer disease 14 (2%) 2 (<1%) 12 (4%) 0.01 
Mild liver disease 21 (4%) 0 21 (7%) <0.001 
Moderate to severe liver disease 7 (1%) 0 7 (2%) 0.02 
Known diabetes 64 (11%) 4 (1%) 60 (20%) <0.001 
Diabetes with organ damage 15 (3%) 0 15 (5%) <0.001 
Moderate to severe renal disease 25 (4%) 0 25 (8%) <0.001 
Solid tumor 51 (9%) 1 (<1%) 50 (17%) <0.001 
Metastatic solid tumor 20 (3%) 0 20 (7%) <0.001 









Severity of chronic underlying disorder(s) according 
to McCabe & Jackson classification 
    
Rapidly fatal underlying disease 30 (5%) 19 (6%) 11 (4%) ns 
Ultimately fatal disease [< 5 years] 58 (10%) 17 (6%) 41 (14%) ns 
Non-fatal underlying disease  132 (22%) 22 (7%) 110 (37%) <0.001 
Type of infection     
Bloodstream infection 79 (13%) 29 (10%) 50 (17%) ns 
Non-bacteremic infection 521 (87%) 271 (90%) 250 (83%) ns 
Acute clinical presentation     
Severe sepsis 38 (6%) 18 (6%) 20 (7%) ns 
Septic shock 7 (1%) 2 (<1%) 5 (2%) ns 
Clinical site(s) of infection      
Superficial skin infection 348 (58%) 191 (64%) 157 (52%) ns 
Deep skin abscess 121 (20%) 82 (27%) 39 (13%) 0.002 
Bone 22 (4%) 0 22 (7%) <0.001 
Joint 20 (3%) 3 (1%) 17 (6%) ns 
Muscle 11 (2%) 4 (1%) 7 (2%) ns 
Fascia 2 (<1%) 1 (<1%) 1 (<1%) ns 
Respiratory tract 25 (4%) 6 (2%) 19 (6%) ns 
Heart 5 (1%) 0 5 (2%) ns 
Central nervous system 1 (<1%) 1 (<1%) 0 ns 
Urinary tract 7 (1%) 0 7 (2%) ns 
Other 87 (15%) 20 (7%) 67 (22%) <0.001 
New metastatic lesions 54 (9%) 25 (8%) 29 (10%) ns 
*p-values were calculated by Chi-square corrected for multiple testing    






1. Aanensen, D.M. &  B.G. Spratt, (2005) The multilocus sequence typing network: 
mlst.net. Nucleic acids research 33: W728-733. 
2. Abdulgader, S.M., A.O. Shittu, M.P. Nicol & M. Kaba, (2015) Molecular 
epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic 
review. Frontiers in microbiology 6: 348. 
3. Abubakar, U. & A.S. Syed, (2018) Prevalence, trend and antimicrobial 
susceptibility of methicillin resistant Staphylococcus aureus in Nigeria: a systematic 
review. Journal of Infection and Public Health 11: 763–770. 
4. Aires-de-Sousa, M., K. Boye, H. de Lencastre, A. Deplano, M.C. Enright, J. 
Etienne, A. Friedrich, D. Harmsen, A. Holmes, X.W. Huijsdens, A.M. Kearns, A. 
Mellmann, H. Meugnier, J.K. Rasheed, E. Spalburg, B. Strommenger, M.J. Struelens, 
F.C. Tenover, J. Thomas, U. Vogel, H. Westh, J. Xu & W. Witte, (2006) High 
interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter 
study. Journal of clinical microbiology 44: 619-621. 
5. Aires-de-Sousa, M. & H. De Lencastre, (2003) Evolution of sporadic isolates of 
methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to 
isolates of community-acquired MRSA. Journal of clinical microbiology 41: 3806–3815. 
6. Ako-Nai, A.K., A.D. Ogunniyi, A. Lamikanra & S.E. Torimiro, (1991) The 
characterisation of clinical isolates of Staphylococcus aureus in Ile-Ife, Nigeria. Journal of 
medical microbiology 34: 109-112. 
7. Akulenko, R., M. Merl & V. Helms, (2016) BEclear: Batch Effect Detection and 
Adjustment in DNA Methylation Data. PLoS One 11: e0159921. 
8. Alonzo, F., 3rd &  V.J. Torres, (2014) The bicomponent pore-forming leucocidins 
of Staphylococcus aureus. Microbiology and molecular biology reviews: MMBR 78: 199-
230. 
9. Anah, M.U., J.J. Udo, S.O. Ochigbo & L.N. Abia-Bassey, (2008) Neonatal 
septicaemia in Calabar, Nigeria. Tropical doctor 38: 126-128. 
10. Archer, G.L., (1998) Staphylococcus aureus: a well-armed pathogen. Clinical 
infectious diseases : an official publication of the Infectious Diseases Society of America 
26: 1179-1181. 
11. Archer, G.L. & C.G. Mayhall, (1983) Comparison of epidemiological markers used 
in the investigation of an outbreak of methicillin-resistant Staphylococcus aureus 
infections. Journal of Clinical Microbiology 18: 395-399. 
12. Arciola, C.R., D. Campoccia, P. Speziale, L. Montanaro & J.W. Costerton, (2012) 
Biofilm formation in Staphylococcus implant infections. A review of molecular 
mechanisms and implications for biofilm-resistant materials. Biomaterials 33: 5967-5982. 
13. Argudin, M.A., M.C. Mendoza & M.R. Rodicio, (2010) Food poisoning and 
Staphylococcus aureus enterotoxins. Toxins 2: 1751-1773. 
14. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. 
Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto & K. Hiramatsu, (2002) 




Lancet 359: 1819-1827. 
15. Baig, S., T.B. Johannesen, S. Overballe-Petersen, J. Larsen, A.R. Larsen & M. 
Stegger, (2018) Novel SCCmec type XIII (9A) identified in an ST152 methicillin-resistant 
Staphylococcus aureus. Infection, genetics and evolution: journal of molecular 
epidemiology and evolutionary genetics in infectious diseases 61: 74-76. 
16. Bailey, A.L., M.A. Monck & P.R. Cullis, (1997) pH-induced destabilization of lipid 
bilayers by a lipopeptide derived from influenza hemagglutinin. Biochimica et biophysica 
acta 1324: 232-244. 
17. Barber, M. & J.E. McCartney, (1952) S. aureus infection in a maternity hospital. 
Edinburgh Medicinal Journal 59: 200–207. 
18. Barbuddhe, S.B., T. Maier, G. Schwarz, M. Kostrzewa, H. Hof, E. Domann, T. 
Chakraborty & T. Hain, (2008) Rapid identification and typing of listeria species by matrix-
assisted laser desorption ionization-time of flight mass spectrometry. Applied and 
environmental microbiology 74: 5402-5407. 
19. Bartels, M.D., H. Larner-Svensson, H. Meiniche, K. Kristoffersen, K. Schonning, 
J.B. Nielsen, S.M. Rohde, L.B. Christensen, A.W. Skibsted, J.O. Jarlov, H.K. Johansen, 
L.P. Andersen, I.S. Petersen, D.W. Crook, R. Bowden, K. Boye, P. Worning & H. Westh, 
(2015) Monitoring meticillin resistant Staphylococcus aureus and its spread in 
Copenhagen, Denmark, 2013, through routine whole genome sequencing. Euro 
surveillance: bulletin Europeen sur les maladies transmissibles = European 
communicable disease bulletin 20. 
20. Basset, P., U. Nübel, W. Witte, D.S. Blanc, (2012) Evaluation of adding a second 
marker to overcome Staphylococcus aureus spa typing homoplasies. Journal of Clinical 
Microbiology 50:1475–1477. 
21. Bayer, M.G., J.H. Heinrichs & A.L. Cheung, (1996) The molecular architecture of 
the sar locus in Staphylococcus aureus. Journal of bacteriology 178: 4563-4570. 
22. Becker K., S. van Alen, E.A. Idelevich, N. Schleimer, J. Seggewiß, A. Mellmann, 
U. Kaspar, G. Peters, (2018) Plasmid-encoded transferable mecB-mediated methicillin 
resistance in Staphylococcus aureus. Emerging Infectious Diseases 24: 242-248. 
23. Becker, K., A.W. Friedrich, G. Lubritz, M. Weilert, G. Peters & C. von Eiff, (2003) 
Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins 
among strains of Staphylococcus aureus isolated from blood and nasal specimens. 
Journal of clinical microbiology 41: 1434-1439. 
24. Ben Nejma, M., M. Mastouri, B. Bel Hadj Jrad & M. Nour, (2013) Characterization 
of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant 
Staphylococcus aureus clone in Tunisia. Diagnostic microbiology and infectious disease 
77: 20-24. 
25. Benagli, C., V. Rossi, M. Dolina, M. Tonolla & O. Petrini, (2011) Matrix-assisted 
laser desorption ionization-time of flight mass spectrometry for the identification of 
clinically relevant bacteria. PLoS One 6: e16424. 
26. Berger-Bachi, B. &  S. Rohrer, (2002) Factors influencing methicillin resistance in 
staphylococci. Archives of microbiology 178: 165-171. 
27. Berkley, J.A., B.S. Lowe, I. Mwangi, T. Williams, E. Bauni, S. Mwarumba, C. 
Ngetsa, M.P. Slack, S. Njenga, C.A. Hart, K. Maitland, M. English, K. Marsh & J.A. Scott, 




England journal of medicine 352: 39-47. 
28. Bernardo, K., N. Pakulat, M. Macht, O. Krut, H. Seifert, S. Fleer, F. Hunger &. 
Kronke, (2002) Identification and discrimination of Staphylococcus aureus strains using 
matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 
2: 747-753. 
29. Billal, D.S., J. Feng, P. Leprohon, D. Legare & M. Ouellette, (2011) Whole genome 
analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and 
compensatory mutations. BMC genomics 12: 512. 
30. Blair, J.E. & R.E.0. Williams, (1961) Phage typing of staphylococci. Bulletin of the 
World Health Organization 24: 771-784. 
31. Blanc, D.S., P. Francioli & P.M. Hauser, (2002) Poor value of pulsed-field gel 
electrophoresis to investigate longterm scale epidemiology of methicillin-resistant 
Staphylococcus aureus. Infection, genetics and evolution : journal of molecular 
epidemiology and evolutionary genetics in infectious diseases 2: 145-148. 
32. Blomfeldt, A., H.V. Aamot, A.N. Eskesen, F. Muller & S. Monecke, (2013) 
Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from 
bacteremic patients in a Norwegian University Hospital. Journal of clinical microbiology 
51: 345-347. 
33. Bohme, K., S. Morandi, P. Cremonesi, I.C. Fernandez No, J. Barros-Velazquez, 
B. Castiglioni, M. Brasca, B. Canas & P. Calo-Mata, (2012) Characterization of 
Staphylococcus aureus strains isolated from Italian dairy products by MALDI-TOF mass 
fingerprinting. Electrophoresis 33: 2355-2364. 
34. Bosch, T. & L.M. Schouls, (2015) Livestock-associated MRSA: innocentor serious 
health threat? Future Microbiology 10: 445–447. 
35. Boswihi, S.S., E.E. Udo, N. Al-Sweih, (2016) Shifts in the clonal distribution of 
methicillin-resistant Staphylococcus aureus in Kuwait Hospitals: 1992-2010. PLos One 
11: e0162744. 
36. Breurec, S., S.B. Zriouil, C. Fall, P. Boisier, S. Brisse, S. Djibo, J. Etienne, M.C. 
Fonkoua, J.D. Perrier-Gros-Claude, R. Pouillot, C.E. Ramarokoto, F. Randrianirina, A. 
Tall, J.M. Thiberge, i. Working Group on Staphylococcus aureus, F. Laurent & B. Garin, 
(2011) Epidemiology of methicillin-resistant Staphylococcus aureus lineages in five major 
African towns: emergence and spread of atypical clones. Clinical microbiology and 
infection: the official publication of the European Society of Clinical Microbiology and 
Infectious Diseases 17: 160-165. 
37. Bronner, S., H. Monteil & G. Prevost, (2004) Regulation of virulence determinants 
in Staphylococcus aureus: complexity and applications. FEMS microbiology reviews 28: 
183-200. 
38. Bryant, D. & V. Moulton, (2004) Neighbor-Net: An Agglomerative Method for the 
Construction of Phylogenetic Networks. Molecular Biology and Evolution 21: 255–265. 
39. Budimir, A., R.H. Deurenberg, Z. Bosnjak, E.E. Stobberingh, H. Cetkovic & S. 
Kalenic, (2010) A variant of the Southern German clone of methicillin-resistant 
Staphylococcus aureus is predominant in Croatia. Clinical microbiology and infection : 
the official publication of the European Society of Clinical Microbiology and Infectious 
Diseases 16: 1077-1083. 




future. Current protocols in molecular biology Chapter 22: Unit 22.21. 
41. Caddick, J.M., A.C. Hilton, R.A. Armstrong, P.A. Lambert, T. Worthington & T.S. 
Elliott, (2006) Description and critical appraisal of principal components analysis (PCA) 
methodology applied to pulsed-field gel electrophoresis profiles of methicillin-resistant 
Staphylococcus aureus isolates. Journal of microbiological methods 65: 87-95. 
42. Cadena, J., J. Thinwa, E.A. Walter & C.R. Frei, (2016) Risk factors for the 
development of active methicillin-resistant Staphylococcus aureus (MRSA) infection in 
patients colonized with MRSA at hospital admission. American journal of infection control 
44: 1617-1621. 
43. Camacho, C., G. Coulouris, V. Avagyan, N. Ma, J. Papadopoulos, K. Bealer & T.L. 
Madden, (2009) BLAST+: architecture and applications. BMC bioinformatics 10: 421. 
44. Camoez, M., J.M. Sierra, M.A. Dominguez, M. Ferrer-Navarro, J. Vila & I. Roca, 
(2015) Automated categorization of methicillin-resistant Staphylococcus aureus clinical 
isolates into different clonal complexes by MALDI-TOF mass spectrometry. Clinical 
microbiology and infection: the official publication of the European Society of Clinical 
Microbiology and Infectious Diseases 22: 161.e1-161.e7. 
45. Campbell, S.J., H.S. Deshmukh, C.L. Nelson, I.G. Bae, M.E. Stryjewski, J.J. 
Federspiel, G.T. Tonthat, T.H. Rude, S.L. Barriere, R. Corey & V.G. Fowler, Jr., (2008) 
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of 
complicated skin and skin structure infections. Journal of clinical microbiology 46: 678-
684. 
46. Candès, E. &  B. Recht, (2012) Exact Matrix Completion via Convex Optimization. 
Foundations of Computational Mathematics 55: 712-772. 
47. Chambers, H.F. &  F.R. DeLeo, (2009) Waves of resistance: Staphylococcus 
aureus in the antibiotic era. Nature reviews. Microbiology 7: 629-641. 
48. Chambers, H.F., (2001) The changing epidemiology of Staphylococcus 
aureus? Emerging Infectious Diseases. 7:178-182. 
49. Chavakis, T., K.T. Preissner & M. Herrmann, (2007) The anti-inflammatory 
activities of Staphylococcus aureus. Trends in immunology 28: 408-418. 
50. Chavakis, T., K. Wiechmann, K.T. Preissner & M. Herrmann, (2005) 
Staphylococcus aureus interactions with the endothelium: the role of bacterial "secretable 
expanded repertoire adhesive molecules" (SERAM) in disturbing host defense systems. 
Thrombosis and haemostasis 94: 278-285. 
51. Cheung, A.L., M.G. Bayer & J.H. Heinrichs, (1997) sar Genetic determinants 
necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus 
aureus. Journal of bacteriology 179: 3963-3971. 
52. Christner, M., H. Rohde, M. Wolters, I. Sobottka, K. Wegscheider & M. 
Aepfelbacher, (2010) Rapid identification of bacteria from positive blood culture bottles 
by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry 
fingerprinting. Journal of clinical microbiology 48: 1584-1591. 
53. Chua, K., F. Laurent, G. Coombs, M.L. Grayson & B.P. Howden, (2011) 
Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus 
aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial 
resistance and implications for therapy. Clinical infectious diseases: an official publication 




54. Chuang, Y.Y. & Y.C. Huang, (2013) Molecular epidemiology of community-
associated meticillin-resistant Staphylococcus aureus in Asia. The Lancet. Infectious 
diseases 13: 698-708. 
55. Coia, J.E., F. Thomson-Carter & D. Baird, J. Platt, (1990) Characterisation of 
methicillin- resistant Staphylococcus aureus by biotyping, immunoblotting and restriction 
enzyme fragment patterns. Journal of Medical Microbiology 31: 125-32. 
56. Collen, D., (1998) Staphylokinase: a potent, uniquely fibrin-selective thrombolytic 
agent. Nature medicine 4: 279-284. 
57. Conceicao, T., C. Coelho, I.S. Silva, H. de Lencastre & M. Aires-de-Sousa, (2015) 
Staphylococcus aureus in former Portuguese colonies from Africa and the Far East: 
missing data to help fill the world map. Clinical microbiology and infection : the official 
publication of the European Society of Clinical Microbiology and Infectious Diseases 21: 
842 e841-842 e810. 
58. Cooper, J.E. &  E.J. Feil, (2004) Multilocus sequence typing--what is resolved? 
Trends in microbiology 12: 373-377.  
59. Crisóstomo, M.I., H. Westh, A. Tomasz, M. Chung, D.C. Oliveira & H. de 
Lencastre, (2001) The evolution of methicillin resistance in Staphylococcus aureus: 
Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant 
isolates and contemporary epidemic clones. Proceedings of the National Academy of 
Sciences of the United States of America 98: 9865–9870. 
60. Cucarella, C., M.A. Tormo, E. Knecht, B. Amorena, I. Lasa, T.J. Foster & J.R. 
Penades, (2002) Expression of the biofilm-associated protein interferes with host protein 
receptors of Staphylococcus aureus and alters the infective process. Infection and 
immunity 70: 3180-3186. 
61. Cue, D., M.G. Lei & C.Y. Lee, (2012) Genetic regulation of the intercellular 
adhesion locus in staphylococci. Frontiers in cellular and infection microbiology 2: 38. 
62. Cuny, C., F. Layer, G. Werner, D. Harmsen, I. Daniels-Haardt, A. Jurke, 
A. Mellmann, W. Witte & R. Köck, (2015) State-wide surveillance of antibiotic resistance 
patterns and spa types of methicillin-resistant Staphylococcus aureus from blood cultures 
in North Rhine-Westphalia, 2011-2013. Clinical  microbiology and infection 21: 750-757. 
63. Cuny, C. & F. Layer, (2011) Auftreten und Verbreitung von MRSA in Deutschland  
2010. Epidemiologisches Bulletin 26: 233-241. 
64. Daum, R.S., T. Ito, K. Hiramatsu, F. Hussain, K. Mongkolrattanothai, M. Jamklang 
& S. Boyle-Vavra, (2002) A novel methicillin-resistance cassette in community-acquired 
methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. The 
Journal of infectious diseases 186: 1344-1347. 
65. David, M.Z. & R.S. Daum, (2010) Community-associated methicillin-resistant 
Staphylococcus aureus: epidemiology and clinical consequences of an emerging 
epidemic. Clinical Microbiology reviews 23: 616-687. 
66. DeLeo, F.R., M. Otto, B.N. Kreiswirth & H.F. Chambers, (2010) Community-
associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568. 
67. Deurenberg, R.H., E. Nulens, H. Valvatne, S. Sebastian, C. Driessen, J. 
Craeghs, E. De Brauwer, B. Heising, Y.J. Kraat, J. Riebe, F.S. Stals, T.A. Trienekens, J. 
Scheres, A.W. Friedrich, F.H. van Tiel, P.S. Beisser & E.E. Stobberingh, (2009) Cross-




region. Emerging Infectious Diseases 15: 727–734.  
68. Deurenberg, R.H. &  E.E. Stobberingh, (2008) The evolution of Staphylococcus 
aureus. Infection, genetics and evolution: journal of molecular epidemiology and 
evolutionary genetics in infectious diseases 8: 747-763. 
69. Dieckmann, R., R. Helmuth, M. Erhard & B. Malorny, (2008) Rapid classification 
and identification of salmonellae at the species and subspecies levels by whole-cell 
matrix-assisted laser desorption ionization-time of flight mass spectrometry. Applied and 
environmental microbiology 74: 7767-7778. 
70. Dinges, M.M., P.M. Orwin & P.M. Schlievert, (2000) Exotoxins of Staphylococcus 
aureus. Clinical microbiology reviews 13: 16-34, table of contents. 
71. Dingle, T.C. &  S.M. Butler-Wu, (2013) Maldi-tof mass spectrometry for 
microorganism identification. Clinics in laboratory medicine 33: 589-609. 
72. Djoudi, F., C. Bonura, S. Benallaoua, A. Touati, D. Touati, A. Aleo, C. Cala, T. 
Fasciana & C. Mammina, (2013) Panton-Valentine leukocidin positive sequence type 80 
methicillin-resistant Staphylococcus aureus carrying a staphylococcal cassette 
chromosome mec type IVc is dominant in neonates and children in an Algiers hospital. 
The new microbiologica 36: 49-55. 
73. Du, Z., R. Yang, Z. Guo, Y. Song & J. Wang, (2002) Identification of 
Staphylococcus aureus and determination of its methicillin resistance by matrix-assisted 
laser desorption/ionization time-of-flight mass spectrometry. Analytical chemistry 74: 
5487-5491. 
74. Dubin, G., (2002) Extracellular proteases of Staphylococcus spp. Biological 
chemistry 383: 1075-1086. 
75. Duim, B, T.M. Wassenaar, A. Rigter & J. Wagenaar, (1999) High-resolution 
genotyping of Campylobacter strains isolated from poultry and humans with amplified 
fragment length polymorphism fingerprinting. Applied and environmental microbiology 65: 
2369–2375. 
76. Edwards-Jones, V., M.A. Claydon, D.J. Evason, J. Walker, A.J. Fox & D.B. 
Gordon, (2000) Rapid discrimination between methicillin-sensitive and methicillin-
resistant Staphylococcus aureus by intact cell mass spectrometry. Journal of medical 
microbiology 49: 295-300. 
77. Egyir, B., L. Guardabassi, M. Sørum, S.S. Nielsen, A. Kolekang, E.Frimpong, K.K. 
Addo,M. Jemima Newman & A.R. Larsen, (2014) Molecular epidemiology and 
antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions 
in Ghana. PLoS One 9: e89716. 
78. Enany, S., E. Yaoita, Y. Yoshida, M. Enany & T. Yamamoto, (2010) Molecular 
characterization of Panton-Valentine leukocidin-positive community-acquired methicillin-
resistant Staphylococcus aureus isolates in Egypt. Microbiological research 165: 152-
162. 
79. Enright, M.C., D.A. Robinson, G. Randle, E.J. Feil, H. Grundmann, & B.G. Spratt, 
(2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). 
Proceedings of the National Academy of Sciences of the United States of America 99: 
7687–7692. 
80. Enright, M.C., N.P. Day, C.E. Davies, S.J. Peacock & B.G. Spratt, (2000) 




susceptible clones of Staphylococcus aureus. Journal of clinical microbiology 38: 1008-
1015. 
81. Falagas, M.E., D.E. Karageorgopoulos, J. Leptidis & I.P. Korbila, (2013) MRSA in 
Africa: filling the global map of antimicrobial resistance. PLoS One 8: e68024. 
82. Fasehun, F., (1999) The antibacterial paradox: essential drugs, effectiveness, and 
cost. Bulletin of the World Health Organization 77: 211-216. 
83. Feil, E.J. &  M.C. Enright, (2004) Analyses of clonality and the evolution of bacterial 
pathogens. Current opinion in microbiology 7: 308-313. 
84. Feil, E.J., J.E. Cooper, H. Grundmann, D.A. Robinson, M.C. Enright, T. Berendt, 
S.J. Peacock, J.M. Smith, M. Murphy, B.G. Spratt, C.E. Moore & N.P. Day, (2003) How 
clonal is Staphylococcus aureus? Journal of bacteriology 185: 3307-3316. 
85. Feng, Y., C.J. Chen, L.H. Su, S. Hu, J. Yu & C.H. Chiu, (2008) Evolution and 
pathogenesis of Staphylococcus aureus: lessons learned from genotyping and 
comparative genomics. FEMS microbiology reviews 32: 23-37. 
86. Fitzgerald, J.R. & J.M. Musser, (2001) Evolutionary genomics of pathogenic 
bacteria. Trends in Microbiology 9: 547–553. 
87. Foster, T.J., (2016) The remarkably multifunctional fibronectin binding proteins of 
Staphylococcus aureus. European journal of clinical microbiology & infectious diseases : 
official publication of the European Society of Clinical Microbiology 35:1923-1931. 
88. Foster, T.J., J.A. Geoghegan, V.K. Ganesh & M. Hook, (2014) Adhesion, invasion 
and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nature 
reviews. Microbiology 12: 49-62.  
89. Foster, T.J., (2005) Immune evasion by staphylococci. Nature reviews. Microbiology 
3: 948-958. 
90. Foster, T.J. &  M. Hook, (1998) Surface protein adhesins of Staphylococcus 
aureus. Trends in microbiology 6: 484-488. 
91. Fowler, V.G., Jr., C.L. Nelson, L.M. McIntyre, B.N. Kreiswirth, A. Monk, G.L. 
Archer, J. Federspiel, S. Naidich, B. Remortel, T. Rude, P. Brown, L.B. Reller, G.R. Corey 
& S.R. Gill, (2007) Potential associations between hematogenous complications and 
bacterial genotype in Staphylococcus aureus infection. The Journal of infectious diseases 
196: 738-747. 
92. Frenay, H.M., A.E. Bunschoten, L.M. Schouls, W.J. van Leeuwen, C.M. 
Vandenbroucke-Grauls, J. Verhoef & F.R. Mooi, (1996) Molecular typing of methicillin-
resistant Staphylococcus aureus on the basis of protein A gene polymorphism. European 
journal of clinical microbiology & infectious diseases: official publication of the European 
Society of Clinical Microbiology 15: 60-64. 
93. Frey, B.J. &  D. Dueck, (2007) Clustering by passing messages between data 
points. Science 315: 972-976. 
94. Friães, A., C. Resina, V. Manuel, L. Lito,M. Ramirez & J. Melo-Cristino, (2015) 
Epidemiological survey of the first case of vancomycin-resistant Staphylococcus aureus 
infection in Europe. Epidemiology and infection 143: 745-748.  
95. Gasteiger, E., A. Gattiker, C. Hoogland, I. Ivanyi, R.D. Appel & A. Bairoch, (2003) 
ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic 




96. Gentleman, R.C., V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. 
Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, 
F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, 
J.Y. Yang & J. Zhang, (2004) Bioconductor: open software development for 
computational biology and bioinformatics. Genome biology 5: R80. 
97. Ghasemzadeh-Moghaddam, H., E. Ghaznavi-Rad, Z. Sekawi, L. Yun-Khoon, M.N. 
Aziz, R.A. Hamat, D.C. Melles, A. van Belkum, M.N. Shamsudin & V. Neela, (2011) 
Methicillin-susceptible Staphylococcus aureus from clinical and community sources are 
genetically diverse. International journal of medical microbiology : IJMM 301: 347-353. 
98. Ghaznavi-Rad, E., M. Nor Shamsudin, Z. Sekawi, A. van Belkum & V. Neela, (2010) 
A simplified multiplex PCR assay for fast and easy discrimination of globally distributed 
staphylococcal cassette chromosome mec types in meticillin resistant Staphylococcus 
aureus. Journal of Medical Microbiology, 59: 1135–1139. 
99. Ghebremedhin, B., M.O. Olugbosi, A.M. Raji, F. Layer, R.A. Bakare, B. Konig & 
W. Konig, (2009) Emergence of a community-associated methicillin-resistant 
Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. 
Journal of clinical microbiology 47: 2975-2980. 
100. Gill, S.R., D.E. Fouts, G.L. Archer, E.F. Mongodin, R.T. Deboy, J. Ravel, I.T. 
Paulsen, J.F. Kolonay, L. Brinkac, M. Beanan, R.J. Dodson, S.C. Daugherty, R. Madupu, 
S.V. Angiuoli, A.S. Durkin, D.H. Haft, J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. 
Dimitrov, L. Jiang, H. Qin, J. Weidman, K. Tran, K. Kang, I.R. Hance, K.E. Nelson & C.M. 
Fraser, (2005) Insights on evolution of virulence and resistance from the complete 
genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a 
biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. Journal of 
bacteriology 187: 2426-2438. 
101. Gillaspy, A.F., C.Y. Lee, S. Sau, A.L. Cheung & M.S. Smeltzer, (1998) Factors 
affecting the collagen binding capacity of Staphylococcus aureus. Infection and immunity 
66: 3170-3178. 
102. Gillet, Y., B. Issartel, P. Vanhems, J.C. Fournet, G. Lina, M. Bes, F. Vandenesch, 
Y. Piemont, N. Brousse, D. Floret & J. Etienne, (2002) Association between 
Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly 
lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753-759. 
103. Goering, R.V., R.M. Shawar, N.E. Scangarella, F.P. O'Hara, H. Amrine-Madsen, 
J.M. West, M. Dalessandro, J.A. Becker, S.L. Walsh, L.A. Miller, S.F. van Horn, E.S. 
Thomas & M.E. Twynholm, (2008) Molecular epidemiology of methicillin-resistant and 
methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. Journal 
of clinical microbiology 46: 2842-2847. 
104. Gordon, R.J. &  F.D. Lowy, (2008) Pathogenesis of methicillin-resistant 
Staphylococcus aureus infection. Clinical infectious diseases: an official publication of the 
Infectious Diseases Society of America 46: 350-359. 
105. GraphPad Software Inc., http://www.graphpad.com/quickcalcs/contingency1/. 
106. Grumann, D., U. Nubel & B.M. Broker, (2014) Staphylococcus aureus toxins--their 
functions and genetics. Infection, genetics and evolution: journal of molecular 
epidemiology and evolutionary genetics in infectious diseases 21: 583-592. 




Harmsen, A.W. Friedrich & G. European Staphylococcal Reference Laboratory Working, 
(2010) Geographic distribution of Staphylococcus aureus causing invasive infections in 
Europe: a molecular-epidemiological analysis. PLoS medicine 7: e1000215. 
108. Guss, B., M. Uhlen, B. Nilsson, M. Lindberg, J. Sjoquist & J. Sjodahl, (1984) Region 
X, the cell-wall-attachment part of staphylococcal protein A. European journal of 
biochemistry / FEBS 138: 413-420. 
109. Hallin M., A. Deplano, O. Denis, R. De Mendonça, R. De Ryck, & M. J. Struelens, 
(2007) Validation of Pulsed-Field Gel Electrophoresis and spa Typing for Long-Term, 
Nationwide Epidemiological Surveillance Studies of Staphylococcus aureus Infections. 
Journal of Clinical Microbiology 45: 127–133. 
110. Hallin, M., O. Denis, A. Deplano, R. De Ryck, S. Crevecoeur, S. Rottiers, R. de 
Mendonca & M.J. Struelens, (2008) Evolutionary relationships between sporadic and 
epidemic strains of healthcare-associated methicillin-resistant Staphylococcus aureus. 
Clinical microbiology and infection: the official publication of the European Society of 
Clinical Microbiology and Infectious Diseases 14: 659-669. 
111. Hanaki, H., K. Kuwahara-Arai, S. Boyle-Vavra, R.S. Daum, H. Labischinski & K. 
Hiramatsu, (1998) Activated cell-wall synthesis is associated with vancomycin resistance 
in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. The Journal 
of antimicrobial chemotherapy 42: 199-209. 
112. Harmsen, D., H. Claus, W. Witte, J. Rothganger, H. Claus, D. Turnwald & U. Vogel, 
(2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital 
setting by using novel software for spa repeat determination and database management. 
Journal of clinical microbiology 41: 5442-5448. 
113. Harris, S.R., E.J. Feil, M.T.G. Holden, M.A. Quail, E.K. Nickerson, N. Chantratita, 
S. Gardete, A. Tavares, N. Day, J.A. Lindsay, J.D. Edgeworth, H. de Lencastre, J. 
Parkhill, S.J. Peacock & S.D. Bentley, (2010) Evolution of MRSA during hospital 
transmission and intercontinental spread. Science 327: 469 – 474. 
114. He, L., Z. Hong-Xiang, Y. Wang, K.Y. Le, Q. Liu, J. Shang, Y. Dai, H.Meng, X. 
Wang, T. Li, Q. Gao, J. Qin, H. Lu, M. Otto & M. Li, (2018) Detection and analysis of 
Methicillin resistant human-adapted sequence type 398 allows insight into community 
associated methicillin-resistant Staphylococcus aureus evolution. Genome Medicine 10: 
5. 
115. Herold, B.C., L.C. Immergluck, M.C. Maranan, D.S. Lauderdale, R.E. Gaskin, S. 
Boyle-Vavra, C.D. Leitch & R.S. Daum, (1998) Community-acquired methicillin-resistant 
Staphylococcus aureus in children with no identified predisposing risk. JAMA 279: 593-
598. 
116. Herrmann, M., S. Abdullah, A. Alabi, P. Alonso, A.W. Friedrich, G. Fuhr, A. 
Germann, W.V. Kern, P.G. Kremsner, I. Mandomando, A.C. Mellmann, G. Pluschke, S. 
Rieg, U. Ruffing, F. Schaumburg, M. Tanner, G. Peters, H. von Briesen, C. von Eiff, L. 
von Muller & M.P. Grobusch, (2013a) Staphylococcal disease in Africa: another neglected 
'tropical' disease. Future microbiology 8: 17-26. 
117. Herrmann, M., C. Petit, A. Dawson, J. Biechele, A. Halfmann, L. von Muller, S. 
Graber, S. Wagenpfeil, R. Klein & B. Gartner, (2013b) Methicillin-resistant 
Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence 




118. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi 
& I. Kobayashi, (1997) Dissemination in Japanese hospitals of strains of Staphylococcus 
aureus heterogeneously resistant to vancomycin. Lancet 350: 1670-1673. 
119. Hiramatsu, K., I. Teruyo, S. Tsubakishita, T. Sasaki, F. Takeuchi, Y. Morimoto, Y. 
Katayama, M. Matsuo, K. Kuwahara-Arai, T. Hishinuma & T. Baba, (2013) Genomic basis 
for methicillin resistance in Staphylococcus aureus. Infection & Chemotherapy 45: 117-
136. 
120. Holtfreter, S., D. Grumann, V. Balau, A. Barwich, J. Kolata, A. Goehler, S. Weiss, 
B. Holtfreter, S.S. Bauerfeind, P. Döring, E. Friebe, N.Haasler, K. Henselin, K. Kühn, S. 
Nowotny, D. Radke, K.Schulz, S.R. Schulz, P. Trübe, C.H. Vu, B. Walther, S. Westphal, 
C.Cuny, W. Witte, H. Völzke, H.J. Grabe, T. Kocher, I. Steinmetz & B.M. Bröker, (2016) 
Molecular Epidemiology of Staphylococcus aureus in the General Population in Northeast 
Germany: Results of the Study of Health in Pomerania (SHIP-TREND-0). Journal of 
clinical microbiology 54: 2774–2785. 
121. Holtfreter, S., D. Grumann, M. Schmudde, H.T. Nguyen, P. Eichler, B. 
Strommenger, K. Kopron, J. Kolata, S. Giedrys-Kalemba, I. Steinmetz, W. Witte & B.M. 
Broker, (2007) Clonal distribution of superantigen genes in clinical Staphylococcus 
aureus isolates. Journal of clinical microbiology 45: 2669-2680. 
122. Howden, B.P., A.Y. Peleg & T.P. Stinear, (2014) The evolution of vancomycin 
intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. Infection, genetics 
and evolution : journal of molecular epidemiology and evolutionary genetics in infectious 
diseases 21: 575-582. 
123. Hu, D.L., K. Omoe, F. Inoue, T. Kasai, M. Yasujima, K. Shinagawa & A. Nakane, 
(2008) Comparative prevalence of superantigenic toxin genes in meticillin-resistant and 
meticillin-susceptible Staphylococcus aureus isolates. Journal of medical microbiology 
57: 1106-1112. 
124. Hu, Q., H. Peng & X. Rao, (2016) Molecular Events for Promotion of Vancomycin 
Resistance in Vancomycin Intermediate Staphylococcus aureus. Frontiers in 
microbiology 7: 1601. 
125. Huijsdens, X.W., B.J. van Dijke, E. Spalbur, M.G. van Santen-Verheuvel, M. EOC 
Heck, G.N. Pluister, A. Voss, W.J.B. Wannet & A.J. de Neeling, (2006) Community-
acquired MRSA and pig-farming. Annals of Clinical Microbiology and Antimicrobials 5: 
26. 
126. Huson, D.H. & D. Bryant, (2006) Application of phylogenetic networks in 
evolutionary studies. Molecular biology and evolution 23: 254-267. 
127. Hussain, M., C. von Eiff, B. Sinha, I. Joost, M. Herrmann, G. Peters & K. Becker, 
(2008) eap gene as novel target for specific identification of Staphylococcus aureus. 
Journal of clinical microbiology 46: 470-476. 
128. Hussain, M., K. Becker, C. von Eiff, G. Peters & M. Herrmann, (2001) Analogs of 
eap protein are conserved and prevalent in clinical Staphylococcus aureus isolates. 
Clinical and diagnostic laboratory immunology 8: 1271-1276. 
129. Ihaka, R. & R. Gentleman, (1996) R: A Language for Data Analysis and Graphics. 
Journal of Computational and Graphical Statistics 5: 299-314. 
130. Ito, T., K. Kuwahara-Arai, Y. Katayama, Y. Uehara, X. Han, Y. Kondo & K. 




MRSA. Methods in Molecular Biology 1085: 131-148. 
131. Ito, T., K. Hiramatsu, A. Tomnasz, H. de Lencastre, V. Perreten, M.T.G. Holden, 
D.C. Coleman, R. Goering P.M. Giffard, R.L. Skov, K. Zhang, H. Westh, F. O’Brien, F.C. 
Tenover, D.C. Oliveira, S. Boyle-Vavra, F. Laurent, A.M. Kearns, B. Kreiswirth, K. Soo 
Ko, H. Grundmann, J.E. Sollid, J.F. John, Jr., R. Daum, B. Soderquist & G. Buistx on 
behalf of the International Working Group on the Classification of Staphylococcal 
Cassette Chromosome Elements (IWG-SCC), (2012) Guidelines for Reporting Novel 
mecA Gene Homologues. Antimicrobial agents and chemotherapy 56: 4997-4999. 
132. Jackson, K.A., V. Edwards-Jones, C.W. Sutton & A.J. Fox, (2005) Optimisation of 
intact cell MALDI method for fingerprinting of methicillin-resistant Staphylococcus aureus. 
Journal of microbiological methods 62: 273-284. 
133. Jaton, L., T. Pillonel, K. Jaton, E. Dory, G. Prod'hom, D.S. Blanc, F. Tissot, P. 
Bodenmann & G. Greub, (2016) Common skin infection due to Panton–Valentine 
leucocidin-producing Staphylococcus aureus strains in asylum seekers from Eritrea: a 
genome-based investigation of a suspected outbreak. Clinical Microbiology and Infection 
22: 739.e5-8. 
134. Jessen, O., K. Rosendal, P. Bulow, V. Faber & K.R. Eriksen, (1969) Changing 
staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of 
bacteremia. The New England Journal of Medicine 281: 627-635. 
135. Jevons, M., (1961) “Celbenin” - resistant staphylococci. British Medical Journal 1: 
124-125. 
136. Joost I., D. Blass,M. Burian, C. Goerke, C. Wolz, L. von Müller, K. Becker, K. 
Preissner, M. Herrmann & M. Bischoff, (2009) Transcription analysis of the extracellular 
adherence protein from Staphylococcus aureus in authentic human infection and in vitro. 
The journal of infectious diseases 199: 1471-1478. 
137. Josten, M., J. Dischinger, C. Szekat, M. Reif, N. Al-Sabti, H.G. Sahl, M. Parcina, I. 
Bekeredjian-Ding & G. Bierbaum, (2014) Identification of agr-positive methicillin-resistant 
Staphylococcus aureus harbouring the class A mec complex by MALDI-TOF mass 
spectrometry. International journal of medical microbiology: IJMM 304: 1018-1023. 
138. Josten, M., M. Reif, C. Szekat, N. Al-Sabti, T. Roemer, K. Sparbier, M. Kostrzewa, 
H. Rohde, H.G. Sahl & G. Bierbaum, (2013) Analysis of the matrix-assisted laser 
desorption ionization-time of flight mass spectrum of Staphylococcus aureus identifies 
mutations that allow differentiation of the main clonal lineages. Journal of clinical 
microbiology 51: 1809-1817. 
139. Kirkliauskienė A., A. Ambrozaitis A., R.L. Skov & N. Frimodt-Moller, (2010) The 
prevalence of Staphylococcus aureus nose and throat carriage by healthy adults. „Vis 
uomenės sveikata” 2: 124-131. 
140. Kluytmans, J., A. van Belkum & H. Verbrugh, (1997) Nasal carriage of 
Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. 
Clinical microbiology reviews 10: 505-520. 
141. Köck, R., F. Schaumburg, A. Mellmann, M. Köksal, A. Jurke, K. Becker, A.W. 
Friedrich, (2013) Livestock-associated methicillin-resistant staphylococcus aureus 
(MRSA) as causes of human infection and colonization in Germany. PLoS One 8: 
e55040. 




Mielke, G. Peters, R.L. Skov, M.J. Struelens, E. Tacconelli, A. Navarro Torne, W. Witte & 
A.W. Friedrich, (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of 
disease and control challenges in Europe. Euro surveillance : bulletin Europeen sur les 
maladies transmissibles = European communicable disease bulletin 15: 19688. 
142. Köck, R., L. Brakensiek, A. Mellmann, F. Kipp, M. Henderikx, D. Harmsen, I. 
Daniels-Haardt, C. von Eiff, K. Becker, M.G. Hendrix & A.W. Friedrich, (2009) Cross-
border comparison of the admission prevalence and clonal structure of meticillin-resistant 
Staphylococcus aureus. Journal of Hospital Infection 71: 320-326. 
143. Kolawole, D.O., A. Adeyanju, F. Schaumburg, A.L. Akinyoola, O.O. Lawal, Y.B. 
Amusa, R. Kock & K. Becker, (2013) Characterization of colonizing Staphylococcus 
aureus isolated from surgical wards' patients in a Nigerian university hospital. PLoS One 
8: e68721. 
144. Koren, Y., R. Bell & C. Volinsky, (2009) Matrix Factorization Techniques for 
Recommender Systems. Computer 42: 30-37. 
145. Kraef, C., A.S. Alabi, G. Peters, K. Becker, P.G. Kremsner, E.G. Rossatanga, A. 
Mellmann, M.P. Grobusch, P. Zanger & F. Schaumburg, (2015) Co-detection of Panton-
Valentine leukocidin encoding genes and cotrimoxazole resistance in Staphylococcus 
aureus in Gabon: implications for HIV-patients' care. Frontiers in microbiology 6: 60. 
146. Koreen, L., S.V. Ramaswamy , E.A. Graviss , S. Naidich, J.M. Musser & B.N. 
Kreiswirth, (2004) Spa typing method for discriminating among Staphylococcus aureus 
isolates: implications for use of a single marker to detect genetic micro- and 
macrovariation. Journal of clinical microbiology 42:792-799. 
147. Krupa, P., J. Bystroń, M. Podkowik, J. Empel, A. Mroczkowska & J. Bania, (2015) 
Population structure and oxacillin Resistance of Staphylococcus aureus from pigs and 
pork meat in South-West of Poland. BioMed research international 2015: 141475. 
148. Laabei, M., M. Recker, J.K. Rudkin, M. Aldeljawi, Z. Gulay, T.J. Sloan, P. Williams, 
J.L. Endres, K.W. Bayles, P.D. Fey, V.K. Yajjala, T. Widhelm, E. Hawkins, K. Lewis, S. 
Parfett, L. Scowen, S.J. Peacock, M. Holden, D. Wilson, T.D. Read, J. van den Elsen, 
N.K. Priest, E.J. Feil, L.D. Hurst, E. Josefsson & R.C. Massey, (2014) Predicting the 
virulence of MRSA from its genome sequence. Genome research 24: 839-849. 
149. Lacey, K.A., J.A. Geoghegan & R.M. McLoughlin, (2016) The Role of 
Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine 
Antigens. Pathogens 5. 
150. Lartigue, M.F., G. Hery-Arnaud, E. Haguenoer, A.S. Domelier, P.O. Schmit, N. van 
der Mee-Marquet, P. Lanotte, L. Mereghetti, M. Kostrzewa & R. Quentin, (2009) 
Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by 
matrix-assisted laser desorption ionization-time of flight mass spectrometry. Journal of 
clinical microbiology 47: 2284-2287. 
151. Lasch, P., C. Fleige, M. Stammler, F. Layer, U. Nubel, W. Witte & G. Werner, 
(2014) Insufficient discriminatory power of MALDI-TOF mass spectrometry for typing of 
Enterococcus faecium and Staphylococcus aureus isolates. Journal of microbiological 
methods 100: 58-69. 
152. Lattar, S.M., L.P. Tuchscherr, R.L. Caccuri, D. Centron, K. Becker, C.A. Alonso, 
C. Barberis, G. Miranda, F.R. Buzzola, C. von Eiff & D.O. Sordelli, (2009) Capsule 




patients with chronic or acute osteomyelitis. Infection and immunity 77: 1968-1975. 
153. Lemichez, E., M. Lecuit, X. Nassif & S. Bourdoulous, (2010) Breaking the wall: 
targeting of the endothelium by pathogenic bacteria. Nature reviews. Microbiology 8: 93-
104. 
154. Lemon, K.P., V. Klepac-Ceraj, H.K. Schiffer, E.L. Brodie, S.V. Lynch & R. Kolter, 
(2010) Comparative analyses of the bacterial microbiota of the human nostril and 
oropharynx. mBio 1. 
155. Lenz, W., E. Eilers & U. Lehmacher, (1988) Characterization of methicillin-resistant 
Staphylococcus aureus strains isolated from 1974 to 1983 in West Germany with respect 
to the results of lysotyping. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene 268: 
277-293. 
156. Leopold, S.R., R.V. Goering, A. Witten, D. Harmsen & A. Mellmann, (2014) 
Bacterial whole-genome sequencing revisited: portable, scalable, and standardized 
analysis for typing and detection of virulence and antibiotic resistance genes. Journal of 
clinical microbiology 52: 2365-2370. 
157. Limbago, B.M., A.J. Kallen, W. Zhu, P. Eggers, L.K. McDougal & V.S. Albrecht, 
(2014) Report of the 13th Vancomycin-resistant Staphylococcus aureus isolate from the 
United States. Journal of clinical microbiology 52: 998 –1002. 
158. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M.O. Peter, V. Gauduchon, F. 
Vandenesch & J. Etienne, (1999) Involvement of Panton-Valentine leukocidin-producing 
Staphylococcus aureus in primary skin infections and pneumonia. Clinical infectious 
diseases: an official publication of the Infectious Diseases Society of America 29: 1128-
1132. 
159. Lindsay, J.A. &  M.T. Holden, (2004) Staphylococcus aureus: superbug, super 
genome? Trends in microbiology 12: 378-385. 
160. Lindsay, J.A., C.E. Moore, N.P. Day, S.J. Peacock, A.A. Witney, R.A. Stabler, S.E. 
Husain, P.D. Butcher & J. Hinds, (2006) Microarrays reveal that each of the ten dominant 
lineages of Staphylococcus aureus has a unique combination of surface-associated and 
regulatory genes. Journal of bacteriology 188: 669-676. 
161. Liu, Q., W.S. Yeo & T. Bae, (2016) The SaeRS Two-Component System of 
Staphylococcus aureus. Genes 7. 
162. Lowy, F.D., (1998) Staphylococcus aureus infections. The New England journal of 
medicine 339: 520-532. 
163. Lowy, F.D., (2003) Antimicrobial resistance: the example of Staphylococcus 
aureus. The Journal of clinical investigation 111: 1265-1273. 
164. Maiden, M.C., J.A. Bygraves, E. Feil, G. Morelli, J.E. Russell, R. Urwin, Q. Zhang, 
J. Zhou, K. Zurth, D.A. Caugant, I.M. Feavers, M. Achtman & B.G. Spratt, (1998) 
Multilocus sequence typing: a portable approach to the identification of clones within 
populations of pathogenic microorganisms. Proceedings of the National Academy of 
Sciences of the United States of America 95: 3140-3145. 
165. Manual Identibac® S. aureus Genotyping-Kit, (2015) Manual S. aureus 
Genotyping Kit 2.0. Alere-technologies GmbH. 
166. Mariem, B.J., T. Ito, M. Zhang, J. Jin, S. Li, B.B. Ilhem, H. Adnan, X. Han & K. 




leukocidin positive Staphylococcus aureus clones disseminating in Tunisian hospitals and 
in the community. BMC microbiology 13: 2. 
167. Marples, R. R. & V.T. Rosdahl, (1997) International quality control of phage typing 
of staphylococcus aureus. Journal of medical microbiology 46: 511-6. 
168. Marques, R.C., J.V. Bernardi, J.G. Dorea, W.R. Bastos & O. Malm, (2008) Principal 
component analysis and discrimination of variables associated with pre- and post-natal 
exposure to mercury. International journal of hygiene and environmental health 211: 606-
614. 
169. McAdow, M., D.M. Missiakas & O. Schneewind, (2012) Staphylococcus aureus 
secretes coagulase and von Willebrand factor binding protein to modify the coagulation 
cascade and establish host infections. Journal of innate immunity 4: 141-148. 
170. McDevitt, D., P. Francois, P. Vaudaux & T.J. Foster, (1994) Molecular 
characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. 
Molecular microbiology 11: 237-248. 
McGuinness, W.A., S.D. Kobayashi & F.R. DeLeo, (2016) Evasion of Neutrophil Killing 
by Staphylococcus aureus. Pathogens 5. 
171. Mehraj, J., M.K. Akmatov, J. Strompl, A. Gatzemeier, F. Layer, G. Werner, D.H. 
Pieper, E. Medina, W. Witte, F. Pessler & G. Krause, (2014) Methicillin-sensitive and 
methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-
hospitalized adult population in northern Germany. PLoS One 9: e107937. 
172. Melles, D.C., K.L. Taylor, A.I. Fattom & A. van Belkum, (2008) Serotyping of Dutch 
Staphylococcus aureus strains from carriage and infection. FEMS immunology and 
medical microbiology 52: 287-292. 
173. Meyer, E., C. Schröder, P. Gastmeier & C. Geffers, (2014) The reduction of 
nosocomial MRSA infection in Germany—an analysis of data from the Hospital Infection 
Surveillance System (KISS) between 2007 and 2012. Deutsches Ärzteblatt International 
111: 331–336. 
174. Monecke, S., H. Kanig, W. Rudolph, E. Muller, G. Coombs, H. Hotzel, P. Slickers 
& R. Ehricht, (2010) Characterisation of Australian MRSA strains ST75- and ST883-
MRSA-IV and analysis of their accessory gene regulator locus. PLoS One 5: e14025. 
175. Monecke, S., R. Ehricht, P. Slickers, N. Wiese & D. Jonas, (2009) Intra-strain 
variability of methicillin-resistant Staphylococcus aureus strains ST228-MRSA-I and ST5-
MRSA-II. European journal of clinical microbiology & infectious diseases: official 
publication of the European Society of Clinical Microbiology 28: 1383-1390. 
176. Monecke, S., P. Slickers & R. Ehricht, (2008) Assignment of Staphylococcus 
aureus isolates to clonal complexes based on microarray analysis and pattern 
recognition. FEMS immunology and medical microbiology 53: 237-251. 
177. Monecke, S., B. Berger-Bächi, G. Coombs, A. Holmes, I. Kay,A. Kearns,H.J. 
Linde, F. O'Brien, P. Slickers & R. Ehricht. (2007) Comparative genomics and DNA array-
based genotyping of pandemic Staphylococcus aureus strains encoding Panton-
Valentine leukocidin. Clinical Microbiology and Infection 13: 236–249. 
178. Monecke, S. & R. Ehricht, (2005) Rapid genotyping of methicillin-resistant 
Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. 
Clinical microbiology and infection: the official publication of the European Society of 




Moran, G.J., M.D., A. Krishnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, R.B. 
Carey, D.A. Talan & the EMERGEncy ID Net Study Group, (2006) Methicillin-resistant S. 
aureus infections among patients in the emergency department. The new england journal 
of medicine 355: 666-674. 
179. Morbidity and mortality weekly report, (1999) Four pediatric deaths from 
community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North 
Dakota. JAMA 282: 1123-1125. 
180. Mortimer, P. & C. Arnold C, (2001) FAFLP: last word in microbial genotyping? 
Journal of Medical Microbiology 50: 393-5. 
181. Mugalu, J., M.K. Nakakeeto, S. Kiguli & D.H. Kaddu-Mulindwa, (2006) Aetiology, 
risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia 
in Mulago hospital, Uganda. African health sciences 6: 120-126. 
182. Mulholland, E.K. &  R.A. Adegbola, (2005) Bacterial infections-a major cause of 
death among children in Africa. The New England journal of medicine 352: 75-77. 
183. Murchan S., M.E. Kaufmann, A. Deplano, R. de Ryck, M. Struelens, C.E. Zinn, V. 
Fussing, S. Salmenlinna, J. Vuopio-Varkila, N. El Solh, C. Cuny, W. Witte, P.T. 
Tassios, N. Legakis, W. van Leeuwen, A. van Belkum, A. Vindel, I. Laconcha, J. 
Garaizar, S. Haeggman, B. Olsson-Liljequist, U. Ransjo, G. Coombes & B. Cookson, 
(2003) Harmonization of pulsed-field gel electrophoresis protocols for epidemiological 
typing of strains of methicillin-resistant Staphylococcus aureus: a single approach 
developed by consensus in 10 European laboratories and its application for tracing the 
spread of related strains. Journal of clinical microbiology 41: 1574-1585. 
184. Naimi, T.S., K.H. LeDell, K. Como-Sabetti, S.M. Borchardt, D.J. Boxrud, J. Etienne, 
S.K. Johnson, F. Vandenesch, S. Fridkin, C. O'Boyle, R.N. Danila & R. Lynfield, (2003) 
Comparison of community- and health care-associated methicillin-resistant 
Staphylococcus aureus infection. JAMA 290: 2976-2984. 
185. Nelson J.L., K. C. Rice, S. R. Slater, P. M. Fox, G.L. Archer, K. W. Bayles, P.D. Fey, 
B.N. Kreiswirth & G.A. Somerville, (2007) Vancomycin-Intermediate Staphylococcus 
aureus Strains Have Impaired Acetate Catabolism: Implications for Polysaccharide 
Intercellular Adhesin Synthesis and Autolysis. Antimicrobial agents and Chemotherapy 
51: 616–622  
186. Nethercott C., A. N. Mabbett, M. Totsika, P. Peters, J.C. Ortiz, G. R. Nimmo,  G.W. 
Coombs, M.J. Walker & M.A. Schembria, (2013) Molecular Characterization of 
Endocarditis-Associated Staphylococcus aureus. Journal of clinical microbiology 51: 
2131–2138. 
187. Ni Eidhin, D., S. Perkins, P. Francois, P. Vaudaux, M. Hook & T.J. Foster, (1998) 
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of 
Staphylococcus aureus. Molecular microbiology 30: 245-257. 
188. Nienaber, J.J., B.K. Sharma Kuinkel, M. Clarke-Pearson, S. Lamlertthon, L. Park, 
T.H. Rude, S. Barriere, C.W. Woods, V.H. Chu, M. Marin, S. Bukovski, P. Garcia, G.R. 
Corey, T. Korman, T. Doco-Lecompte, D.R. Murdoch, L.B. Reller, V.G. Fowler, Jr. & I. 
International Collaboration on Endocarditis-Microbiology, (2011) Methicillin-susceptible 
Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 
genotype and a distinct repertoire of enterotoxins and adhesins. The Journal of infectious 




189. Nishifuji, K., M. Sugai & M. Amagai, (2008) Staphylococcal exfoliative toxins: 
"molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. 
Journal of dermatological science 49: 21-31. 
190. Novick, R.P., (2003) Autoinduction and signal transduction in the regulation of 
staphylococcal virulence. Molecular microbiology 48: 1429-1449. 
191. Nübel, U., B. Strommenger, F. Layer & W. Witte, (2011) From types to trees: 
Reconstructing the spatial spread of Staphylococcus aureus based on DNA variation. 
International Journal of Medical Microbiology: IJMM 301: 614– 618. 
192. Nübel ,U.,P. Roumagnacc, M. Feldkampc, J. Songe, K.S.Kof, Y. Huangg, G. 
Coombsh, M.I.H. Westh, R. Skov, M.J. Struelensm, R.V. Goering, B. Strommenger, A. 
Weller, W. Witte & M. Achtman, (2008) Frequent emergence and limited geographic 
dispersal of methicillin-resistant Staphylococcus aureus. Proceedings of the National 
Academy of Sciences 105: 14130 –14135.  
193. Nulens, E., E.E. Stobberingh, H. van Dessel, S. Sebastian, F.H. van Tiel, P.S. 
Beisser,  R.H. Deurenberg, (2008) Molecular characterization of Staphylococcus aureus 
bloodstream isolates collected in a Dutch University Hospital between 1999 and 2006. 
Journal of clinical microbiology 46: 2438–2441. 
194. O'Riordan, K. & J.C. Lee, (2004) Staphylococcus aureus capsular 
polysaccharides. Clinical microbiology reviews 17: 218-234. 
195. Obaro, S., L. Lawson, U. Essen, K. Ibrahim, K. Brooks, A. Otuneye, D. Shetima, 
P. Ahmed, T. Ajose, M. Olugbile, D. Idiong, D. Ogundeji, C. Ochigbo, G. Olanipekun, W. 
Khalife & R. Adegbola, (2011) Community acquired bacteremia in young children from 
central Nigeria-a pilot study. BMC infectious diseases 11: 137. 
196. Ogston, A., (1882) Micrococcus Poisoning. Journal of anatomy and physiology 17: 
24-58. 
197. Okon, K.O., P. Basset, A. Uba, J. Lin, B. Oyawoye, A.O. Shittu & D.S. Blanc, 
(2009) Cooccurrence of predominant Panton-Valentine leukocidin-positive sequence 
type (ST) 152 and multidrug-resistant ST 241 Staphylococcus aureus clones in Nigerian 
hospitals. Journal of clinical microbiology 47: 3000-3003. 
198. Oosthuysen, W.F., H. Orth, C.J. Lombard, B. Sinha & E. Wasserman, (2014) 
Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South 
Africa, reveals a diverse population, a high prevalence of Panton-Valentine leukocidin 
genes, and unique local methicillin-resistant S. aureus clones. Clinical microbiology and 
infection: the official publication of the European Society of Clinical Microbiology and 
Infectious Diseases 20: 652-659. 
199. Ostergaard, C., S.G. Hansen & J.K. Moller, (2015) Rapid first-line discrimination of 
methicillin-resistant Staphylococcus aureus strains using MALDI-TOF MS. International 
journal of medical microbiology: IJMM 305: 838-847. 
200. Otter, J.A. &  G.L. French, (2012) Community-associated meticillin-resistant 
Staphylococcus aureus: the case for a genotypic definition. Journal of Hospital Infection 
81: 143e148. 
201. Otter, J.A. &  G.L. French, (2010) Molecular epidemiology of community-
associated meticillin-resistant Staphylococcus aureus in Europe. The Lancet. Infectious 
diseases 10: 227-239. 




immunology 322: 207-228. 
203. Parker, M.T. & J.H. Hewitt, (1970) Methicillin resistance in Staphylococcus 
aureus. Lancet 295: 800-804. 
204. Phaku, P., M. Lebughe, L. Strauss, G. Peters, M. Herrmann, D. Mumba, A. 
Mellmann, J.J. Muyembe-Tamfum & F. Schaumburg, (2016) Unveiling the molecular 
basis of antimicrobial resistance in Staphylococcus aureus from the Democratic Republic 
of the Congo using whole genome sequencing. Clinical microbiology ancd infection : the 
official publication of the European Society of Clinical Microbiology and Infectious 
Diseases 22: 644 e641-645. 
205. Popovic, M., D. Steinort, S. Pillai & C. Joukhadar (2010) Fosfomycin: an old, new 
friend? European journal of clinical microbiology & infectious diseases : official publication 
of the European Society of Clinical Microbiology 29: 127-142. 
206. Prévost G, B. Pottecher, M. Dahlet, M. Bientz, J.M. Mantz & Y. Piémont, (1991) 
Pulsed field gel electrophoresis as a new epidemiological tool for monitoring methicillin-
resistant Staphylococcus aureus in an intensive care unit. Journal of Hospital Infection 
17: 255-269. 
207. Price, J., N.C. Gordon, D. Crook, M. Llewelyn & J. Paul, (2013) The usefulness of 
whole genome sequencing in the management of Staphylococcus aureus infections. 
Clinical microbiology and infection: the official publication of the European Society of 
Clinical Microbiology and Infectious Diseases 19: 784-789. 
208. Pryer, J.A., R. Nichols, P. Elliott, B. Thakrar, E. Brunner & M. Marmot, (2001) 
Dietary patterns among a national random sample of British adults. Journal of 
epidemiology and community health 55: 29-37. 
209. Quackenbush, J., (2001) Computational analysis of microarray data. Nature 
reviews. Genetics 2: 418-427. 
210. R Development Core Team, (2008) R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, http://R-project.org. 
211. Ramdani-Bouguessa, N., M. Bes, H. Meugnier, F. Forey, M.E. Reverdy, G. Lina, 
F. Vandenesch, M. Tazir & J. Etienne, (2006) Detection of methicillin-resistant 
Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-
Valentine leukocidin genes in an Algiers hospital. Antimicrobial agents and chemotherapy 
50: 1083-1085. 
212. Rammelkamp, Ch. & T. Maxon, (1942) Resistance of Staphylococcus aureus to 
the action of penicillin. Experimental Biology and Medicine 51(3): 386-389. 
213. Rasmussen, G., S. Monecke, O. Brus, R. Ehricht & B. Soderquist, (2014) Long 
term molecular epidemiology of methicillin-susceptible Staphylococcus aureus 
bacteremia isolates in Sweden. PLoS One 9: e114276. 
214. Redpath, M.B., T.J. Foster & C.J. Bailey, (1991) The role of the serine protease 
active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. FEMS 
microbiology letters 65: 151-155. 
215. Rijnders M.I.A., R.H. Deurenberg, M.L.L. Boumans, J.A.A. Hoogkamp-Korstanje, 
P.S. Beisser, the Antibiotic Resistance Surveillance Group & E.E. Stobberingh, (2009) 
Population structure of Staphylococcus aureus strains isolated from intensive care unit 
patients in the Netherlands over an 11-Year Period (1996 to 2006). Journal of clinical 




216. Robert Koch Institut, (2018) Ständige Impfkommission: Empfehlungen der 
Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiologisches Bulletin 
34: 335 – 382. 
217. Robert Koch Institut, (1997) MRSA mit nur noch intermediärer 
Glykopeptidempfindlichkeit in Japan und in den USA. Epidemiologisches Bulletin 45: 314-
315. 
218. Robinson, D. A. & M.C. Enright, (2003) Evolutionary Models of the Emergence of 
Methicillin-Resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 47: 
3926-3934. 
219. Rolo, J., P. Worning, J.B. Nielsen, R. Bowden, O. Bouchami, P. Damborg, L. 
Guardabassi, V. Perreten, A. Tomasz, H. Westh, H. de Lencastre & M. Miragaia, (2017) 
Evolutionary origin of the staphylococcal cassette chromosome mec (SCCmec). 
Antimicrobial agents and chemotherapy 61: e02302- 16. 208. 
220. Rosenbach, F.J., (1884). Mikro-Organismen bei den. Wund-Infections-
Krankheiten des Menschen. JF Bergmann’s Verlag, Wiesbaden, 18: 1–122. 
221. Rountree, P.M. & M.A. Beard, (1968) Hospital strains of Staphylococcus aureus 
with particular reference to methicillin-resistant strains. Medical Journal of Australia 
2:1163–1168. 
222. Ruffing, U., R. Akulenko, M. Bischoff, V. Helms, M. Herrmann & L. von Muller, 
(2012) Matched-cohort DNA microarray diversity analysis of methicillin sensitive and 
methicillin-resistant Staphylococcus aureus isolates from hospital admission patients. 
PLoS One 7: e52487. 
223. Ruffing, U., A. Alabi, T. Kazimoto, D.C. Vubil, R. Akulenko, S. Abdulla, P. Alonso, 
M. Bischoff, A. Germann, M.P. Grobusch, V. Helms, J. Hoffmann, W.V. Kern, P.G. 
Kremsner, I. Mandomando, A. Mellmann, G. Peters, F. Schaumburg, S. Schubert, L. 
Strauß, M. Tanner, H. von Briesen, L. Wende, L. von Muller & M. Herrmann, (2017) 
community-associated Staphylococcus aureus from Sub-Saharan Africa and Germany: 
a cross-sectional geographic correlation Study. Scientific Reports 7: 154. 
224. Ruimy, R., A. Maiga, L. Armand-Lefevre, I. Maiga, A. Diallo, A.K. Koumare, K. 
Ouattara, S. Soumare, K. Gaillard, J.C. Lucet, A. Andremont & E.J. Feil, (2008) The 
carriage population of Staphylococcus aureus from Mali is composed of a combination of 
pandemic clones and the divergent Panton-Valentine leukocidin-positive genotype 
ST152. Journal of bacteriology 190: 3962-3968. 
225. Sabat, A.J., A. Budimir, D. Nashev, R. Sa-Leao, J. van Dijl, F. Laurent, H. 
Grundmann, A.W. Friedrich & E.S.G.o.E. Markers, (2013) Overview of molecular typing 
methods for outbreak detection and epidemiological surveillance. Euro surveillance : 
bulletin Europeen sur les maladies transmissibles = European communicable disease 
bulletin 18: 20380. 
226. Saitou, N. &  M. Nei, (1987) The neighbor-joining method: a new method for 
reconstructing phylogenetic trees. Molecular biology and evolution 4: 406-425. 
227. Saravolatz, L.D., D.J. Pohlod & L.M. Arking, (1982) Community-acquired 
methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial 
outbreaks. Annals of Internal Medicine 97: 325–329.  
228. Sauget, M., N. van der Mee-Marquet, X. Bertrand & D. Hocquet, (2016) Matrix-




Staphylococcus aureus clonal complex 398. Journal of microbiological methods 127: 20-
23. 
229. Schaumburg, F., A.S. Alabi, G. Peters & K. Becker, (2014) New epidemiology of 
Staphylococcus aureus infection in Africa. Clinical microbiology and infection : the official 
publication of the European Society of Clinical Microbiology and Infectious Diseases 20: 
589-596. 
230. Schaumburg, F., R. Köck, A. Mellmann, L. Richter, F. Hasenberg, A. Kriegeskorte, 
A.W. Friedrich, S. Gatermann, G. Peters, C. von Eiff, K. Becker & study group, (2012) 
Population Dynamics among methicillin-tesistant Staphylococcus aureus isolates in Germany 
during a 6-year period. Journal of clinical microbiology 50:3186-3192. 
231. Schaumburg, F., R. Köck,, A.W. Friedrich, S. Soulanoudjingar, U.A. Ngoa, C. von 
Eiff, S. Issifou, P.G. Kremsner, M. Herrmann, G. Peters & K. Becker, (2011) Population 
structure of Staphylococcus aureus from remote African Babongo Pygmies. PLoS 
neglected tropical diseases 5: e1150. 
232. Seibold, E., T. Maier, M. Kostrzewa, E. Zeman & W. Splettstoesser, (2010) 
Identification of Francisella tularensis by whole-cell matrix-assisted laser desorption 
ionization-time of flight mass spectrometry: fast, reliable, robust, and cost-effective 
differentiation on species and subspecies levels. Journal of clinical microbiology 48: 
1061-1069. 
233. Seng, P., M. Drancourt, F. Gouriet, B. La Scola, P.E. Fournier, J.M. Rolain & D. 
Raoult, (2009) Ongoing revolution in bacteriology: routine identification of bacteria by 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clinical 
infectious diseases : an official publication of the Infectious Diseases Society of America 
49: 543-551. 
234. Shallcross, L.J., E. Fragaszy, A.M. Johnson & A.C. Hayward, (2013) The role of 
the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and 
meta-analysis. The Lancet. Infectious diseases 13: 43-54. 
235. Shanson, D.C., (1981) Antibiotic resistant Staphylococcus aureus. Journal of 
Hospital Infection 2: 11-36. 
236. Shittu, A.O., O. Oyedara, K. Okon, A. Raji, G. Peters, L. von Muller, F. 
Schaumburg, M. Herrmann & U. Ruffing, (2015) An assessment on DNA microarray and 
sequence-based methods for the characterization of methicillin-susceptible 
Staphylococcus aureus from Nigeria. Frontiers in microbiology 6: 1160. 
237. Shopsin, B., M. Gomez, S.O. Montgomery, D.H. Smith, M. Waddington, D.E. 
Dodge, D.A. Bost, M. Riehman, S. Naidich & B.N. Kreiswirth, (1999) Evaluation of protein 
A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. 
Journal of clinical microbiology 37: 3556-3563. 
238. Sigauque, B., A. Roca, I. Mandomando, L. Morais, L. Quinto, J. Sacarlal, E. 
Macete, T. Nhamposa, S. Machevo, P. Aide, Q. Bassat, A. Bardaji, D. Nhalungo, M. 
Soriano-Gabarro, B. Flannery, C. Menendez, M.M. Levine & P.L. Alonso, (2009) 
Community-acquired bacteremia among children admitted to a rural hospital in 
Mozambique. The Pediatric infectious disease journal 28: 108-113. 
239. Sina, H., T.A. Ahoyo, W. Moussaoui, D. Keller, H.S. Bankole, Y. Barogui, Y. 
Stienstra, S.O. Kotchoni, G. Prevost & L. Baba-Moussa, (2013) Variability of antibiotic 




soft tissue, and bone related infections. BMC microbiology 13: 188. 
240. Smith, T.L., M.L. Pearson, K.R. Wilcox, C. Cruz, M.V. Lancaster, B. Robinson-
Dunn, F.C. Tenover, M.J. Zervos, J.D. Band, E. White & W.R. Jarvis, (1999) Emergence 
of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate 
Staphylococcus aureus Working Group. The New England journal of medicine 340: 493-
501. 
241. Sogawa, K., M. Watanabe, T. Ishige, S. Segawa, A. Miyabe, S. Murata, T. Saito, 
A. Sanda, K. Furuhata & F. Nomura, (2017) Rapid discrimination between methicillin-
sensitive and methicillin-resistant Staphylococcus aureus using MALDI-TOF mass 
spectrometry. Biocontrol Science 22: 163-169. 
242. Somerville, G.A. &  R.A. Proctor, (2009) At the crossroads of bacterial metabolism 
and virulence factor synthesis in staphylococci. Microbiology and molecular biology 
reviews: MMBR 73: 233-248. 
243. Sparbier, K., C. Lange, J. Jung, A. Wieser, S. Schubert & M. Kostrzewa, (2013) 
MALDI biotyper-based rapid resistance detection by stable-isotope labeling. Journal of 
clinical microbiology 51: 3741-3748. 
244. Spaulding, A.R., W. Salgado-Pabon, P.L. Kohler, A.R. Horswill, D.Y. Leung & P.M. 
Schlievert, (2013) Staphylococcal and streptococcal superantigen exotoxins. Clinical 
microbiology reviews 26: 422-447. 
245. Stegger, M., T. Wirth, P.S. Andersen, R.L. Skov, A. De Grassi, P. Martins Simões, 
A. Tristan, A. Petersen, M. Aziz, K. Kiil, I. Cirković, E.E. Udo, R. del Campo, J. Vuopio-
Varkila, N. Ahmad, S. Tokajian, G. Peters, F. Schaumburg, B.Olsson-Liljequist, 
M.Givskov, E.E. Driebe, H.E. Vigh, A. Shittu, N. Ramdani-Bougessa, J.-P. Rasigade, L.B. 
Price, F. Vandenesch, A.R. Larsen & F. Laurent, (2014) Origin and evolution of european 
community-acquired methicillin-resistant Staphylococcus aureus. mBio 5: e01044-14. 
246. Strauss, L., U. Ruffing, S. Abdulla, A. Alabi, R. Akulenko, M. Garrine, A. Germann, 
M.P. Grobusch, V. Helms, M. Herrmann, T. Kazimoto, W. Kern, I. Mandomando, G. 
Peters, F. Schaumburg, L. von Muller & A. Mellmann, (2016) Detecting Staphylococcus 
aureus Virulence and Resistance Genes - a Comparison of Whole Genome Sequencing 
and DNA Microarray Technology. Journal of clinical microbiology. 
247. Strommenger, B., C. Kettlitz, T. Weniger, D. Harmsen, A.W. Friedrich & W. Witte, 
(2006) Assignment of Staphylococcus isolates to groups by spa typing, SmaI 
macrorestriction analysis, and multilocus sequence typing. Journal of clinical 
microbiology 44: 2533-2540. 
248. Szabados, F., M. Kaase, A. Anders & S.G. Gatermann, (2012) Identical MALDI 
TOF MS-derived peak profiles in a pair of isogenic SCCmec-harboring and SCCmec-
lacking strains of Staphylococcus aureus. The Journal of infection 65: 400-405. 
249. Tacconelli, E., G. De Angelis, C. de Waure C, M. A. Cataldo, G. La Torre, R. Cauda, 
(2009) Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital 
admission: systematic review and meta-analysis. The Lancet. Infectious diseases 9: 546-
554. 
250. Taglialegna, A., S. Navarro, S. Ventura, J.A. Garnett, S. Matthews, J.R. Penades, 
I. Lasa & J. Valle, (2016) Staphylococcal Bap Proteins Build Amyloid Scaffold Biofilm 
Matrices in Response to Environmental Signals. PLoS pathogens 12: e1005711. 




H. Isobe, S. Dohmae, K. Ozaki, M. Takano, Y. Iwao, M. Shibuya, T. Okubo, S. Yabe, D. 
Shi, I. Reva, L.J. Teng & T. Yamamoto, (2008) Novel characteristics of community-
acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus 
sequence type 59 in Taiwan. Antimicrobial agents and chemotherapy 52: 837-845. 
252. Takeuchi, F., S. Watanabe, T. Baba, H. Yuzawa, T. Ito, Y. Morimoto, M. Kuroda, 
L. Cui, M. Takahashi, A. Ankai, S. Baba, S. Fukui, J.C. Lee & K. Hiramatsu, (2005) Whole-
genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of 
its genome and the evolution of human-colonizing staphylococcal species. Journal of 
bacteriology 187: 7292-7308. 
253. Talbert, A.W., M. Mwaniki, S. Mwarumba, C.R. Newton & J.A. Berkley, (2010) 
Invasive bacterial infections in neonates and young infants born outside hospital admitted 
to a rural hospital in Kenya. The Pediatric infectious disease journal 29: 945-949. 
254. Tristan, A., J.P. Rasigade, E. Ruizendaal, F. Laurent, M. Bes, H. Meugnier, G. 
Lina, J. Etienne, M. Celard, P. Tattevin, S. Monecke, V. Le Moing, F. Vandenesch & 
A.s.G.o.I.E. French, (2012) Rise of CC398 lineage of Staphylococcus aureus among 
Infective endocarditis isolates revealed by two consecutive population-based studies in 
France. PLoS One 7: e51172. 
255. Tsubakishita, S., K. Kuwahara-Arai, T. Sasaki & K. Hiramatsu, (2010) Origin and 
molecular evolution of the determinant of methicillin resistance in staphylococci. 
Antimicrobial agents and chemotherap 54: 4352-4359. 
256. Udo, E.E., M.A. Al-Bustan, L.E. Jacob & T.D. Chugh, (1999) Enterotoxin 
production by coagulase-negative staphylococci in restaurant workers from Kuwait City 
may be a potential cause of food poisoning. Journal of Medical Microbioogy 48: 819–823. 
257. Udo, E.E, J.W. Pearman & W.B. Grubb; (1993) Genetic analysis of community 
isolates of methicillin-resistant Staphylococcus aureus in Western Australia. The Journal 
of Hospital Infection 25: 97–108. 
258. Ueda, O., S. Tanaka, Z. Nagasawa, H. Hanaki, T. Shobuike & H. Miyamoto, (2015) 
Development of a novel matrix-assisted laser desorption/ionization time-of-flight mass 
spectrum (MALDI-TOF-MS)-based typing method to identify meticillin-resistant 
Staphylococcus aureus clones. The Journal of hospital infection 90: 147-155. 
259. Uhlen, M., B. Guss, B. Nilsson, S. Gatenbeck, L. Philipson & M. Lindberg, (1984) 
Complete sequence of the staphylococcal gene encoding protein A. A gene evolved 
through multiple duplications. The Journal of biological chemistry 259: 1695-1702. 
260. Urwin, R. & M.C. Maiden, (2003) Multi-Locus sequence typing: a tool for global 
epidemiology. Trends in Microbiology, 10: 479-487. 
261. van Belkum, A., D.C. Melles, J. Nouwen, W.B. van Leeuwen, W. van Wamel, M.C. 
Vos, H.F. Wertheim & H.A. Verbrugh, (2009) Co-evolutionary aspects of human 
colonisation and infection by Staphylococcus aureus. Infection, genetics and evolution: 
journal of molecular epidemiology and evolutionary genetics in infectious diseases 9: 32-
47. 
262. van Belkum A., W. van Leeuwen, M.E. Kaufmann, B. Cookson, F. Forey, J. 
Etienne, R. Goering, F. Tenover, C. Steward, F. O'Brien, W. Grubb, P. Tassios, N. 
Legakis, A. Morvan, N. El Solh, R. de Ryck, M. Struelens, S. Salmenlinha, J. Vuopio-
Varkila, M. Kooistra, A. Talens, W. Witte & H. Verbrugh, (1998) Assessment of resolution 




field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. Journal 
of clinical microbiology 36: 1653-1659. 
263. van Cleef, B.A.G.L., D. L. Monnet, A. Voss, K. Krziwanek, F. Allerberger, M. 
Struelens, H. Zemlickova, R.L. Skov, J. Vuopio-Varkila, C. Cuny, A.W. Friedrich, I. 
Spiliopoulou, J. Pászti, H. Hardardottir, A. Rossney, A. Pan, A. Pantosti, M. Borg, H. 
Grundmann, M. Mueller-Premru, B. Olsson-Liljequist, A. Widmer, S. Harbarth, A. 
Schweiger, S. Unal, & J.A.J.W. Kluytmans, (2011) Livestock associated Methicillin-
Resistant Staphylococcus aureus in Humans, Europe. Emerging Infectious Diseases 17: 
502-505. 
264. van der Meeren, B.T., P.S. Millard, M. Scacchetti, M.H. Hermans, M. Hilbink, T.B. 
Concelho, J.J. Ferro & P.C. Wever, (2014) Emergence of methicillin resistance and 
Panton-Valentine leukocidin positivity in hospital- and community-acquired 
Staphylococcus aureus infections in Beira, Mozambique. Tropical medicine & 
international health: TM & IH 19: 169-176. 
265. van Rensburg, B.W., A.M. van Staden, G.J. Rossouw & G. Joubert, (2010) The 
profile of adult nephrology patients admitted to the Renal Unit of the Universitas Tertiary 
Hospital in Bloemfontein, South Africa from 1997 to 2006. Nephrology, dialysis, 
transplantation: official publication of the European Dialysis and Transplant Association - 
European Renal Association 25: 820-824. 
266. Vandenesch, F., G. Lina & T. Henry, (2012) Staphylococcus aureus hemolysins, 
bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-
damaging virulence factors? Frontiers in cellular and infection microbiology 2: 12. 
267. Vandenesch, F., T. Naimi, M.C. Enright, G. Lina, G.R. Nimmo, H. Heffernan, N. 
Liassine, M. Bes, T. Greenland, M.E. Reverdy & J. Etienne, (2003) Community-acquired 
methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leuko-cidin genes: 
worldwide emergence. Emerging Infectious Diseases 9: 978–984. 
268. Vazquez, V., X. Liang, J.K. Horndahl, V.K. Ganesh, E. Smeds, T.J. Foster & M. 
Hook, (2011) Fibrinogen is a ligand for the Staphylococcus aureus microbial surface 
components recognizing adhesive matrix molecules (MSCRAMM) bone sialoprotein-
binding protein (Bbp). The Journal of biological chemistry 286: 29797-29805. 
269. von Eiff, C., A.W. Friedrich, G. Peters & K. Becker, (2004) Prevalence of genes 
encoding for members of the staphylococcal leukotoxin family among clinical isolates of 
Staphylococcus aureus. Diagnostic microbiology and infectious disease 49: 157-162. 
270. Vos, P., R. Hogers, M. Bleeker, M. Reijans, T. van de Lee, M- Hornes, A. Frijters, 
J. Pot, J. Peleman, M.Kuiper & M. Zabeau, (1995) AFLP: a new technique for DNA 
fingerprinting. Nucleic Acids Research 23: 4407-14. 
271. Vranckx K.,  K. De Bruyne & B. Pot, (2017) Analysis of MALDI‐TOF MS Spectra 
using the BioNumerics Software, Wiley online library, 10.1002/9781118960226.ch21, 
Editors: H.N. Shah, Saheer E. Gharbia. 
272. Wang, Y.R., Q. Chen, S.H. Cui & F.Q. Li, (2013) Characterization of 
Staphylococcus aureus isolated from clinical specimens by matrix assisted laser 
desorption/ionization time-of-flight mass spectrometry. Biomedical and environmental 
sciences: BES 26: 430-436. 
273. Weese J.S., M. Archambault, B.M. Willey, H. Dick, P. Hearn, B.N. Kreiswirth, B. 




resistant Staphylococcus aureus in horses and horse personnel, 2000–2002. Emerging 
Infectious Diseases 11: 430-435. 
274. Weller, T.M., (2000) Methicillin-resistant Staphylococcus aureus typing methods: 
which should be the international standard? The Journal of hospital infection 44: 160-172. 
275. Wertheim, H.F., M.C. Vos, A. Ott, A. van Belkum, A. Voss, J.A. Kluytmans, P.H. 
van Keulen, C.M. Vandenbroucke-Grauls, M.H. Meester & H.A. Verbrugh, (2004) Risk 
and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus 
non-carriers. Lancet 364: 703-705. 
276. Williamson, Y.M., H. Moura, A.R. Woolfitt, J.L. Pirkle, J.R. Barr, G. Carvalho Mda, 
E.P. Ades, G.M. Carlone & J.S. Sampson, (2008) Differentiation of Streptococcus 
pneumoniae conjunctivitis outbreak isolates by matrix-assisted laser desorption 
ionization-time of flight mass spectrometry. Applied and environmental microbiology 74: 
5891-5897. 
277. Witte, W., (2009) Community-acquired methicillin-resistant Staphylococcus 
aureus: what do we need to know? Clinical microbiology and infection: the official 
publication of the European Society of Clinical Microbiology and Infectious Diseases 15: 
17-25. 
278. Witte, W., I. Klare, U. Nübel, B. Strommenger & G. Werner, (2008) Emergence and 
spread of antibiotic resistant Gram positive bacterial pathogens. International journal of 
medical microbiology: IJMM 298: 365–377. 
279. Witte, W., V.D. Nguyen & K. Dunnhaupt, (1986) Methicillin-resistant 
Staphylococcus aureus (MRSA) in the German Democratic Republic. Incidence and 
strain characteristics. Journal of hygiene, epidemiology, microbiology, and immunology 
30: 185-193. 
280. Wolters, M., H. Rohde, T. Maier, C. Belmar-Campos, G. Franke, S. Scherpe, M. 
Aepfelbacher & M. Christner, (2011) MALDI-TOF MS fingerprinting allows for 
discrimination of major methicillin-resistant Staphylococcus aureus lineages. International 
journal of medical microbiology: IJMM 301: 64-68. 
281. Wu S., C. Pscitelli, H. de Lencastre & A. Tomasz, (1996) Tracking the evolutionary 
origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA 
from a methicillin susceptible strain of Staphylococcus sciuri. Microbial drug resistance 
2:435-441. 
282. Zanger, P., D. Nurjadi, R. Schleucher, H. Scherbaum, C. Wolz, P.G. Kremsner & 
B. Schulte, (2012) Import and spread of Panton-Valentine Leukocidin-positive 
Staphylococcus aureus through nasal carriage and skin infections in travelers returning 
from the tropics and subtropics. Clinical infectious diseases: an official publication of the 
Infectious Diseases Society of America 54: 483-492. 
283. Zhang, T., J. Ding, X. Rao, J. Yu, M. Chu, W. Ren, L. Wang & W. Xue, (2015) 
Analysis of methicillin-resistant Staphylococcus aureus major clonal lineages by Matrix-
Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF 
MS). Journal of microbiological methods 117: 122-127. 
284. Zhao, S., S.E. Mitchell, J. Meng, S. Kresovich, M.P. Doyle, R.E. Dean, , A. M. Casa 
& J.W. Weller, (2000) Genomic typing of Escherichia coli O157:H7 by semi-automated 
fluorescent AFLP analysis. Microbes and Infection 2: 107-13.   
Publications / congress contributions 
177 
 
8 Publications / congress contributions 
Publications: 
 Ruffing U, Alabi A, Kazimoto T, Vubil D,  Akulenko R, Abdulla S, Alonso P, Bischoff 
M, Germann A, Grobusch M, Helms V, Hoffmann J, Kern W, Kremsner P, 
Mandomando I, Mellmann A, Peters G, Schaumburg F, Schubert S, Strauß L, Tanner 
M, von Briesen H, Wende L, von Müller L &Herrmann M. Community-associated 
Staphylococcus aureus from Sub-Saharan Africa and Germany: A cross-sectional 
geographic correlation study. Sci Rep. 2017 Mar; 7(1):154. 
 Strauß L, Ruffing U, Abdulla S, Alabi A, Akulenko R, Garrine M, Germann A, Grobusch 
M, Helms V, Herrmann M, Kazimoto T, Kern W, Mandomando I, Peters G, 
Schaumburg F, von Müller L, Mellmann A. Detecting Staphylococcus aureus virulence 
and resistance genes – a comparison of whole genome sequencing and DNA 
microarray technology. J Clin Microbiol. 2016 April; 54(4): 1008-1116. 
 Shittu AO, Oyedara O, Okon K, Raji A, Peters G, von Müller L, Schaumburg, Herrmann 
M and Ruffing U. An assessment on DNA microarray and sequence-based methods 
for the characterization of methicillin-susceptible Staphylococcus aureus from Nigeria. 
Front Microbiol. 2015 Oct; 6: 1160. 
 Ruffing U, Akulenko R, Bischoff M, Helms V, Herrmann M, von Müller L. Matched-
cohort DNA microarray diversity analysis of methicillin-sensitive and methicillin-




 Ruffing U, Genomic Comparison of a Large Cohort of Non-Nosocomial Commensal 
and Clinical Staphylococcus aureus of African and German origin. 17th International 
Symposium on Staphylococci and Staphylococcal Infections (ISSSI), Seoul, 30 August 
– 2 September, 2016. Invited Speaker. 
 Strauß L, Ruffing U, Akulenko R, Mellmann A and the StaphNet Consortium. Inferring 
Staphylococcus aureus Virulence and Resistance Traits from Whole Genome 
Sequences – Comparison of the Alere Indentibac© Microarray and the Respective In 
Publications / congress contributions 
178 
 
Silico Typing Scheme. 67th Annual Meeting of the German society for Hygiene and 
Microbiology (DGHM), Münster, 22-25 September 2015. International Journal of 
Medical Microbiology, DVV314, p120. 
 Ruffing U, von Müller L, Herrmann M and the StaphNet consortium. Comparison of 
the molecular staphylococcal epidemiology in Sub-Saharan Africa vs. Germany: a 
prospective, multicentre cohort study on community associated Staphylococcus 
aureus. 9th European Congress on Tropical Medicine and International Health 
(ECTMIH), Basel, 6-10 September 2015 O.LB2.002, p145. 
 Ruffing U, Vranckx K, Herrmann M, von Müller L. Identification of clonal complex 121 
Staphylococcus aureus strains by MALDI-TOF mass spectrometry, StaphNet 
consortium. 25th European Congress of Clinical Microbiology and Infectious Diseases 
(ECCMID), Copenhagen, 25-28 April 2015, www.escmid.org, O234. 
 Ruffing U, Alab A, Abdulla S, Akulenko R, von Briesen H, Germann A, Grobusch MP, 
Helms V, Kazimoto T, Kern W, Mandomando I, Mellmann A, von Müller L, Peters G, 
Schaumburg F, Schubert S, Vubil D, Wende L, Herrmann M. Molecular genotyping of 
1200 community acquired nasal and clinical associated Staphylococcus aureus 
isolates of the African-German StaphNet multicenter study. 66th Annual Meeting of the 
German society for Hygiene and Microbiology (DGHM), and Annual Conference for 
the Associaton for General and Applied Microbiology (VAAM), Dresden, 05-08 Octobre 
2014. BIOspectrum, KMV06, p121. 
 Ruffing U, Wende L, Schubert S, Kazimoto T, Abdulla S, Akulenko R, Alabi A, Bischoff 
M, Germann A, Grobusch MP, Helms V, Hofman J, Kern W, Mandomando I, Mellmann 
A, Peters G, Schaumburg F, Vubil D, Herrmann M, von Müller L. African and German 
multicentre screening study of 1200 Staphylococcus aureus isolates. 65th Annual 
Meeting of the German society for Hygiene and Microbiology (DGHM), and German 
Society of Infectious Diseases (DGI), Rostock, 22-25 September 2013. International 
Journal of Medical Microbiology, MSV01, p77.  
Publications / congress contributions 
179 
 
Published Abstracts and poster presentations: 
 Ruffing U, Roth LE, Touré FS, Monemo P, Tia H, Cissé A, Diané B, Herrmann M, 
Akoua-Koffi C., Becker S. Comparative genotypic characterization of community 
associated Staphylococcus aureus from clinical infections and asymptomatic carriers 
in central Côte d’Ivoire. 13th Congress of Infectious diseases and tropical medicine 
(KIT), Würzburg, 15-18 june, 2016, www.kit2016.de/PDF/Abstract_Book.pdf, P-059. 
 Ruffing U, Halfmann A, Bischoff M, Herrmann M, von Müller L. MRSA risk factors 
associated with predominant spa-types in hospitals – experience from a statewide 
MRSA admission screening (MRSAarNet). 66th Annual Meeting of the German society 
for Hygiene and Microbiology (DGHM), and Annual Conference for the Associaton for 
General and Applied Microbiology (VAAM), Dresden, 05-08 Octobre 2014. 
BIOspectrum, KMP18, p121. 
 Ruffing U, Akulenko R, Wende L, Schubert S, Kazimoto T, Delfino V, Alabi A, 
Herrmann M, Schaumburg F, Kern W, Herrmann M, von Müller L and the StaphNet 
consortium. Molecular Epidemiology of Staphylococcus aureus Infections in Germany 
and Africa – a Multicenter Cohort Study using DNA Microarray to Characterize Invasive 
and Commensal Community-associated Isolate. Interscience Conference on 
Antimicrobial Agents and Chemotherapy (ICAAC). 5-9 September 2014, 
www.icaaconline.com, C-814. 
 Ruffing U, Akulenko R, Wende L, Schubert S, Kazimoto T, Delfino V, Alabi A, 
Herrmann M, Schaumburg F, Kern W. DNA microarray based genotyping of 1200 
Staphylococcus aureus isolates of the African-German StaphNet multicentre study. 
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 
Barcelona, 10-13 May 2014, www.escmid.org, P1539. 
 Ruffing U, Wende L, Schubert S, Kazimoto T, Abdulla S, Akulenko R, Alabi A, Bischoff 
M, Germann A, Grobusch MP, Helms V, Hofmann J, Kern W, Mandomando I, 
Mellmann A, Peters G, Schaumburg F, Vubil D, Herrmann M, von Müller L on behalf 
of the German-African study group of Staphylococcus aureus. Characterisation of 
Staphylococcus aureus isolates of an African and German multicentre screening by 
DNA microarray-based genotyping, 24th European Congress of Clinical Microbiology 
and Infectious Diseases (ECCMID), Barcelona, 27-30 April 2013, www.escmid.org, 
R2682. 
Publications / congress contributions 
180 
 
 Wende L, Schubert S, Ruffing U, Bischoff M, Kern W, Hofmann J, Abdulla S, 
Schaumburg F, Peters G, Alabi A, Grobusch MP, Mandomando I, Mellmann A, 
Germann A, Herrmann M, von Müller L. Characterization of Staphylococcus aureus 
isolates of an African and German multicentre screening by DNA microarray based 
genotyping. 64th Annual Meeting of the German society for Hygiene and Microbiology 
(DGHM), Hamburg, 30 September to 03 October 2012. International Journal of Medical 
Microbiology, MSP07, p87. 
 Ruffing U, Akulenko R, Petit C, Bischoff M, Helms V, Herrmann M, von Müller L. 
Comparison of microarray-based genotyping and spa-typing for routine typing of 
Staphylococcus aureus. 64th Annual Meeting of the German society for Hygiene and 
Microbiology (DGHM), Hamburg, 30 September - 03 October 2012. International 
Journal of Medical Microbiology, KMP10, p49. 
 Ruffing U, Petit C, Halfmann A, Bischoff M, Herrmann M, von Müller L. 
Characterization of MRSA and MSSA strains of a federal state multicenter screening 
by spa-typing and microarray-based genotyping. 63th Annual Meeting of the German 
society for Hygiene and Microbiology (DGHM), Essen 25-28 September 2011. 






My special thanks goes to Prof. Dr. Mathias Herrmann for the opportunity of this versatile 
and interesting topic, the steady willingness to engage in discussion and stimulating 
criticism, the trust in my work as well as for the excellent and diverse job opportunities at 
the institute. 
I give my warmest regards to my supvervisor Prof. Dr. Markus Bischoff for the 
supervision, inspiring discussion and helpful suggestions and especially to Prof. Dr. Lutz 
von Müller, my project supervisor and mentor, for his suggestions, positive motivation, 
constructive criticism and steady engagement. 
I want to thank Univ.-Prof. Dr. Martina Sester for the friendly willingness to write the 
second opinion of this work. 
Thank you to all our African and German cooperation partners, especially of the African-
German-StaphNet, for provision of isolates, interesting discussions, suggestions and 
fruitful collaboration. 
I thank Univ.-Prof. Dr. Volkhard Helms and especially Dr. Ruslan Akulenko for their 
bioinformatic support and their patience in explaining me everything.  
Thanks to my first medical students, Sabine Schubert and Laura Stichter, for the isolate 
collection work at the university clinic of Homburg. Thank you to our scientific 
guestworkers, Theckla Kazimoto and Delfino Vubil. Thanks to Adebayo Shittu, my 
brother, who supports me in my first “real” English steps. Especially, thank you all for the 
great time and your patience with your unexperienced teacher. 
I would like to thank Eloise Müller-Schulte and Sarah Wendlandt for proofreading. 
Thanks a lot to Rosmarie Gaupp and Robert Skov not only for proofreading, but also for 
his suggestions, constructive criticism and support. 
Thank you to all colleagues of the institute, especially Susanne Loibl, Sabine Freis and 
Karin Hilgert, for the friendly working atmosphere and support in the diagnostic and 
research lab. 
Thanks to my parents and my friends for their support and interest in my work. 
Finally, special thank to my spouse, his support and patience. 
